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The bloodstream form of Trypanosoma brucei differentiates into the stumpy form in 
the mammalian bloodstream, completing differentiation into the procyclic form on 
uptake by the tsetse fly.  The underlying genetic events occurring during this 
differentiation process in pleomorphic cell lines were investigated through whole-
genome microarray studies of key time points during differentiation from stumpy 
form cells to the procyclic form found in the insect midgut.  The microarray was 
extensively validated and bioinformatic experiments conducted to detect motifs over 
represented in stumpy form or slender form cells.  A positional-dependent motif was 
identified that was over represented in stumpy form cells, possibly representing a 
regulatory domain.  The transcripts found to be enriched in stumpy form cells 
included a chloride channel, although RNAi directed against this gene showed no 
phenotype, suggesting the protein is redundant, as three other homologous proteins 
exist in the genome and showed similar mRNA profiles on the microarray.  
 
Stumpy form cells are G0 arrested and two proteins implicated in G0/G1 regulation 
in other organisms, Target of Rapamycin (Tor) and Cdh1, were investigated in T. 
brucei to determine whether these proteins were involved in differentiation.  The 
result of depletion of either protein was rapid cell death in bloodstream form cells, 
although treatment with the drug rapamycin did not have any effect on the cells in 
contrast to other eukaryotes where this drug causes G1 arrest.  A method for 
synchronisation of bloodstream form cells was also designed using a supravital dye 
and flow cytometry to allow investigation into cell cycle-dependent processes.  This 
method was particularly suitable for harvesting populations enriched in G0/G1 stage 
cells, however differentiation of the isolated G0/G1 and G2/M populations did not 
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1 - Introduction 
1.1 African Sleeping Sickness 
The parasitic kinetoplastid Trypanosoma brucei is the causative agent of both human 
African sleeping sickness (HAT) and the animal wasting disease Nagana in sub-
Saharan Africa.  The human disease can be caused by one of two subspecies, 
T.b.gambiense and T.b.rhodesiense, resulting in a chronic or acute infection 
respectively.  The parasite carries out part of its life cycle in the tsetse fly and is 
spread into the mammalian host when the fly takes a bloodmeal.  The vector is found 
across a third of the African continent (Kennedy, 2008), however instances of 
African sleeping sickness occur in discrete foci (Hide and Tait, 2006).  Most cases of 
HAT are caused by the chronic T.b.gambiense form (Fevre et al., 2008), and 
measures aimed at controlling the number of human cases have been highly 
successful in reducing the spread of the disease as an animal reservoir of this 
subspecies is considered relatively insignificant for the transmission of the parasite, 
in contrast to the T.b.rhodesiense form (Simarro et al., 2008).  A recently established 
database aims to generate an atlas of HAT cases, as has been initiated for malaria 
(http://www.map.ox.ac.uk/), to better understand the epidemiology of the disease.  
Figure 1.1 shows some of the preliminary data from this project including, 
importantly, those areas screened that were negative for cases of sleeping sickness 
(Cecchi et al., 2009).  
 
A parasite infection is detrimental to the fly because exposure to the parasites 
triggers the immune response, which is an energy-requiring process and necessitates 
a reduction in fecundity (Hu et al., 2008).  Thus, most instances of trypanosome 
uptake with a bloodmeal do not result in infection, as the parasites are destroyed in 
the tsetse midgut (Krafsur, 2009).  Indeed, tsetse flies have established relationships 
with maternally-inherited endosymbionts such as Wigglesworthia through expression 
of a tsetse peptidoglycan recognition protein that prevents the fly’s immune system 
from destroying these cells (Wang et al., 2009).  The presence of several species of 
symbionts prevents establishment of a trypanosome infection, possibly through the 
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release by the symbionts of lectins in response the bloodmeal, which effectively 
destroy the parasites (Welburn and Maudlin, 1999).  However, once a trypanosome 
population is established, the fly will remain infective for the duration of its lifespan 
(Kennedy, 2008). 
 
Figure 1.1. Local level mapping of HAT cases compiled as part of the HAT 
atlas project.  Incidences of sleeping sickness and screening events leading to the 
identification of no cases can be mapped accurately enabling better understanding 
of the epidemiology of HAT (Cecchi et al., 2009). 
The disease in humans has two distinct phases; in the early stage the symptoms are 
general and can be confused with those for other diseases, with typical symptoms 
including fever and possibly a skin rash.  However, it is the symptoms arising during 
the second stage that are the hallmark of the disease and to which the disease owes 
its name; once the parasites have crossed the blood-brain barrier and infected the 
central nervous system, the patient experiences disrupted sleeping patterns which 
eventually lead to coma and death (Kennedy, 2008).  At present only four drugs are 
prescribed for the treatment of HAT, two of which are available for the early disease, 
prior to the parasite crossing the blood brain barrier.  Treatment for the late stage of 
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the disease is by either eflornithine (for only T.b.gambiense) or melarsoprol (for 
either subspecies), which has a range of side effects including death in 5% of patients 
who go on to develop neurological problems.  Recently the use of nifurtimox, 
traditionally used to treat South American trypanosomiasis, has been partially 
successful in clearing parasites that prove resistant to other drug treatments (Rodgers, 
2009).  All these drugs require lengthy courses of administration, often 
intravenously.  A better treatment regime for the stage two T.b.gambiense infection 
that has recently passed phase III clinical trials, uses a combination of nifurtimox 
with eflornithine, allowing the treatment to be completed sooner than with 
eflornithine alone, without such an intensive regime of infusions, resulting in fewer 
adverse side effects (Priotto et al., 2009).  The use of a combination of drugs is 
always preferred as the chance of the parasite developing resistance to the drugs is 
much reduced.    
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1.2 Life cycle 
 
Figure 1.2.  Life cycle diagram of T. brucei.  Drawings showing the morphological 
changes of T. brucei as it differentiates into the different forms for survival in the 
tsetse salivary glands and midgut and the mammalian bloodstream (Vickerman, 
1985).  The epimastigotes show modification of the flagellum for attachment to the 
salivary gland, which is lost as the cells differentiate into the metacyclic form which 
is injected into the mammalian bloodstream when the fly feeds.  The metacyclic form 
differentiates into the slender form in the bloodstream, which in turn differentiates 
into the stumpy form via an intermediate form in response to density- dependent 
signalling.  The stumpy form is preadapted for uptake into the tsetse fly, and 
differentiates rapidly into the procyclic form, which crosses into the salivary glands 
through differentiation in the mesocyclic form. 
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1.2.1. Cell structure 
The procyclic form trypanosome cell is around 15µm by 3µm in size (Sherwin and 
Gull, 1989), however the morphology of the cells changes dramatically as cells 
progress through the different stages of the life cycle (Figure 1.2) (Vickerman, 1985).  
All life stages have a flagellum, which exits the cell at the flagella pocket towards the 
posterior of the cell; the only site of endo- and exocytosis (Sherwin and Gull, 1989).  
Internally, the organelles of T. brucei are kept strictly controlled in terms of number 
and positioning during the different life cycle stages, including the kinetoplast.  The 
presence of a kinetoplast is a unique feature of all kinetoplastid organisms, where 
this disc shaped organelle contains the DNA from the single mitochondrion (Liu et 
al., 2005).  
1.2.2 Procyclic forms 
T. brucei stumpy form cells are transmitted between mammalian hosts using, as a 
vector, the tsetse fly.  The number of parasites present in the midgut of the fly three 
days post infection is a fraction of the number that are uptaken.  This is due to the 
high levels of parasite death that occur as parasites adapt to the new environment, but 
those surviving after this time will then resume proliferation as a trypomastigote 
procyclic population (Van Den Abbeele et al., 1999).  As stumpy forms complete 
differentiation to the procyclic form in the midgut, the mitochondrion of the cell 
rapidly becomes more elaborated, with the formation of a branched network of 
cristae, as the metabolic requirements of the cell change with the new environment 
(Vickerman et al., 1988).  Other morphological changes accompanying 
differentiation include the repositioning of the kinetoplast from the extreme posterior 
of the cell, towards the nucleus, facilitated through the elongation of the posterior of 
the cell through the extension of cytoskeletal microtubules, although the reason for 
this is not known (Matthews et al., 1995).  Once the differentiation process to 
procyclic form is completed the cells begin proliferation and the kinetoplasts will 
segregate.  However, kinetoplast segregation can be uncoupled in cells that are 
unable to reposition their kinetoplasts, showing that differentiation events, although 
occurring in a strictly ordered manner, are not completely interdependent (Hendriks 
and Matthews, 2005).  The variant surface glycoproteins (VSG) coat covering the 
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bloodstream form cell is not necessary in procyclic form cells, which instead are 
coated with a more sparse coat of procyclins, named after the repetitive amino acids 
found within them, with up to 27 ‘EP’ repeats found in the EP procyclins, and five 
‘GPEET’ repeats in GPEET procyclins.  In contrast to the vast array of VSG proteins 
in bloodstream form cells, only three procyclin proteins are expressed on the surface 
of procyclic form cells in vivo with all three of these expressed during the early 
stages of a midgut infection; GPEET, EP1 and EP3, although with time, GPEET 
expression is lost (Acosta-Serrano et al., 2001).  A fourth protein, EP2, can also be 
expressed but has not been detected in tsetse midgut infections (Acosta-Serrano et 
al., 2001).  The function of the procyclin coat is a mystery; complete depletion of all 
EP and GPEET genes is not overly detrimental to cells and they are still able to 
infect tsetse flies, although the procyclin depleted cell lines are easily out-competed 
by wild type infections with intact procyclin coats (Vassella et al., 2009).  However, 
potential functions for the EP surface coat include protection from proteases found in 
the insect midgut, or as signalling proteins generated by the removal of their N 
glycan (Acosta-Serrano et al., 2001).  Other cellular features that are less active in 
this life stage are also down graded, such as endocytosis, which plays an important 
role in bloodstream form cells, possibly as a method to rapidly remove immune 
system proteins from the surface of cells (Engstler et al., 2007).  Such a process is 
not required in procyclic form cells and, consequently, the proteins required for 
endocytosis are seen to rapidly fall as cells differentiate from the stumpy form into 
the procyclic form (Natesan et al., 2007).  Procyclic form cells must migrate to the 
salivary glands in order to allow future transmission, so first the cells breach the 
peritrophic membrane to invade the endoperitrophic space and differentiate into 
mesocyclic form cells (Vickerman, 1985). 
1.2.3 Epimastigote form 
Mesocyclic trypomastigotes are arrested in G0/G1, presumably induced through a 
factor present in the midgut or nutrient limitation, as removal of these cells into 
culture triggers them to resume proliferation immediately (Van Den Abbeele et al., 
1999).  Once the mesocyclic trypomastigotes are released from their cell cycle arrest, 
they differentiate into a long epimastigote form.  The epimastigote form is unusual in 
that it divides asymmetrically, such that one daughter cell is long like the parental 
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cell, whereas the other is much shorter.  Only the shorter form is capable of attaching 
to the salivary gland due to the specialised nature of its flagellum, but the long form 
is required for migration to the salivary gland as the short flagellum of the short form 
impairs its motility (Van Den Abbeele et al., 1999).  Epimastigote form parasites 
express a BARP surface coat (brucei alanine-rich proteins), although the function of 
this surface coat is unknown (Urwyler et al., 2007).  These cells also start to show an 
increase in endocytosis again, possibly as a pre-adaptation for life in the mammalian 
host until, once the cells differentiate into the metacyclic form, the levels of 
endocytosis almost reach the same level as bloodstream form trypanosomes (Natesan 
et al., 2007). 
1.2.4. Metacyclic form 
The epimastigote form differentiates into the metacyclic form whilst still attached to 
the salivary glands, but once formed, the metacyclic cell is released from the 
epithelial wall to allow transmission the next time the insect takes up a bloodmeal 
(Vickerman et al., 1988).  The attachment to the salivary gland is required for the 
differentiation to the metacyclic form, as shaking cultures of T. congolense (which 
can complete the life cycle in vitro) prevents differentiation, although the 
epimastigote forms are still capable of proliferation (Vickerman et al., 1988). Release 
from the epithelial cells is possible due to the modification of the flagellum in 
metacyclic forms cells, which becomes smaller and unbranched and so terminating 
attachment (Vickerman et al., 1988).  The differentiation of epimastigotes to 
metacyclics is not synchronous within the population, with parasites at all stages of 
development found in close proximity in the salivary glands (Tetley et al., 1987).  
Prior to injection into a mammalian host, the parasites must again express a VSG 
coat, although metacyclic cells use a different repertoire of VSGs to those used in 
slender cells.  These metacyclic VSGs (MVSGs), in contrast to bloodstream form 
VSGs, are expressed monocistronically, although in common with bloodstream 
VSGs, they are transcribed using RNA polymerase I (Barry et al., 1998).  These 
genes are located at telomeric regions, which allows them to be effectively silenced 
in the other life stages of the parasite when MVSGs are not required (Ginger et al., 
2002).  The repertoire of MVSGs is much more limited than the bloodstream form 
VSGs, with only around 27 different genes to chose from, and interestingly the 
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nascent metacyclics do not express the same surface antigen as each other (Tetley et 
al., 1987).  It has been suggested that the heterogeneity of MVSGs expressed by the 
trypanosome population is a defence against the immune system of the mammalian 
host, which may have previously experienced a T. brucei infection and thus raised 
antibodies against some of the MVSGs (Barry et al., 1998).    
1.2.5 Bloodstream slender form 
Trypanosomes are released into the dermal connective tissue of the host when the 
tsetse fly feeds, and from here the parasites migrate into the bloodstream via the 
lymphatic drainage system (Vickerman, 1985).  The slender form cells present in the 
mammalian host are free living in the bloodstream and must evade clearance by the 
immune system and so have evolved a mechanism of expressing a dense surface coat 
of proteins solely to shield the essential immunogenic receptors.  This surface coat is 
comprised of VSGs are routinely switched, so that whilst the majority of cells will be 
cleared through an antibody attack, a few cells will express a different surface coat 
and will not be recognised by the immune system, meaning the parasite infection is 
never entirely eliminated from the bloodstream (Seed and Wenck, 2003).  
Bloodstream form parasites exclusively use glycolysis to generate energy, exploiting 
the plentiful glucose available in the blood, and so the mitochondrion of these cells is 
relatively undeveloped, lacking cristae and consequently inactive with respect to 
ATP generation (Vickerman, 1965). 
1.2.6 Stumpy form 
A universal agreement cannot be reached upon whether stumpy forms are the pre-
adapted cells required to survive uptake by a tsetse fly or whether they represent 
dying cells, which merely act to limit parasite numbers in the bloodstream. The 
switch from slender form to stumpy forms, which are unable to vary the VSG coat, 
means that these are rapidly cleared from the bloodstream by the host immune 
system unless they are taken up by a tsetse fly.  The fluctuating levels of 
parasitaemia that are generated from this periodic clearing of the majority of the 
trypanosomes allows the infection to continue in a host much longer than in a 
monomorphic infection, where a single parasite can cause death within five days 
(Seed and Wenck, 2003).  Certainly stumpy cells are growth arrested and 
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differentiation from the slender form is irreversible, leading to the hypothesis that 
this differentiation event is used to lower parasitaemia and thus prevent death of the 
host (Seed and Wenck, 2003, Tyler, 2003).  The process of slender forms 
differentiating into stumpy form cells is clearly a major determinant of the 
progression of an infection and has been used as one of the main variables in a 
mathematical model developed to predict antigenic variation during a parasitaemia 
(Lythgoe et al., 2007).    
 
A number of features inherent to stumpy forms make them good candidates for 
uptake into the tsetse fly.  In response to acidic environments, slender form cells 
show an increase in cytoplasmic pH, lose their VSG coat and rapidly die, whereas 
the cytoplasmic pH of stumpy form cells remains unaltered and they show no 
sensitivity to acid treatment (Nolan et al., 2000).  Stumpy cells also show much 
higher resistance to proteases than slender cells, which the cells would be expected to 
encounter on uptake into the fly midgut (Sbicego et al., 1999, Nolan et al., 2000).  
Interestingly, stumpy cells are also more resistant to antibody-mediated killing whilst 
in the host bloodstream than slender cells (McLintock et al., 1993), a useful attribute 
considering these cells are incapable of switching their VSG coat.  The mechanism 
for this immune-system resistance appears to stem from the increased rate of 
endocytosis (Engstler et al., 2007).  The motion of the swimming parasite allows the 
VSG surface coat, and any immunoglobulins attached to it, to be forced towards to 
posterior of the cells where the flagella pocket is situated where both are exported 
into the cells, with the VSG recycled and the immunoglobulin destroyed in the 
lysosomes (Engstler et al., 2007). 
 
Significantly, the mitochondrion of stumpy form cells is larger than slender cells, and 
a small number of cristae are formed, reflecting the ability of the cells to initiate 
mitochondrial metabolism upon uptake into the fly where the source of energy is no 
longer glucose, but proline (Vickerman, 1965).  The activation of the mitochondria in 
differentiating cells appears to initiate in ‘intermediate’ cells; these are cells still 
slender in appearance, but having committed to differentiate into stumpy forms.  The 
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pre-emptive activation of a mitochondria is a useful attribute for stumpy cells, as 
once they are ingested into the tsetse fly midgut, the residual glucose from the 
bloodstream disappears in as little as 15 minutes, thus a rapid change in metabolism 
is required (Milne et al., 1998).  Indeed, studies examining the activity of the 
mitochondria in pleomorphic bloodstream form populations have shown that both 
intermediate and stumpy form cells accumulate rhodamine 123, a dye that is 
confined to mitochondria only when a membrane potential is maintained (Bienen et 
al., 1991).  In slender cells, in contrast, the dye is dispersed throughout the cytoplasm 
showing that the mitochondria in this life form does not maintain the membrane 
potential and thus cannot be active (Bienen et al., 1991).  Therefore, even prior to the 
morphological events that allow discrimination of stumpy form cells, the cells are 
already switching over their metabolic functions in preparation for transmission.  
Despite this, slender form cells devoid of kinetoplasts (diskinetoplastid cells) created 
through treatment with intercalating dyes, have been shown to successfully complete 
differentiation into the stumpy form, although these parasites are unable to enter the 
cell cycle to become proliferative procyclic form cells (Timms et al., 2002). 
 
One other adaptation that stumpy form cells undergo is to prime themselves to 
receive the differentiation trigger they will be exposed to in the midgut.  It is known 
that cold shock enhances the differentiation of stumpy form cells to procyclic forms 
when exposed to cis aconitate or citrate, and recently the genes encoding the 
transporter for these molecules was characterised (Dean et al., 2009).  Stumpy form 
cells initiate expression of PAD1 and PAD2 which, under cold shock conditions, are 
exported to the cell surface thus allowing active importation of cis aconitate or citrate 
resulting in differentiation to the procyclic form (Dean et al., 2009). 
1.3 Differentiation of slender to procyclic form  
The appearance of stumpy form cells in the bloodstream has been found to occur in a 
density dependent manner, such that once a critical threshold has been reached, the 
cells will differentiate from the proliferating slender form into the growth arrested 
stumpy form (Reuner et al., 1997).  In has been hypothesised that a substance of low 
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molecular weight, termed Stumpy Induction Factor (SIF), is secreted from the 
parasites and gradually accumulates, which crosses the cell membrane and triggers 
differentiation (Vassella et al., 1997).  Culture adapted cells lose the ability to 
differentiate in response to SIF and form monomorphic populations of homogenous 
slender forms, which are unable to progress into the stumpy life cycle stage (Fenn 
and Matthews, 2007, Vassella et al., 1997).  Whilst these cell lines will not 
differentiate when stimulated with SIF-containing medium, addition of cis-aconitate 
coupled with temperature reduction to 27˚C induces the monomorphic cells to 
undergo a non-synchronous differentiation from bloodstream form to procyclic form 
(Ziegelbauer et al., 1990).  This in vitro differentiation can be induced through 
addition of cis-aconitate or citrate, but not any other of the Kreb cycle intermediates 
(Sbicego et al., 1999, Brun and Schonenberger, 1981). 
 
Cyclic AMP (cAMP) was known to show differential levels throughout the parasite 
development cycle, and further study demonstrated that pCPTcAMP, a derivative of 
cAMP which is capable of crossing the cell membrane, caused differentiation of 
slender cells into stumpy form cells (Vassella et al., 1997, Breidbach et al., 2002).  
This differentiation event was even possible in monomorphic cell lines that were 
unable to differentiate in response to SIF, suggesting that cAMP was a downstream 
messenger in the SIF pathway (Vassella et al., 1997, Breidbach et al., 2002).  A more 
recent study however, has shown that the products formed from hydrolysis of cAMP 
analogues are even more potent at inducing differentiation from slender form to 
stumpy forms, and that analogues resistant to hydrolysis were unable to trigger 
differentiation, effectively demonstrating that it is the hydrolysis products of cAMP 
that are responsible for differentiation (Laxman et al., 2006).  Other chemical triggers 
will also induce differentiation from slender form to stumpy form, including the 
diabetic drug troglitazone which causes pleomorphic cells to take up a ‘stumpy-like’ 
morphology, although in monomorphic cells treatment with this drug does not result 
in cell cycle arrest (Denninger et al., 2007).  Other differentiation triggers which are 
more likely to be representative of the events in the fly midgut include pronase, 
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trypsin and thermolysin, but addition of any of these into the medium of cells also 
caused high levels of cell death, at least among slender cells (Sbicego et al., 1999).  
Cold shock of more than 15˚C has been shown to be sufficient to cause slender form 
cells to express EP, however the EP protein is retained within the cells (Engstler and 
Boshart, 2004).  Interestingly, stumpy form cells subjected to cold shock also express 
EP but direct it to the cell surface (Engstler and Boshart, 2004).  The cold shock of 
stumpy form cells also made them hypersensitive to cis aconitate, such that the 
concentration required to trigger differentiation was reduced to within the 
micromolar range (Engstler and Boshart, 2004).  Subsequently, PAD2 was found to 
have increased expression in cells subjected to cold shock and the temperature 
change also caused this transporter protein to be routed onto the surface of the cells, 
in which position the protein allows the uptake of cis aconitate, thus triggering 
differentiation (Dean et al., 2009).  The role of the temperature reduction in 
differentiation is intriguing; differentiation of stumpy form cells can be triggered 
through addition of cis-aconitate without an accompanying temperature reduction to 
27˚C, but these cells are unable to re-enter the cell cycle to become proliferative 
procyclic form cells (Matthews and Gull, 1997).  The result of this, and previous 
studies (Matthews and Gull, 1994), has shown that differentiation from the stumpy 
form and cell cycle re-entry can be separated, which is interesting as the two events 
are required to act in tandem for successful establishment of an infection in the tsetse 
fly.    
1.4 Cell cycle 
The cell cycle of T. brucei varies significantly from the highly conserved events that 
are seen in most eukaryotic cells.  Major cell cycle checkpoints are absent (McKean, 
2003) and the mitochondrial DNA present in the kinetoplast is replicated in an 
ordered fashion in conjunction with the nuclear DNA replication, and has been 
implicated as being responsible for a novel checkpoint (Ploubidou et al., 1999). 
Using the microtubule inhibitor rhizoxin, it was discovered that a point existed 
towards to final stages of nuclear S phases when the drug had no effect on cells, 
whereas addition of rhizoxin at earlier points, when the kinetoplast was also in S 
phase, caused mitotic defects resulting in divisions where one daughter had two 
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nuclei and the other one none (Ploubidou et al., 1999).  This generated anucleate 
cytoplasts, called zoids.   
 
Under normal conditions, the events for the cell cycle are highly predictable, with the 
length of the cell cycle in procyclic forms having been variously shown to range 
from 8.5 hours (Woodward and Gull, 1990) to over 12 hours (Siegel et al., 2008a, 
Siegel et al., 2008b).  Detailed analysis of the bloodstream form cell cycle has not 
been conducted, but from even the limited data we have so far, it is predicted that it 
would vary from procyclic form cells significantly.  Differences between the cell 
cycle of bloodstream form cells and procyclic form cells known so far include the 
length of the cell cycle, which, at six hours, is considerably shorter in bloodstream 
form cells (Vickerman, 1985), to the consequences of depletion of cell cycle genes 
resulting in different phenotypes between bloodstream form cells and procyclic form 
cells (Hammarton et al., 2003, Hammarton et al., 2004, Kumar and Wang, 2005, 
Janzen et al., 2006, Li and Wang, 2006, Gourguechon and Wang, 2009).  
 
In the procyclic form cell, the basal body is formed from the immature pro-basal 
body early on in G1, prior to replication of any other organelle, and from this the 
daughter flagellum starts to grow (McKean, 2003) (Figure 1.3A).  The nascent 
flagellum grows along the length of the parental flagellum, attaching via the flagella 
connector (Figure 1.3B), a feature that is not present in the bloodstream form cells 
(Briggs et al., 2004).  After this, the Golgi apparatus duplicates and then the basal 
bodies and Golgi separate, in a manner that appears to be coupled (Hammarton, 
2007).  The migration of the basal bodies initiates before the daughter flagellum has 
reached its full length (Sherwin and Gull, 1989).  The basal bodies are physically 
associated with the kinetoplasts, thus the separation of the basal bodies also results in 
separation of the kinetoplasts (McKean, 2003).  Prior to cytokinesis, two new pro-
basal bodies are generated, which are inherited along with the mature basal body, 
preparing the daughter cells for further proliferation once cytokinesis is completed 












Figure 1.3.  Diagram of procyclic form cell cycle progression.  (A) A cell 
entering the cell cycle has a single copy of the nucleus, basal body, nucleus and 
kinetoplast.  (B) In early S phase a new flagellum grows from the replicated basal 
body. (C) Cytokinesis progresses from the anterior to the posterior of the cell 
(arrow).  (Vaughan and Gull, 2008) 
1.4.1 DNA replication 
Kinetoplast DNA is arranged into approximately 50 maxicircles over 20kb in length, 
mostly comprising genes coding for rRNA and proteins required for respiration, as is 
the case for the mitochondrial genomes of most organisms (Liu et al., 2005).  
Separate to the protein coding sequences found on the maxicircles, thousands of 
minicircles contain the sequences for guide RNAs, these being used to allow editing 
of the transcripts generated from the maxicircles (Liu et al., 2005).  These minicircles 
are all interlocked, and so must be released and move towards to mitochondrial 
membrane, where the minicircle replication machinery is situated in order to 
replicate.  This contrasts with the maxicircles which are not released from the 
network during replication (Liu et al., 2005).  
 
The nuclear DNA is arranged into 11 megabase chromosomes and a large number of 
minichromosomes, the telomeric regions of which appear to harbour VSGs with the 
remainder of the sequence consisting of tandem repeats (El-Sayed et al., 2000).  A 
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final DNA element in T. brucei is the intermediate chromosomes which do not 
appear to have any necessary genes, but which appear to harbour VSG genes.  The 
number of these chromosomes does not seem to be strictly important, with different 
stocks of cells showing varying numbers of intermediate chromosomes (El-Sayed et 
al., 2000).   Replication of all chromosomes initiates shortly after that of the 
kinetoplast, but takes longer, not being completed until half way through kinetoplast 
G2 phase (Figure 1.4). 
 
Once all the cellular contents are duplicated and arranged appropriately, a cleavage 
furrow appears between the two nuclei and basal bodies (Sherwin and Gull, 1989).   
Cytokinesis is initiated from the anterior of the cell (Figure 1.3C), following the 
cleavage furrow and takes approximately 0.1 unit of the cell cycle to complete in 
procyclic form cells (Figure 1.4), but is much faster in bloodstream form cells 
















Figure 1.4.  Schematic diagram of sequential events of the cell cycle in 
procyclic T. brucei.  The diagram shows the time intervals for G1, S, and G2 
phases of the cell cycle for both the nuclear and kinetoplast DNA.  The ‘D’ phase of 
kinetoplast replication is the point at which the daughter kinetoplast segregates and 
is followed by the ‘A’ phase; the apportioning phase, which encompasses the time 
that the basal bodies continue to move apart.  Mitosis of the nuclear DNA does not 
occur until part way through the apportioning phase of the kinetoplast division and is 
followed by cytokinesis (C).  Due to the staggering of the duplication of the two types 
of DNA, visualising of the DNA of the cell during the cell cycle allows identification of 
cells with different karyotypes.  The 1K1N arrangement is seen for the majority of 
the cell cycle with the 2K1N karyotype present for 0.15 units of replication and 2K2N 
for the remaining 0.1 unit (Modified from McKean, 2003). 
As can be seen, the duplication of the organelles and DNA is tightly linked, however 
treatment with a number of drugs, and mutations of a range of cell cycle related 
genes have been found to uncouple cytokinesis from mitosis (Das et al., 1994).  This 
is not possible in other eukaryotes due to the presence of a checkpoint prior to 
cytokinesis, which is absent in T. brucei (Ploubidou et al., 1999).   
1.5 Differentiation and cell cycle position 
Cell cycle position appears to be intimately linked with differentiation of the 
parasites; in both the mammalian and insect host, cells preparing for transmission 
into the next host are arrested in G0/G1 and only initiate differentiation and cell 
cycle re-entry upon successful passage into the next environment. Stumpy forms are 
arrested in G0/G1, allowing them to proceed through differentiation in a synchronous 
manner, although the exact role of the cell cycle in differentiation is unclear (Li et 
1K1N   2K1N 2K2N 
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al., 2003, Matthews and Gull, 1994, Mutomba and Wang, 1996).  Some doubts have 
been cast on the requirement of G0 arrest for differentiation, as cells stimulated to 
arrest in different stages of the cell cycle are seen to differentiate with equal 
efficiency (Li et al., 2003, Mutomba and Wang, 1996).  However the methods used 
to arrest the cells, namely treatment with toxic doses of aphidicolin or hydroxyurea 
(Mutomba and Wang, 1996) and depletion of subunits of the proteosome (Li et al., 
2003), were invariably lethal.  Hence the results must be interpreted with care, as 
dying cells are known to undergo some differentiation events (eg mitochondrial 
activation, surface antigen exchange) as a default pathway.  For example, Mutomba 
and Wang (1996) used aphidicolin or high doses of hydroxyurea to attempt to 
synchronise cells before mitosis or before cytokinesis respectively, before inducing 
the cells to differentiate with cis aconitate addition and temperature reduction.  The 
authors saw no difference between cells in different cell cycle stages and their ability 
to differentiate.  However, the cells had been incubated with the drugs for 12 hours 
and so were severely stressed, and hence clear conclusions cannot be reached from 
these experiments (Mutomba and Wang, 1996).   
 
Bass and Wang (1991) also conducted differentiation experiments to demonstrate 
that slender, intermediate and stumpy forms were all able to differentiate in vitro to 
procyclic form cells with the same kinetics, concluding that stumpy forms were not 
required for successful differentiation.  However, the classification in this study that 
a cell was differentiated relied solely on morphological traits rather than using other 
markers such as surface proteins or cell cycle position, and thus accurate 
differentiation kinetics could not be determined from this experiment (Bass and 
Wang, 1991).  In contrast to these studies, evidence also exists to show that stumpy 
cells initiated to differentiate proceed through the cell cycle synchronously, 
suggesting that the cells must first be primed at G1 (Matthews and Gull, 1994).  
Supporting this, tracking the re-entry of stumpy form cells into the cell cycle by 
uptake of BrdU during differentiation revealed that most cells initiate S phase 
between 6-8 hours after initiation of differentiation (Matthews and Gull, 1994).  
Slender form cells, in contrast, differentiate in an inefficient, asynchronous fashion, 
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and tracking of re-entry into the cell cycle of these cells showed that their BrdU 
incorporation occurred with the same kinetics as differentiation, suggesting that those 
cells that initiate differentiation, do so in a cell cycle specific fashion (Matthews and 
Gull, 1994).  The authors designed a model to demonstrate the role of cell cycle 
position with capacity to differentiate (Figure 1.5).  This shows the possible 
outcomes for bloodstream form cells upon reception of the differentiation signal; 
stumpy cells (A) are prepared for differentiation, already arrested in G0/G1 and in 
response to the differentiation signal, they differentiate readily.  For the slender cells 
in the population, three remaining options remain, (B) those cells at the ‘receptive’ 
point in the cell cycle, probably G1, are able to differentiate, however those not at the 
receptive window (C) can either continue progressing through the cell cycle until 
reaching the receptive window, where upon they may differentiate.  Alternatively the 
cells will arrest in response to the unfavourable conditions and die (Matthews and 
Gull, 1994).  This theory supports previous observations from differentiation 
experiments conducted on monomorphic cell lines, which were shown to 
differentiate into procyclic forms in an asynchronous manner (Ziegelbauer et al., 
1990), suggesting that these cells must first reach the optimum point in the cell cycle 



























Figure 1.5.  Model for initiation of differentiation.  Arrowheads denote position of 
a trypanosome in the cell cycle in relation to the window in which cells are receptive 
to differentiation (filled box).  (A) Stumpy cells are G0/G1 arrested and committed to 
differentiation and thus in the receptive window. (B) Slender cells in the receptive 
window will also differentiate.  (C) Slender cells not in the receptive window may 
either progress through the remainder of the cell cycle and differentiate, or arrest 
and die (Matthews and Gull, 1994). 
However, Matthews and Gull (1994) then went on to show that returning to a 
proliferative status does not need to occur in tandem with other features of 
differentiation.  Thus, treating stumpy form cells with aphidicolin in order to block 
DNA synthesis had no effect on differentiation, despite all cells having arrested 
before S phase (Matthews and Gull, 1994).  Similarly, inhibition of cell cycle 
progression during differentiation of monomorphic bloodstream form cells also 
confirmed that growth arrested cells were able to differentiate into morphological 
procyclic form but were unable to resume proliferation (Mutomba and Wang, 1998).  
























which caused cells to exchange antigenic coats as expected but not to re-enter the 
cell cycle (Matthews and Gull, 1997).   
 
Further evidence concerning the role of G0 arrest in differentiation was provided 
from a study looking at a protein tyrosine phosphatase (TbPTP1), which was 
required to maintain G0 arrest and whose removal resulted in the spontaneous 
differentiation of stumpy form cells (Szoor et al., 2006).  Strikingly, a subset of 
slender form cells could also be triggered to differentiate into the procyclic form 
upon depletion of TbPTP1, and it was proposed that these cells had already 
undergone cell cycle arrest, and were thus primed for differentiation (Szoor et al., 
2006).  Taking into account the evidence from all published experiments, it appears 
as though, whilst G0/G1 arrest appears to be beneficial for stumpy form cells in order 
to progress through differentiation in a synchronous manner, it is not certain that a 
specific cell cycle position is absolutely required for differentiation.  
1.6 Cell cycle synchronisation 
If a method for synchronisation of T. brucei populations existed, the cell cycle of the 
parasite would be able to be studied in much greater detail, and debates over the role 
of cell cycle position in differentiation could be resolved.  However trypanosomes 
have proved difficult to synchronise using standard techniques to arrest cells such as 
chemicals or serum starvation. 
1.6.1 Block-release induced synchronisation 
Chemicals used to synchronise populations in other organisms have been trialled on 
T. brucei cultures, including hydroxyurea (HU) and aphidicolin (APH), which cause 
cell cycle arrest through preventing synthesis of dNTPs and inhibiting the action of 
DNA polymerase α respectively.  Historically these methods were not routinely 
utilised for synchronising trypanosomes as the drugs proved toxic to the cells 
(Mutomba and Wang, 1996), however recent work has optimised the dosage and 
length of treatment with these drugs to find concentrations low enough to arrest cell 
growth without lethality (Chowdhury et al., 2008, Forsythe et al., 2008).  The 
optimum dose to arrest bloodstream form cells was 10µM HU, with cells completely 
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arrested after nine hours, although incubation for longer than this was lethal 
(Forsythe et al., 2008).  If cells were removed from the drug after six hours it was 
possible to get a population comprising 75% cells with the 2K1N configuration, 
which, if the size and shape of the kinetoplasts of the 1K1N cells were examined, 
could be classed as S phase cells for <90% of the cells (Forsythe et al., 2008).  When 
cells were released from the drug, 35% of cells were found to be in the 2K2N 
configuration three hours after release.  This relative synchrony was not maintained 
however, and so this method was not suitable for isolating pure populations of G1 
stage cells. 
 
Serum starvation has also been attempted with varying success; whilst partial 
synchrony as been recorded previously (Gale et al., 1994a, Gale et al., 1994b), this 
method proved hard to reproduce, at least until recently optimised (Archer et al., 
2009).  In this approach, procyclic form cells were grown for two days until the 
density of the population was between 2-4x107cells/ml.  At this point the media was 
depleted of nutrients, such that the cells were effectively starved with population 
growth having reached a plateau with the majority of the population stalled in G1 
(Archer et al., 2009).  Dilution of these cells into fresh media then allowed the cells 
to resume proliferation in a semi-synchronous manner.  The limitation of this method 
of synchronisation, however, is that it is confined to procyclic cells alone, as 
bloodstream forms are extremely sensitive to serum deprivation. 
 
All of the above methodologies are intrinsically flawed since artificially inducing cell 
cycle arrest does not necessarily inhibit cell growth (Cooper, 2003).  Hence, cells 
with incomplete DNA replication will continue expanding cellular mass during their 
cell cycle inhibition and upon release, all cells will progress forward into the next 
cell cycle size regardless of cell size.  Abundance of cell cycle regulated transcripts 
was shown to be uncoupled from DNA replication in human cells arrested with a 
variety of cell cycle inhibitors, representing a perturbation of the normal relationship 
between cell growth and cell division (Urbani et al., 1995).  Considering also the 
toxicity of the chemical inhibitors of cell cycle, even using low doses renders it 
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difficult to interpret results yielded from these cells, as obstruction of the cell cycle 
will invariably stress the cells, having downstream effects on a variety of cellular 
activities including gene expression.  Numerous microarrays have been launched to 
find cell cycle regulated genes in yeast cells synchronised in different ways, yet 
scrutiny of the results shows that the cells were not truly synchronous, and few genes 
demonstrating cell cycle differential expression overlapped between the different 
synchronisation methods (Cooper and Shedden, 2003). 
1.6.2 Sorting cells based upon cell cycle position 
Preferably cells should be sorted according to the cell cycle stage they are naturally 
in, using a ‘selective’ method such as elutriation where cells are separated according 
to size, rather than a batch ‘block and release’ method (Cooper, 2004) such as HU 
treatment.  Better still is a situation where newly separated daughter cells can be 
isolated after cytokinesis when all cells are the same age.  This process is possible in 
bacterial and eukaryotic cell cultures through the development of a ‘baby machine’ 
where cells are adhered to a membrane with a constant stream of media pumped 
from above so that nascent cells are washed off as they separate from the parent cell, 
thus allowing in-depth analysis of the unperturbed cell cycle (Helmstetter et al., 
2003).  Such a set-up for bloodstream form trypanosomes is unlikely to work 
however, as cells must be motile for cytokinesis to occur (Ralston et al., 2006, 
Monnerat et al., 2009); thus adherence to a membrane would be likely to prevent cell 
division.  
 
Sorting trypanosomes based upon DNA content has been used to generate 
particularly pure populations of G1, S phase and G2/M cells through staining with 
propidium iodide.  However, this is toxic to cells and so can only be used for the 
examination of fixed cells (Gale et al., 1994a).  More recently, supravital dyes have 
been used to stain the DNA of living cells to allow sorting of viable cells based upon 
their DNA content (Bradford et al., 2006).  Such techniques have been used to sort 
live procyclic form trypanosomes, although no attempts have been reported to 
culture the sorted populations or to use this method on bloodstream form cells 
(Siegel et al., 2008a, Michael Boshart, personal communication).  Another method 
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for sorting cells in specific stages of the cell cycle is to fluorescently tag a known cell 
cycle regulated gene, making it possible to look at cells with minimal interference 
with the cell (Coquelle et al., 2006).  A number of cell cycle regulated genes are 
characterised in T. brucei, so such a method could be utilised (Archer et al., 2009) 
(Siegel et al., 2009), (Gale et al., 1994a).  The drawback to this method is that a 
tagged cell line must be produced and the tag must be demonstrated to not 
detrimentally affect the cell.  
1.7 Proteins involved in G0/G1 progression 
All stumpy forms are G0 arrested, thus tight regulation must exist to direct slender 
forms into this quiescent phase and also to maintain this until such time as the cells 
are taken into the tsetse midgut and can complete differentiation.  Surprisingly, no 
receptor-linked kinases or G protein coupled receptors have been reported in T. 
brucei, so unlike in other organisms where these pathways are major players in G1 
progression, other mechanisms must exist for G1 control in trypanosomes  
(Hammarton, 2007).  Previously, a protein homologous to the human PTP1B protein 
tyrosine phosphatase, which is involved in quiescence in mammalian cells, was 
shown to be required for inhibition of differentiation in T. brucei (Szoor et al., 2006).  
However, the mechanism causing the activation of the protein to arrest stumpy forms 
is unknown.  Nonetheless, many different proteins are known to function in 
regulation of G0/G1 in other organisms, two of which include the Target of 
Rapamycin (Tor) and the APC/C activator Cdh1. 
1.7.1 Target of Rapamycin 
S. cerevisiae cells are sensitive to the antifungal agent rapamycin (Heitman et al., 
1991).  However, spontaneously arising cells were found that were resistant to 
rapamycin, and further investigations of these resistant cell lines identified mutations 
in either of two genes that were subsequently named the Target of Rapamycin genes: 
Tor1 and Tor2 (Koltin et al., 1991).  Further characterisation of these two genes 
showed that they were highly homologous, and investigations in other organisms 
showed that Tor genes were evolutionarily highly conserved and have subsequently 
been identified in every organism studied to date with the notable exception of 
Plasmodium ssp.  However, yeast were the only organisms reported to date to have 
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two Tor genes which form distinct complexes (TORC1 and TORC2) and function in 
different pathways to control a vast array of cellular events.  Interestingly, TORC2 
only ever contains Tor2, but TORC1 can be composed of either Tor1 or Tor2 
(Loewith et al., 2002).  Apart from fission and budding yeast, all other organisms 
have a single Tor gene coding for a protein that is able to function in both TORC1 
and TORC2 (Figure 1.6A).  The mammalian homologue to Tor, mTor, which shows 
most identity to yeast Tor2 (Sabatini et al., 1994), is ubiquitously expressed 
throughout all cells of the body, but is particularly high in skeletal muscle (Loewith 
et al., 2002, Jacinto et al., 2004).  Raptor, the binding partner of mTor, is also highly 
conserved throughout the eukaryotic lineage and is hypothesised to act as a scaffold 
protein to facilitate the association of mTor with its substrates (Inoki et al., 2005).  
The interaction with mTor is dependent on a number of HEAT repeats and WD40 
domains in raptor, and deletion series of the protein showed that the majority of the 
protein was required for binding (Kim et al., 2002).  However, there is also evidence 
showing that raptor can increase the association with mTor under conditions of high 
nutrients, with the higher association resulting in an inhibition of mTor kinase 
activity (Kim et al., 2002).  Thus, it is possible that raptor may act as a regulator of 
Tor activity.  The LST8 protein is required for both The TORC1 and TORC2 
complexes, and is a remarkably simple protein, consisting almost entirely of seven 















Figure 1.6.  Diagram of the binding partners and pathways of mTor in the 
TORC1 and TORC2 complexes.  Mammalian Tor and LST8 are components of 
both of the Tor complexes, but the other binding partners differ.  (A) TORC1 also 
consists of a potential regulatory protein raptor, and this complex signals to regulate 
translation in response to nutrient availability and is sensitive to rapamycin.  (B) 
TORC2 also contains Sin1, Rictor and Protor, is involved in polarisation of the actin 
cytoskeleton and is insensitive to rapamycin inhibition. 
Rapamycin treatment or Tor depletion in budding yeast causes cells to undergo 
highly similar morphological and cytological changes as are seen under starvation 
conditions (Koltin et al., 1991).  When investigated in more depth, it became clear 
that Tor was required for the regulation of entry in quiescence; rapamycin treated 
cells arrested division in early G1 and gene expression of known G0-regulated 
transcripts matched that for quiescent cells (Barbet et al., 1996).  Tor also appears to 
be involved in the regulation of autophagy, via a number of different mechanisms 
(Diaz-Troya et al., 2008).  In higher eukaryotes, TORC1 is known to directly interact 
with members of the ATG family of autophagy genes, and also regulates 
transcription factors responsible for the initiation of transcription of genes required 
for autophagy (Chan et al., 2001, Chang and Neufeld, 2009). 
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1.7.1.1 Structure of Tor proteins 
Tor proteins are identifiable through the presence of a rapamycin binding domain 
(FRB), but also possess several more general domains of PI3 kinases such as a PI3 
PI4 kinase domain, a FAT domain and, at the extreme C terminus, a FATC domain 
(Figure 1.7).  Despite the PI3 kinase domain in the protein, the presence of the FAT 
and FATC domains and the serine/threonine activity of Tor, place this protein into 
the phosphatidlyinositol kinase-like kinase family (PIKK) (Hay and Sonenberg, 
2004).  This C terminal domain appears to be the most conserved, with overall 
conservation gradually increasing from the N terminus, which harbours the HEAT 
repeats, down to the FATC domain (Sabatini et al., 1994).  FATC domains are 
unique to PIKKs, and the final 31 amino acids of mTor are highly conserved with the 
other human PIKKs (Takahashi et al., 2000).  The FATC domain appears to be 
involved in regulation of mTor activity, as deleting the three cysteine residues within 
the domain, thus abolishing the disulphide bonds required for the structural integrity 
of the FATC domain, results in loss of kinase activity of mTor (Takahashi et al., 
2000).  HEAT repeats are involved in protein-protein interactions, so would be 
expected to vary between organisms, and these domains appear to be required for the 
interaction with the components of the Torc1 and 2 complexes (Kim et al., 2002, 
Sabatini et al., 1994). 
 
 
Figure 1.7.  Schematic diagram showing the architecture of a TOR protein.  
The HEAT repeats are required for Tor association with the remaining proteins on 
the TORC complexes.  The FRB domain is required for binding rapamycin.  The 
FATC domain may be involved in regulation of the protein through folding to interact 
with the FAT domain and the PI3/PI4 kinase domain is the catalytic part of the 
protein.   
New roles for the Tor proteins are discovered constantly, such as the evidence 
showing that TORC1 may directly interact with ribosomal DNA promoters in S. 
cerevisiae (Li et al., 2006).  This function for Tor requires the protein to be localised 
to the nucleus, and a nuclear localisation sequence was discovered towards the N 
HEAT repeats       FAT              FRB        PI3 PI4 kinase    FATC 
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terminus.  The nuclear localisation of Tor was lost during starvation or rapamycin 
treatment, when the protein was directed to the cytoplasm via a nuclear exporting 
sequence, thus preventing activation of ribosomal gene transcription (Li et al., 2006).  
Treatment with rapamycin or nutrient depletion are also known to affect rRNA 
transcription, which is conducted by polymerase III, but has little effect of tRNA 
transcription despite these gene groups both being transcribed by the same 
polymerase (Wei et al., 2009).  The mechanism for this is via TORC1 
phosphorylation of the polymerase III negative regulator, Maf1, which localises to 
the cytoplasm in its phosphorylated form but, upon depletion of TORC1, will move 
to the nucleolus and inhibit transcription of rDNA (Wei et al., 2009). 
 
Tor appears to control one of the pathways required for the regulation of translation.  
Two major substrates of Tor are the 4E-BP1 and S6 kinase (S6K), and through these 
proteins, a variety of translational activities can be controlled (Hay and Sonenberg, 
2004).  Both of these target proteins contain TOS (target of rapamycin signalling) 
motifs, without which they are incapable of phosphorylation by Tor (Inoki et al., 
2005).  The role of 4E-BP1 is to inhibit the action of the eukaryotic translation 
initiation factor 4E (eIF4E), which forms a complex with several other initiation 
factors to form eIF4F.  4E-BP competitively binds to one of these proteins, 
preventing the formation of the active complex, thus inhibiting the activity of the 
translation initiation factors and so inhibiting translation (Inoki et al., 2005).  TORC1 
acts to phosphorylate 4E-BP1 in response to nutrient levels, and upon 
phosphorylation of the substrate, 4E-BP1 is no longer able to bind to eIF4E and so it 
can instead form the active eIF4F complex which is then functional to recruit the 
translational machinery to mRNAs (Raught et al., 2001).  Certain transcripts have 
been seen to be particularly sensitive to rapamycin, and analysis of the 5’ UTRs of 
these transcripts has shown them to be unusually long and having complicated 
structures, a feature that obliges a higher requirement for eIF4F (Gingras et al., 
2001).  The second major substrate of mTor, S6K, is required for the translation of 
mRNAs containing a 5’ Tract Of Pyrimidine (TOP) structure; these primarily 
comprising transcripts for the translational machinery and ribosomes (Raught et al., 
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2001).  Tor phosphorylation of S6K results in its activation, thereby increasing the 
translation of proteins required for translation and thus increasing the capacity of the 
cell for translation (Inoki et al., 2005).  Both S6K and 4E-BP are also targeted by 
PI3K in a separate regulatory pathway, with PI3K and Tor phosphorylating different 
residues in the substrates (Inoki et al., 2005). 
  
Mounting evidence has shown a role for Tor in G1 progression in a variety of 
organisms.  Originally characterised in S. cerevisiae, treatment with rapamycin 
caused cells to arrest as unbudded cells, presumably in G1 arrest (Heitman et al., 
1991).  In S. pombe, nutritional depletion causes cells to arrest in G1 and then to 
undergo sexual differentiation; a mechanism which appeared to be Tor-regulated, as 
Tor2 knock down resulted in a similar effect, with cells becoming smaller and 
entering quiescence, which was fully reversible (Alvarez and Moreno, 2006).  
Further characterisation of Tor2 in fission yeast demonstrated that Tor2 mutants 
showed overexpression of genes required in nitrogen starvation, but no difference 
was seen in genes activated in response to glucose starvation, thus Tor2 is 
specifically regulated by nitrogen availability (Matsuo et al., 2007).  Closer 
examination of the amino acid regulation of mTor in human cell lines was able to 
narrow down the substrates for regulation and found that mTor was specifically 
activated in response to glutamine availability (Nicklin et al., 2009).  It has also been 
shown that microinjection of the FRB domain of mTor into human cells causes a G1 
specific cell cycle arrest (Vilella-Bach et al., 1999).  Disruption of Tor in C. elegans 
causes cells to arrest in division, although these mutant nematodes did not 
differentiate to the duaer form, as might be expected considering that this is the 
natural arrested form that spontaneously arises under conditions of nutrient limitation 
(Long et al., 2002).  Therefore, CeTor is involved in cell cycle progression, but 
causes arrest in a mode distinct from that occurring under nitrogen starvation. 
1.7.1.2 TORC2 
The function of the TORC2 complex was discovered to be in the regulation of the 
polarisation of the actin cytoskeleton, and is under different regulation to TORC1 as 
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the kinase activity of TORC2 showed no effect in response to serum deprivation or 
amino acid starvation (Jacinto et al., 2004).  The Tor binding partner in the TORC2 
complex was named rictor in mammals (rapamycin insensitive companion of Tor) 
due to the fact that this complex is not disrupted in response to rapamycin (Sarbassov 
et al., 2004).  Another component of TORC2 is LST8, as in TORC1, but two 
additional proteins are also required; Sin1 and Protor (Figure 1.6B) (Pearce et al., 
2007).  Interestingly, the S. cerevisiae and S. pombe orthologues of rictor do not 
show a high level of conservation with mammalian rictor, in contrast to all the other 
members of the Tor pathways, with the region of highest homology confined to a 200 
residue region within which the identity reaches 8% (Sarbassov et al., 2004).  
Depletion of the TORC2 complex in human cell lines gave rise to misshapen cells 
due to the aberrant formation of thick actin fibres (Sarbassov et al., 2004).  Signalling 
to the actin cytoskeleton occurs via PKA, however other organisms using the PKA 
signalling pathway for other functions have evolved TORC2 functions specialised 
for different pathways.  For example, the slime mould Dictyostelium uses cAMP 
signalling to regulate chemotaxis and analysis on cell lines ablated for components of 
the TORC2 complex has shown that this complex is directly required for this 
signalling pathway (Lee et al., 2005). 
1.7.1.3 Rapamycin 
Rapamycin is produced by the soil-dwelling bacterium Streptomyces hygroscopicus, 
(Arndt et al., 1999) and was originally used medically as an anti-fungal agent.  Upon 
detection of its anti-proliferation functions, however, rapamycin is now more 
commonly used as an immunosuppressive drug for transplant patients, and is being 
increasingly tested for treating a range of cancers (Ballou and Lin, 2008).  Three 
rapamycin analogues have since been developed for human use, one of which has 
been modified to be water-soluble in order to aid administration to patients (Ballou 
and Lin, 2008).  A recent application of rapamycin has been in extending the life 
span of mice, where treatment with the drug late on in life increased life span by up 
to 14% (Harrison et al., 2009).  The method of action of the rapamycin appeared to 
be from delaying onset of cell deterioration related to ageing, such as cellular stress 











Figure 1.8.  Structure of rapamycin.  The anti-fungal drug rapamycin binds to the 
FRB domain of Tor only when bound to FKBP12. 
Rapamycin is unable to bind Tor directly; and mutational studies in S. cerevisiae 
identified the ligand FKBP12 as a protein that, when mutated, conferred rapamycin 
resistance (Koltin et al., 1991).  FKBP12 is a peptidyl-prolyl cis-trans isomerase 
protein and the usual function of this protein the cell is in the formation of a calcium 
channel (Gothel and Marahiel, 1999).  However, this protein is also responsible for 
rapamycin binding, and deletion of FKBP12 from a rapamycin sensitive cell is 
sufficient to confer complete rapamycin resistance (Kunz et al., 1993, Crespo et al., 
2005).  FKBP12 is extremely well conserved, showing 100% identity between 
human and rabbit orthologues and, in all organisms showing sensitivity to 
rapamycin, FKBP12 has been shown to bind to rapamycin and in this conformation 
interact with Tor at the rapamycin binding domain (FRB), thus inhibiting the activity 
of TORC1.  Extensive characterisation of the FRB domain has been carried out in 
yeast to identify the residues essential for rapamycin binding, and three highly 
conserved residues (serine 1975, tryptophan 2042 and phenylalanine 2049) were 
found, that when mutated abolished rapamycin sensitivity (Stan et al., 1994, Lorenz 
and Heitman, 1995).  The crystal structure of the interaction between rapamycin-
FKBP12-mTor has been solved and shows that the residues identified as essential for 
rapamycin binding all lie at the FRB-FKBP12-rapamycin interface (Choi et al., 
1996).  The same residues required for rapamycin binding to yeast Tors are 
conserved for mTor, and substitution assays of the corresponding serine residue of 
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mTor (2035) (Figure 1.9) showed that only replacement with an alanine residue 
prevented rapamycin resistance (Chen et al., 1995).   
 
 
Figure 1.9.  The structure of human FKBP12-rapamycin complex interacting 
with mTor.  The blue structure is the rapamycin binding domain of mTor, the pink 
structure is human FKBP12 and the brown structure rapamycin.  Highlighted in 
yellow is the conserved serine residue of mTor (serine 2035, correlating to serine 
1975 of S. cerevisiae Tor2) at the mTor-rapamycin interface (Choi et al., 1996). 
Rapamycin has been shown to specifically inhibit the activity of the TORC1 
complex in a wide variety of organisms, from mammals, to slime mould, plants, and 
yeast (Loewith et al., 2002, Cutler et al., 2001, Kim et al., 2002, Crespo et al., 2005, 
Heitman et al., 1991), but sensitivity to rapamycin is not universal across all life 
forms.  Indeed C. elegans shows no effects upon treatment with the drug, despite 
having a highly conserved FKBP12 receptor and the FRB domain of CeTor showing 
high levels of identity to human and yeast Tor, importantly possessing all the 
essential residues including the conserved serine (Long et al., 2002).  Thus, other 
mechanisms apart from mutations in the FRB domain exist to prevent sensitivity to 
rapamycin.  The authors speculate that the nematodes may have evolved a means to 
prevent uptake of rapamycin, possibly in response to the presence of this chemical in 
the soil – the natural habitat of these organisms (Long et al., 2002).  The helminth 
parasite Schistosoma mansoni has also been found to be resistant to rapamycin, 




During the course of this PhD, the Tor pathway in T. brucei was independently 
studied by a number other groups and extensively characterised (Barquilla et al., 
2008, Barquilla and Navarro, 2009b, Barquilla and Navarro, 2009a, Monnerat et al., 
2009).  The results of these studies were surprising and some findings were in direct 
contrast to preliminary data from our lab, so certain aspects of the Barquilla et al 
study (2008) were re-examined in this thesis.  Interestingly, the authors described 
four Tor orthologues in T. brucei, comprising clear Tor1 and Tor2 homologues with 
an additional two Tor-like proteins, with TbTor1 exclusively present in TORC1 and 
TbTor2 uniformly present in TORC2 (Barquilla et al., 2008).  Closer scrutiny 
however, suggests that the Tor-like 2 protein is not a member of the Tor family but 
instead a member of the more general PIKK family as it lacks the rapamycin binding 
domain (FRB) found in all Tor proteins so far identified, which is present even in the 
gene coding for the rapamycin insensitive Tor homologue in C. elegans. 
 
Incubation of bloodstream form T. brucei cells with rapamycin results in specific 
inhibition of the TORC2 pathway (Barquilla et al., 2008), in contrast to all other 
organisms where TORC2 is invariably insensitive to rapamycin action.  Interestingly, 
the rapamycin-TbFKBP12complex is unable to bind to TbTor2 whilst it is associated 
with the TbTORC2 complex, but does associate with free TbTor2, suggesting that 
the phenotype seen is the result of depletion of available TbTor2 (Barquilla et al., 
2008).  This suggestion appears validated by the equivalent phenotype of cells when 
RNAi is directed against TbTor, both regimes resulting in cells with multiple nuclei 
and flagella, with hugely enlarged flagella pockets (Barquilla et al., 2008).  This 
phenotype stems from the role of TbTORC2 in polarisation of the actin cytoskeleton, 
in keeping with the function in yeast.  The function of TbTor1 also mirrors that for in 
other organisms, with depletion in T. brucei resulting in G1 arrest and a decrease in 
cell size and protein synthesis (Barquilla et al., 2008).  TbTor1 depletion in procyclic 
form cells has been shown to result in deregulation of the cell cycle, with 
disappearance of post mitotic cells and accumulation of cells with abnormal numbers 
of nuclei and kinetoplasts, ultimately resulting in death (Monnerat et al., 2009).  
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Results generated in our lab contradict some of these findings, and will be described 
in Chapter 5. 
 
Rapamycin treatment of T. brucei bloodstream form cells was shown to cause a 
reduction in cell number; the dose causing a 50% decrease in cell number was 
calculated as 152nM.  A homologue of Tor in the closely related protozoan parasite 
Leishmania species has not been investigated, however treatment of Leishmania 
major with rapamycin has been shown to kill these parasites with an IC50 of 4.9µM 
(Madeira da Silva et al., 2009), which is surprisingly different to the concentration 
eliciting the same response in T. brucei, considering how similar the Tor proteins are 
between the species.  Interestingly, at lower doses of rapamycin, the treated 
Leishmania major cells appear to have better survival rates in comparison to 
untreated cells (Madeira da Silva et al., 2009).  This phenotype of Tor inhibition 
resulting in extended lifespan has similarities to the depletion of TbTor1 which, prior 
to cell cycle arrest and death, increases the cells resistance to stress caused from 
growing to high density (Barquilla and Navarro, 2009a).  In addition, visualisation of 
TbTORC1 depleted cells shows certain characteristics resembling autophagy, such as 
the appearance of double-membraned vacuoles, suggesting that one of the roles of 
TbTORC1 is in the regulation of autophagy, a role that has been suggested in higher 
eukaryotes (Diaz-Troya et al., 2008, Barquilla et al., 2008, Barquilla and Navarro, 
2009a). 
1.7.2 Cdh1 
The Anaphase Promoting Complex/Cyclosome (APC/C) plays a major role in cell 
cycle progression through controlling the degradation of cell cycle regulatory 
proteins and is highly conserved (Li and Zhang, 2009).  The part played by the 
APC/C in degradation is through catalysing the addition of ubiquitin molecules onto 
targets and thus labelling them for proteolysis (Peters, 2006).  The human APC/C is 
composed of 12 different subunits, although the exact arrangement of these subunits 
is unknown; all that is certain is that the combined molecular weight of the APC/C is 
too high for each subunit to be present only once (Dube et al., 2005).  Further, the 
multiple appearance of the largest subunits can be rejected based on the high weights 
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of these proteins, meaning that there must be more than a single copy of at least one 
of the smaller subunits (Dube et al., 2005).  Nevertheless, these 12 subunits only 
represent the core of the complex, with different proteins recruited to confer different 
substrate recognition at transition points of the cell cycle (Peters, 2006).  These 
recruited proteins are termed activator proteins and these are required to direct the 
APC/C to destroy only the specific targets at the different stages of the cell cycle, 
with the Cdc20 substrate required for the metaphase-anaphase transition and Cdh1 
for regulation of G1 (Skaar and Pagano, 2008).  A third APC/C activator, mfr1, has 
also been identified in yeast, which is only required in meiosis (Blanco et al., 2001), 
and two further meiosis specific co-activators of the APC/C exist in Drosophila 
melanogaster (Peters, 2006).  In addition, four distinct homologues of Cdh1 were 
discovered in chicken, with each having a specific set of target substrates (Wan and 
Kirschner, 2001).  A common feature of all these coactivators (but only the Cdh1-C 
homologue in chicken) is the presence of a C box and an IR tail at the extreme C 
terminus, required for interaction with the APC/C (Peters, 2006).  Cdh1 was 
originally discovered in Saccharomyces cerevisiae in a screen for orthologues of 
Cdc20, and over expression of this gene was found to result in cell cycle arrest 
leading to lethality (Visintin et al., 1997) (Schwab et al., 1997).  Shortly afterwards 
the homologue was discovered in S. pombe (Yamaguchi et al., 1997), with over 
expression resulting in growth arrest and cell lines depleted of Cdh1 were unable to 
arrest in G1 in response to nitrogen starvation as occurs in wildtype cells (Kitamura 
et al., 1998). 
1.7.2.1 Structure of Cdh1 
The Cdh1 protein has seven WD40 repeats that make up the large majority of the C 
terminus which form a propeller structure (Figure 1.10 B), with the ‘outside’ of the 
propeller containing the most evolutionarily conserved residues which are shown to 
be involved in protein interactions with the substrates (Kraft et al., 2005).  
Interestingly, Cdh1 also has two destruction boxes located towards the N terminus 
(Figure 1.10A) that on other proteins targets them as substrates for Cdh1-mediated 
degradation (Listovsky et al., 2004).  In keeping with the other Cdh1 substrates, the 
function of the destruction boxes in Cdh1 was indeed found to be required for 
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ubiquitination of the protein, allowing Cdh1 levels to be regulated in a negative 
feedback loop such that high levels of the protein triggers degradation of free Cdh1 
via the APC/C associated with Cdh1 (Listovsky et al., 2004). When active, Cdh1 
associates with the APC/C within the nucleus, and a well-conserved nuclear 
localisation sequence has been identified (Zhou et al., 2003a).  Cdh1 and Cdc20 also 
have a C box towards the N terminus that is not found in other proteins without 
WD40 domains, consisting of seven amino acids (Schwab et al., 2001).  The final 
two residues of the protein form an IR motif, again present in both Cdc20 and Cdh1, 
which together with the C box, allows binding of Cdh1 to the APC/C (Burton et al., 
2005). 
 
Many of the motifs seen in Cdh1 are shared with those of Cdc20, however a region 
downstream of the C box was identified uniquely in Cdh1 homologues, and so 







Figure 1.10.  Structure of Cdh1.  (A) Schematic showing the domains of Cdh1 with 
the N terminal C-box required for substrate recognition and C terminal IR motif for 
APC/C interaction.  The NLS (nuclear localisation sequence) directs the protein into 
the nucleus where it is able to interact with the APC/C.  Two destruction boxes are 
required for self-mediated degradation (Listovsky et al., 2004).  The seven WD40 
repeats are involved in protein interactions with the substrate and form the propeller 
structure shown in (B) Propeller structure of Cdh1 (Dube et al., 2005) 
Regulation of Cdh1 is multifaceted as is often seen in proteins at the top of control 
pathways.  The Cdh1 activity in higher eukaryotes, as determined by degradation of 
its substrates, is highest in G1 and in cells arrested in G0 through serum starvation or 
naturally quiescent in differentiated tissues (Brandeis and Hunt, 1996).  The mRNA 
of both Cdh1 and Cdc20 show similar profiles, peaking during G2 and maintained 
until the loss of transcript early on in G1 phase (Fang et al., 1998).  The protein 
levels of Cdc20 mirror that of the mRNA, but interestingly despite the fluctuations 
seen in the mRNA levels of Cdh1, the protein levels remain fairly stable (Fang et al., 
1998), leading to the hypothesis that only newly synthesised protein is active due to 
phosphorylational inactivation of older protein (Inbal et al., 1999).  However another, 
more plausible, possibility for protein regulation is the physical separation of the 
protein from its substrates.  In human cells the action of Cdh1 has been shown to be 
repressed via sequestration to the cytoplasm through phosphorylation of the nuclear 
localisation signal (Zhou et al., 2003a, Huynh et al., 2009) resulting in Cdh1 
localisation to the cytoplasm during the earlier parts of mitosis and during G2/M 
(Jaquenoud et al., 2002).  Phosphorylation of Cdh1 also causes it to disassociate from 
APC/C thus resulting in its inactivation (Huynh et al., 2009).  Additionally Cdh1 can 
autoubiquitinate and thus trigger its own destruction (Huynh et al., 2009).  The 
phosphorylation also causes Cdh1 to bind to Msn5, which as it binds at the C box, 




may help regulate activity of Cdh1 as this protein will be competitively binding to 
the same site as the substrates (Jaquenoud et al., 2002). 
 
Other proteins are also involved in the regulation of Cdh1 activity, such as Emi1, a 
zinc-finger-containing protein, which appears to bind to Cdh1 and thus prevent the 
association with the APC/C (Harper et al., 2002).  Interestingly, this protein is able to 
bind to and regulate both Cdh1 and Cdc20 in some organisms, but is specific for 
Cdh1 only in Drosophila (Pesin and Orr-Weaver, 2008). 
 
Cdh1 associates with the APC/C via interactions with the Cdc27 subunit when in a 
low phosphorylation state (Huynh et al., 2009).  More recently it has been shown that 
the activators Cdh1 and Cdc20 both bind, via different motifs, to the subunits Cdc27 
and Cdc23, with the substrate binding to both the APC/C and the activator 
(Matyskiela and Morgan, 2009) (Figure 1.11).  In contrast, the means by which 
Cdc20 activation of the APC/C is regulated appears to be via phosphorylation of the 
APC/C itself, specifically the Cdc27 subunit, although there is conflicting evidence 
relating to this (Blanco et al., 2000). The various targets of Cdh1 in the different cell 
cycle phases are not all degraded at the same time; certain proteins must be removed 
sooner than others, and the mechanism for this has been shown to be the mode of 
polyubiquitination of the substrate (Rape et al., 2006).  Those proteins that are 
removed early on during activation of Cdh1 were shown to have the entire length of 
ubiquitin molecules attached immediately after the substrate was associated with the 
APC/C-Cdh1 complex, however other proteins removed later on would still form an 
interaction with the APC/C-Cdh1 complex, but only a single ubiquitin molecule was 
attached and the protein released, thus requiring the protein to return to the complex 
and gradually accumulate enough ubiquitins to ensure recognition by the proteosome 




Figure 1.11.  Mode of Cdh1 binding to APC/C.  The activators Cdh1 and Cdc20 
bind to the same region of APC/C via binding to the subunits Cdc23 and Cdc27 
(from (Matyskiela and Morgan, 2009)). 
New targets of the APC/C in eukaryotes are being found with impressive regularity, 
as are new regulatory mechanisms, so there is still much as yet unknown of the 
action of Cdh1, even in yeast. 
1.7.2.2 APC/C in T. brucei 
Homologues to seven of the APC/C subunits have been identified in T. brucei, using 
the protein sequences from S. cerevisiae to run pBLAST searches (Kumar and Wang, 
2005).  A Cdc20 homologue in T. brucei was also identified in this study, but a 
putative homologue of Cdh1 was not discovered, however closer inspection of the 
protein makes it difficult to necessarily designate it as Cdc20 rather than Cdh1; this 
will be discussed further in Chapter 5.  The six subunits of the APC/C in T. brucei 
that were known to be essential in yeast were depleted in both procyclic form and 
monomorphic bloodstream form cells, but only Cdc27 and APC1 depletion resulted 
in growth defects, although the phenotypes seen differed between the two life cycle 
stages (Kumar and Wang, 2005).  Whilst the effects of Cdc27 or APC1 depletion in 
procyclic form cells resulted in cells arrested in metaphase in common with the 
phenotype in S. cerevisiae, the same depletions in bloodstream form cells appeared 
to arrest the cells in late anaphase (Kumar and Wang, 2005).  This result is maybe 
not as surprising as it first appears, considering the different roles of other cell cycle 
proteins between procyclic form and bloodstream form cells, the TbAPC/C could 
have different targets in the different life cycle stages and thus disruption of the 
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TbAPC/C would result in the accumulation of different cell cycle proteins.  The 
similarities between the Cdc27 and APC1 of T. brucei with the yeast homologues 
were comparatively low considering the high level of conservation in the proteins 
involved in the APC/C pathway in other organisms, only 20% and 17% identity 
respectively, and neither were able to rescue null yeast cell lines (Kumar and Wang, 
2005).  Taken together it is clear that the APC/C in T. brucei is quite different from 
that in higher eukaryotes, but of particular interest is the presence of only one co-
activator; Cdc20, so it will be interesting to discover how the substrates of TbAPC/C 
are phase specifically targeted for destruction. 
1.8 Gene expression regulation 
A plethora of mechanisms exist for regulation of gene expression in kinetoplastids, 
which differ in many ways from that of higher eukaryotes in part because of the 
unusual method of transcription in these organisms. 
1.8.1 Transcription in T. brucei 
The genomes of the kinetoplastids are arranged into polycistronic units 
encompassing genes for both related and unrelated functions and timing of 
expression (Vanhamme and Pays, 1995).  Hence, gene expression control in these 
organisms is largely post-transcriptional, with a variety of mechanisms in place to 
ensure tight regulation (Figure 1.12).  Few promoters have been identified in the 
genome, although the ribosomal DNA promoter has been found and the promoters 
for the surface antigens VSG and EP are known, as are those for the metacyclic 
VSGs which are arranged into monocistronic units (Clayton, 2002).  All these genes 
are transcribed by RNA PolI, which in higher eukaryotes is used exclusively to 
transcribe ribosomal RNA.  It has been speculated that the reason for the novel use of 
PolI for transcription of the surface antigens is due to its higher processivity, making 
it able to transcribe these genes which are required in much higher abundance than 
other proteins in the cell, and yet have limited gene copy number (Clayton, 2002).  
The putative promoter sequences identified for PolI show a high level of homology 
to those in higher eukaryotes but have little sequence homology to each other 
(Palenchar and Bellofatto, 2006).  The RNA polymerase II promoters by contrast, 
have proved more elusive, although it has been shown that the promoters for the SL 
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RNA genes are recognised by PolII (Gilinger and Bellofatto, 2001).  Recent work 
has suggested that, rather than the method of transcription regulation seen in 
organisms where transcription is monocistronic via conserved sequences in the 
5’UTR of genes that recruit transcription factors, in trypanosomes, DNA 
conformation may play a role in determining sites of transcription initiation.  Histone 
variants showing poor levels of stability are enriched at regions of transcription start 
sites, effectively causing the chromatin to open up and thus making this area 
accessible to transcription factors (Siegel et al., 2009).  The lack of regulation at the 
level of transcription explains the observation that the T. brucei genome has such a 
limited repertoire of predicted transcription factors (Campbell et al., 2003). 
 
Once the polycistronic unit has been transcribed the message must be processed, 
which in trypanosomes requires that the individual genes are trans-spliced and 
polyadenylated (Figure 1.12B).  A Spliced Leader (SL) is annealed to the 5’ end of 
the nascent mRNA at a conserved splice acceptor site, stabilising the transcript and 
making it amenable for translation (Palenchar and Bellofatto, 2006).  The SL RNA 
genes are arranged as multiple repeats throughout the genome and account for a large 
proportion of the RNA synthesis in the cell in order to have enough available for 











Figure 1.12.  Overview of the processes involved in transcription in T. brucei. 
(A) Polycistronic transcription occurs from ill-defined PolII promoters.  (B) Each 
mRNA is then prepared for translation through the addition of a 5’ SL fragment and 
3’ polyadenylation.  (C) The fate of these mRNAs is either degradation or translation 
into proteins.  (D) Those transcripts that are not degraded can then be translated 
with the final proteins either sent to their required localisation or regulated through 
localisation to a place where it will be inactive, (E) alternatively the protein may be 
degraded (Modified from (Haile and Papadopoulou, 2007)). 
As there is little or no regulation of genes at the transcriptional level, other methods 
exist to affect the levels of transcripts.  Degradation of either the transcript or the 
mature protein is one such method, as is the sequestering of a protein from its site of 
action (Figure 1.12D, E).   
1.8.2 Regulatory elements 
A number of regulatory elements have been found, particularly within the 
untranslated regions (UTR) of genes, conferring stage specific expression to them.  
Most of the regulatory elements identified in kinetoplastid genes have been within 
the 3’UTRs.  Typically in higher eukaryotes, regulatory sequences in the 3’UTR are 
AU rich, and such AU rich regions have been discovered to be required for the 
procyclic specific expression of EP1, phosphoglycerate kinase B (PGKB), pyruvate 
phosphate dikinase and many of the COX subunits (Haile and Papadopoulou, 2007).  









1995).  More than one regulatory element has been identified in the 3’UTR of EP1, 
two of which positively regulate gene expression and a Loop II region, which acts as 
a negative regulator.  The Loop II region is targeted by negative regulators to prevent 
expression of this gene in the bloodstream form, but in the procyclic form a zinc 
finger protein, TbZFP3, competes for binding to the Loop II domain, likely 
preventing the negative regulators from binding and causing destabilisation of the 
mRNA (Walrad et al., 2009). 
 
Not all regulatory elements found in kinetoplastid 3’UTRs are AU rich however.  For 
example, a 450 bp region in the 3’UTR of genes up regulated during the amastigote 
stage in Leishmania infantum, showed no enrichment of AU (Boucher et al., 2002).  
Interestingly this region appeared to regulate expression levels through enhancing 
translational efficiency. 
1.8.3 RNA binding proteins 
As is seen from the action of TbZFP3, many of the gene regulatory mechanisms rely 
on RNA binding proteins, with depletion of these genes leading to severe 
phenotypes, (Estevez, 2008, Walrad et al., 2009, Hartmann et al., 2007, Hartmann 
and Clayton, 2008).  Kinetoplastids have significantly more of the proteins involved 
in RNA binding than other organisms that conduct expression regulation at the 
transcriptional level (Archer et al., 2009).  For example, the homologues of the UBP1 
and UBP2 proteins that were originally found in T. cruzi, and which contain a RNA 
recognition motif, have been shown in T. brucei to regulate mRNA levels.  Thus, 
over expression of TbUBP2 leads to an increased half life in one of its substrates, 
CFB1 – a protein potentially involved in cell division, and both over expression or 
depletion of the proteins leads to growth inhibition of both bloodstream and 
procyclic form cells (Hartmann et al., 2007).  Similarly, the RNA recognition motif 
(RRM) containing protein DRBD3 was identified through its ability to associate with 
the 3’UTR of PGKB and was found to be involved in the regulation of a range of 
mRNAs, all of which had a conserved sequence in their 3’UTR, known to be over 
represented in the 3’UTR of genes specifically expressed in the procyclic form 
(Estevez, 2008).  More recently, the targets of one protein of the Pumillo family of 
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RNA binding proteins, Puf9, were identified, with Puf9 found to regulate the timing 
of expression of these transcripts via a conserved motif in their 3’UTR.  Puf9 
appeared to bind this element and specifically stabilised these mRNAs during S 
phase (Archer et al., 2009). 
1.8.4 G-quadruplexes 
Recently, Guanine-rich sequences forming a tertiary structure (G quadruplex) in 
promoter regions of Plasmodium falciparum have been implicated in transcription 
regulation (Smargiasso et al., 2009).  G-quadruplexes cause conformational 
alterations in the DNA structure and can recruit binding proteins which will then 
prevent access by transcriptional machinery, or alternatively, require specific 
helicases in order to unwind these regions.  Depletion of the helicase required to 
unwind the G-quadruplex leads to down regulation of the genes containing these 
sequences in their promoters.  Poly-G sequences have been identified at transcription 
strand switch regions in T. brucei, potentially indicating a role in regulation, although 
it is not clear whether this would be a positive or negative regulation or whether, 
instead, the G-quadruplex structure could act as a barrier to prevent the RNA 
polymerase from proceeding in the wrong direction (Siegel et al., 2009).   
1.8.5 Base J 
A further novel mechanism of gene regulation is through the modification of certain 
T residues into ß-D-glucosyl-hydroxymethyuracil, otherwise known as base J.  This 
phenomenon only occurs in the bloodstream form of T. brucei and the major role 
appears to be in the silencing of the inactive telomeric VSG genes (Borst and 
Sabatini, 2008).  Interestingly, base J also shows enrichment at both divergent and 
convergent polycistronic switching sites, potentially suggesting these modifications 
also play a role in transcription initiation at the level of chromosome structure (Cliffe 
et al., 2009). 
1.9 Microarray 
Despite the largely post-transcriptional regulation of gene expression in T. brucei, the 
use of mRNA stability as a method of regulation means that the amount of transcript 
can give an indication of the importance of a particular protein in certain situations.  
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Microarrays have become an increasingly common method for comparing 
differences in gene expression under various conditions in T. brucei, such as the 
effects of drug treatments and gene knock down and over expression experiments 
(Estevez, 2008, Denninger et al., 2007, Hartmann et al., 2007) or to identify mRNAs 
bound by RNA binding proteins (Archer et al., 2009).  Numerous studies have also 
been conducted to examine the expression profiles of genes in the different life cycle 
forms of the kinetoplastids.  These early experiments were conducted prior to the 
publication of the complete genome sequence, often on custom made glass slides, 
and thus are difficult to interpret.  Moreover, all have been carried out on cultured 
monomorphic bloodstream form cells (Diehl et al., 2002, Brems et al., 2005).  Other 
microarray studies of the life cycle have only considered a subset of the genome (El-
Sayed et al., 2000, Koumandou et al., 2008).  The first attempt at a microarray in T. 
brucei, looked at a T.b.rhodesiense strain and used 400 expressed sequence tags 
(ESTs) as probes and found that 13% of these showed differential regulation between 
bloodstream and procyclic form cells (El-Sayed et al., 2000).  Subsequent studies 
using greater number of ESTs in order to gain almost total genome coverage have 
found that this level of regulated expression is probably an artefact of using highly 
expressed mRNA, which is more likely to show differential expression.  Taking this 
into account, the study calculates the percentage of differentially expressed 
transcripts between these life stages as closer to 2% (Brems et al., 2005, Diehl et al., 
2002).  These early microarray studies gave little insight into the global regulation of 
gene expression but are good proof-of-principle studies demonstrate that T. brucei 
will provide interesting information regarding gene expression regulation between 
different life cycle stages in future experiments (Duncan, 2004). 
 
Koumandou et al (2008) designed microarray slides for the analysis of genes 
involved in membrane transport, comprising around 8% of the genome alongside a 
set of over 100 genes of known expression profile used for reference (Koumandou et 
al., 2008).  Using these slides the difference between monomorphic bloodstream 
forms grown in culture were compared with another monomorphic cell line harvested 
from a rodent infection, with 35 genes found to be up-regulated in the in vitro 
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cultured cells with only three up-regulated in the in vivo derived cell lines 
(Koumandou et al., 2008).  Considering this microarray only investigated 796 genes, 
extrapolation based on this experiment would predict that almost 5% of the genome 
is differentially regulated between in vivo and in vitro cultured bloodstream form 
cells.  This suggested that experiments on parasites derived from long term culture 
may give a very different profile to in vivo derived cells.  For example, the 
percentage of differentially regulated genes found between the in vivo and in vitro 
cultured cells is comparable with percentage difference between the bloodstream 
form and procyclic form cells, which are known to be vastly different in many facets 
of their cell physiology (Koumandou et al., 2008).  Similar conclusions have been 
reached in studying Leishmania cells where comparisons of axenically cultured 
Leishmania infantum amastigote form cells with those harvested from an infection 
showed that 40% of the genome is up-regulated in the axenic cells (Rochette et al., 
2009).  A microarray study has been used to look at the differences between the 
bloodstream form and procyclic form in a monomorphic cells line and compare these 
with the differences seen between these two life stages in a pleomorphic cell line 
(Brems et al., 2005).  Interestingly the majority of the regulated transcripts were the 
same in both cell lines, with only two additional transcripts found to show 
differential regulation in the pleomorphic cell line (Brems et al., 2005).  Life cycle 
stage microarrays have also been conducted on T. cruzi, showing a greater proportion 
of genes that are stage regulated than either T. brucei or the Leishmania ssp (Minning 
et al., 2009).   
 
However, to date none of the microarrays conducted to investigate differences in 
expression profiles in different life cycle stages have looked at the transient changes 
associated with differentiation from one form to the other.  The lack of investigation 
of gene expression throughout a time course of differentiation means little is known 
of the genetic events required for differentiation, and a microarray study on 
Leishmania donovani looking at gene expression over a time course during 
differentiation, found that many genes are transiently regulated during differentiation 
of promastigotes to amastigotes (Saxena et al., 2007).  It is therefore likely that 
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similar events will occur in T. brucei and investigation of this will allow a better 
understanding of the process of differentiation. 
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1.10 The Aims of this PhD 
 
• Investigate orthologues of proteins known to be involved in G0/G1 control in 
other organisms and determine whether they play a role in differentiation in T. 
brucei. 
• Develop a method for isolation of cells in different cell cycle stages and assess 
the differentiation capacity of cells in these different stages. 
• Examine the global gene expression profile of differentiating cells to identify 
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2 – Materials and Methods 
2.1 Trypanosomes 
2.1.1 Strains 
The culture adapted stains used throughout this study are all derived from the non-
human infective subspecies T. b. brucei Lister 427 strain.  These cells are all 
monomorphic; they are unable to take on the stumpy morphology and are 
unresponsive the stumpy induction factor (SIF).  The details relating to the culture 
history of this cell line are available on Professor George Cross’ website 
(http://tryps.rockefeller.edu).  RNA interference (RNAi) was carried out in the single 
marker cell line S16.  This bloodstream form cell line expresses the T7 RNA 
polymerase and tetracycline repressor and contains a neomycin resistance marker 
(Wirtz et al., 1999).  These cultures were maintained in 2.5µg/ml G418 to prevent 
selective loss of the toxic T7 polymerase. 
 
The over-expression cell line 427-449 were used for differentiation experiments as 
this cell line had been demonstrated to have retained the ability to differentiate in 
response to cis-aconitate at high levels.  The 427-449 cell line was derived from 427 
cells transfected with the plasmid pHD449, incorporating a phleomycin resistance 
marker and a tetracycline repressor gene that allows inducible ectopic expression.  A 
benefit of this cell line is that the presence of the pHD449 plasmid is not detrimental 
to the cell and thus this construct is stably maintained without the need to select with 
antibiotics. 
 
Two pleomorphic cell lines were also used in this study, which naturally differentiate 
from the slender to stumpy form.  The pleomorphic cell line AnTat1.1 (Van 
Meirvenne et al., 1975) was used to generate stumpy form cells and for use in the 
differentiation experiments for the microarray as this cell line is still able to complete 
both the mammalian and fly stages of the life cycle and the kinetics of differentiation 
of this cell line are well characterised.  A second pleomorphic cell line, EATRO 
 
2-Materials and Methods 49 
(East African Trypanosomiasis Research Organisation) 2340 T. brucei brucei strain 
(Cunningham and Vickerman, 1962), were also used to generate RNA to compare 
expression of stumpy-specific transcripts in different strains. 
2.1.2 Culturing 
Cells were cultured in HMI-9 medium (Hirumi and Hirumi, 1989) supplemented 
with 20% foetal calf serum (FCS) (Gibco) and 10µg/ml penicillin/streptomycin, at 
37˚C in 5% CO2, in vented flasks (Greiner).  Cell density was kept between 2x105 
cells/ml to 4x106 cells/ml. Cell counts were conducted on a Beckman Coulter 
Counter Z2, calibrated to 2.5-7µm to exclude cell debris.  Differentiation of stumpy 
form cells was carried out through transferring cells into SDM-79 (Brun and 
Schonenberger, 1979, Cross and Manning, 1973), supplemented with 10% FCS and 
2.5µg/ml haemin, with 10mM glycerol and 6mM cis aconitate.  For differentiation, 
cells were transferred to flasks with non-vented lids and incubated at 27˚C. 
 
Cryopresevation of cells was carried out through centrifuging 10ml of a 
logarithmically growing culture at 600xg for 10 minutes.  All but 0.5ml of the 
supernatant was removed and the cells resuspended in the remaining media, then a 
further 0.5ml of HMI-9 medium supplemented with 14% glycerol was added 
dropwise.  The mixture was allowed to stand and then transferred to -80˚C in a 
cryovial. 
2.1.3 Isolation of parasites from blood 
Mice were immune-suppressed through treatment with cyclophosphamide 24 hours 
prior to injection with parasites.  After three days for isolation of slender form cells, 
or six days for stumpy form cells, the blood was harvested through cardiac puncture 
and collection into pre-warmed syringes by a licensed animal worker.  The 
trypanosomes were then purified out from the blood in PSG at 37oC via DEAE 
cellulose columns (Lanham and Godfrey, 1970).  Harvested parasites were then 
centrifuged at 800xg for 10 minutes in a clinical centrifuge, resuspended in HMI-9 
medium pre-warmed to 37˚C, at approximately 1x108/ml and settled for 1 hour. 
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2.1.4 Differentiation 
Monomorphic bloodstream form cells were induced to differentiate in HMI-9 
medium at a density of 5x105 cells/ml.  Cis aconitate was added to a final 
concentration of 6mM, vented lids replaced with solid lids, and cultures transferred 
to a 27˚C incubator.  Pleomorphic AnTat 1.1 cells were induced to differentiate from 
stumpy form cells extracted from blood, through transferring the cells at a density of 
2.5x106 cells/ml into SDM79 with 6mM cis aconitate, pre-warmed to 27˚C.  The 
differentiation medium also contained 10mM glycerol to allow continued expression 
of GPEET (Vassella et al., 2000). 
2.1.5 Transfection 
Between 1-2x107 bloodstream form trypanosomes were centrifuged at 600xg for 10 
minutes, washed once in half volume of ZPFMG and resuspended in 0.5ml of 
ZPFMG.  15µg plasmid DNA linearised overnight with Not1, purified using a 
Qiagen PCR Purification Kit (following the manufacturers instructions) and 
resuspended in 50µl H20 was mixed with the cells in 0.4cm electroporation cuvettes.  
Electroporation was conducted using a BTX 830 Electo Square Porator at 1700v, 
with three pulses for 100µs carried out at 200ms intervals, and immediately 
transferred to 10ml non-selective HMI-9 medium and incubated for 20 hours at 37oC 
in 5% CO2.  Cells were then diluted 1 in 4 in selective media (hygromycin at 
1.5µg/ml and neomycin at 2.5µg/ml) in 24 well plates for seven days and 
successfully transfected cell lines were diluted 1 in 5 into 6 well plates before being 
propagated in 10ml flasks. 
2.2 Viable isolation of cells in specific cell cycle stages 
Bloodstream form cells were harvested during exponential growth by centrifugation 
for 10 minutes in a clinical centrifuge (600xg) at room temperature. The parasite 
pellet was then resuspended to a density of 1x106 cells/ml in HMI-9 medium 
supplemented with 2% FCS and 10µg/ml penicillin/streptomycin.  Vybrant® 
DyeCycle™ Violet (Molecular Probes, Invitrogen V35003) was added to a final 
concentration of 1µg/ml and the cell suspension incubated for 30 minutes at 37˚C, 
the tube being protected from light by wrapping in aluminium foil.  The samples 
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were then concentrated into a one-quarter volume of staining media prior to sorting 
on a FACSAria (BD Biosciences).  Autoclaved PSG was used as the sheath fluid in 
order to minimise cell stress, and the machine cooled to 4˚C prior to cell sorting, 
such that the temperature of the sorting sample would have been below 20˚C, in 
order to limit cell metabolic activity. Intact cells were gated based on FSC/SSC 
profiles, combined with pulse processing for doublet discrimination, in order to 
select single cells. The dye was excited using a 407nm Violet laser and emission 
detected via a 450/40 bandpass filter.  Gates were set up to collect only the 2C 
fraction (G0/G1 cells) and 4C fraction (G2, mitotic and post-mitotic cells), with the 
2C gate set to include 1 quartile either side of the G0/G1 peak and the 4C gate set to 
exclude the first quartile of the G2/M peak, to ensure tight discrimination and 
selection of these cell cycle stages.  In all cases, cells were sorted under conditions of 
minimal ambient light to prevent photoinactivation of the Vybrant® DyeCycle™ 
Violet.  Sort time did not exceed 90 minutes, with cells collected into filter-sterilised 
100% FCS and maintained below 20˚C until the overall sort for all cells was 
completed.  A sample of the recovered cells was re-analysed on the FACSAria to 
confirm purity of the populations.  The cells diluted in PSG were then centrifuged at 
600xg for 10 minutes and resuspended in HMI-9 medium supplemented with 40% 
FCS and cultured at 37˚C.  
2.3 Viability assay using alamarBlue® 
Viability of cells treated with Vybrant® DyeCycle™ Violet stain and exposed to 
temperature reduction was investigated by subjecting cells to the same staining 
regime as for the sort and then analysing cellular metabolism via the redox indicator 
alamarBlue® (Serotec).  Simulating the sorting protocol, 10ml cells were stained at 
1x106 in 2% FCS supplemented HMI-9 with 1µg/ml Vybrant® DyeCycle™  Violet 
at 37˚C for 30 minutes, with a control set of cells not treated with the DNA stain 
incubated in parallel.  Both control and stained cells were then split into two falcon 
tubes and 20ml of PSG added to each tube to simulate the dilution in sheath fluid 
experience by the cells in the FACS sorter and incubated for 90 minutes to replicate 
the average length of a sort, with one of the tubes placed at 4˚C to mimic the FACS 
machine temperature and the other remaining at 37˚C to establish whether the 
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cooling step had a detrimental effect on the cells.  The cells were then counted and 
centrifuged for 10 minutes at 600xg and resuspended at 2x106cells/ml in 40% FCS 
supplemented HMI-9.  200µl of each sample was loaded in triplicate into a 96 well 
plate (Fisher Scientific) with 10% v/v alamarBlue®, with a further control of 
unmanipulated, unstained control cells grown in normal 20% FCS supplemented 
HMI-9, and wells containing 20% FCS and 40% FCS supplemented media alone and 
with 10% v/v alamarBlue®.  Excess cells were transferred into a 6 well plate, sealed 
with Parafilm and incubated at 37˚C.  The 96 plate was then incubated for 1 hour at 
37˚C in 5% CO2 with the lid placed on but not sealed, after which a MicroAmp™ 
optical adhesive film (Applied Biosystems) was adhered over the wells.  The plate 
was loaded into a BioTek® Elx808 plate reader at a temperature of 37˚C and the 
change in absorbance of the alamarBlue® was then recorded at 540 and 595nm 
hourly over a 24 hour time course using Gen5 software.  The data were adjusted 
through application of a correction factor to adjust for the use of a non-preferable 
wavelength of 595 instead of 600nm using the equation: 
Absorbance at 540 of media + alamarBlue® – Absorbance at 540 of media alone    
Absorbance at 595 of media + alamarBlue® – Absorbance at 595 of media alone 
 
calculated for each time point.  The percentage reduction at each time point of the 
alamarBlue® could then be calculated by the equation: 
% reduction = Absorbance at 540 –(Absorbance at 595 x correction factor) x100. 
2.4 Yeast experiments 
2.4.1 Strain and culturing 
The yeast strain used was Saccharomyces cerevisiae BY4741, with the genotype 
MATa, his3∆1 leu2∆0 met15∆0 ura3∆0 (kindly supplied by Aziz El Hage).  This 
strain has a GFP tag fused onto the Net1 gene to allow visualisation of the rDNA 
repeats on chromosome XII.  Frozen stocks of cells in YPD + 15% glycerol were 
streaked onto YPD plates and incubated at 30˚C, and single colonies used to 
inoculate into YPD liquid media.  Liquid cultures were grown in autoclaved conical 
flasks with a capacity at least ten times larger than the volume of liquid, and 
incubated at 30˚C with constant shaking.  
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2.4.2 Growth assays 
2.4.2.1 Growth in liquid culture 
The optical density of an overnight culture was assessed using the 600nm 
wavelength on an Eppendorf BioPhotometer and diluted to an OD600 of 0.005 into 
prewarmed YPD media.  The cells were then incubated with shaking until the 
OD600 of the culture reached 0.01, at which point the cells would be in logarithmic 
growth.  The culture was then split into autoclaved glass vials with a 35ml capacity 
and 3ml of the culture was placed into each vial with various doses of rapamycin (LC 
Laboratories), the solvent (100% ethanol) or left untreated.  The cultures were 
returned to the incubator and grown for a further eight hours with the OD600 
recorded every two hours.  Alternatively, 100µl samples of the drugged cultures were 
loaded in triplicate into 96 well plates, sealed with a MicroAmp™ optical adhesive 
film (Applied Biosystems) and incubated in a BioTek® Elx808 plate reader at 30˚C 
with continuous shaking set to ‘medium’.  This machine does not have a 600nm 
setting, thus the OD595 was recorded every hour for 12 hours using Gen5 software. 
2.4.2.2 Spot assays 
Yeast cells grown in liquid culture to an OD600 of 0.01 were used to make 10-fold 
serial dilutions with sterile water and 10µl spotted onto YPD plates containing either 
ethanol, 100nM, 500nM or 1µM rapamycin.  The plates were allowed to dry and 
then incubated at 30˚C for 48 hours. 
2.5 Molecular biology 
2.5.1 Small scale DNA preparation of plasmids 
Overnight bacterial cultures were prepared through inoculation of a single colony 
into 2ml of LB with 100µg/ml ampicillin and incubation in a shaking incubator at 
37˚C overnight.  The DNA was extracted from these cells using the rapid alkaline 
extraction procedure (Birnboim and Doly, 1979).  1.5ml of the overnight culture was 
centrifuged in an Eppendorf at maximum speed for 5 minutes and the supernatant 
removed.  The pellet was resuspended into 100µl ice cold Solution I through 
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pipetting and incubated on ice for 5 minutes.   200µl Solution II was then added, 
mixed through inverting the tube and incubated on ice for 5 minutes.  150µl of cold 
Solution III was added and the neutralisation reaction allowed to continue for 5 
minutes through incubation on ice.  The cell lysate was centrifuged at maximum 
speed for 10 minutes after which time the supernatent was transferred into an 
Eppendorf containing 900µl 100% ethanol, and incubated on ice for 15 minutes.  
Another centrifugation at maximum speed for 10 minutes was conducted to pellet the 
DNA, with the supernatant discarded.  The DNA was washed in 200µl 70% ethanol, 
air-dried and resuspended in 40µl sterile water containing 20µg/ml RNase. 
2.5.2 Large scale DNA preparation of plasmids 
Large scale preparations of DNA plasmids were carried out using a Qiagen midi-
prep kit following the manufacturer’s instructions from a 200ml overnight culture.   
2.5.3 Separation of DNA on an agarose gel 
Agarose gels of either 30ml of 100ml were cast in a tank (Bio Rad), through melting 
agars in TAE, with Safe View (NBS Biologicals) added to a final concentration of 
3.5%.  Routinely a 1% gel was used for resolution of sequences, although for 
separation of DNA sequences less than 400bp, 2% gels were used.  DNA loading 
buffer was added to samples and these were run alongside 5µl of the size marker 
SmartLadder (Eurogentec).  Gels were immersed in TAE buffer and subjected to 
electrophoresis at 100V until the DNA was resolved.  DNA was visualised on a UV 
light course and photographed using GeneSnap software (Syngene).  
2.5.4 Cloning 
Chemically competent Esherichia coli XL1-Blue (Stratagene) cells were transformed 
with plasmid constructs.  Cells, stored at -80˚C, were thawed on ice and 100µl was 
gently added to transforming DNA then incubated on ice for 20 minutes.  The cells 
were heat-shocked at 42˚C for 45 seconds, briefly cooled on ice, then recovered in 
100µl LB broth by incubation at 37˚C with shaking for 1 hour.  The entire reaction 
was then plated onto LB agar with 100µ/ml ampicillin and incubated overnight at 
37˚C. 
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2.5.5 Polymerase Chain Reaction (PCR) 
PCRs were carried out using as a template genomic DNA from monomorphic 427 
cells.  Genomic DNA was prepared using an animal tissue extraction kit (Qiagen) 
following the manufacturer’s instructions.  Standard PCR reactions consisted of a 
50µl reaction comprising: 20% 5x Green Buffer, 0.2mM dNTPs, 1.5mM MgCl2, 
1µM each of forward and reverse primers and 0.0375 units/µl GoTaq.  The 5x buffer 
used contains loading dyes, thus allowing the final product to be loaded directly into 
an agarose gel.  Both the GoTaq and buffers were purchased from Promega and 
primers ordered from Sigma.  Reactions were conducted in a ThermoCycler (Thermo 
Electron Corporation), with an initial denaturation step of 5 minutes at 95˚C, 
followed by 30 cycles of 30 seconds at 95˚C, a 30 second annealing step at 60˚C and 
an elongation step of 2 minutes at 72˚C, with a single final elongation at 72˚C for 5 
minutes. 
2.5.6 Restriction enzyme digests 
Digestion of DNA using restriction enzymes was typically carried out using: up to 
15µg DNA, 10% 10x recommended buffer (NEB), 10 units enzyme and 10% 
10xBSA as required.  Reactions were incubated at 37˚C for 90 minutes, or overnight 
for large amounts of DNA. 
2.5.7 Ligation 
Ligation into pGem T-Easy was carried out directly from PCR products via the T 
overhangs.  The reaction comprised: 50ng pGemT-Easy vector (Promega), 5% 
supplied 2x Buffer (Promega), approximately 150ng insert DNA and 1 Weiss Unit 
T4 Ligase (Promega), and were incubated at room temperature for 1 hour.  For 
ligation into other vectors, restriction digests were first carried out in order to 
generate complementary stick ends and both the insert DNA and the vector were 
separated on an agarose gel and excised using a clean scalpel to remove any uncut 
fragments, and purified using a gel purification column (Machery Nagel).  These 
ligation reactions comprised: 10% 10x ligase buffer (Promega), 0.15U/µl T4 DNA 
ligase and a ratio of 6:1 of insert:vector DNA, and were incubated at 4˚C overnight. 
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2.5.8 Sequencing 
Prior to transfection into cells, RNAi constructs were sequenced to ensure the insert 
was correct either from the pGem-T-Easy plasmid using the universal M13 
sequencing primers, or from the RNAi plasmid using the primers designed to amplify 
the insert.  All sequencing was performed by the Gene Pool (Edinburgh University) 
using an ABI 3730 capillary sequencing machine.  10-40ng of plasmid DNA was 
required in addition to a primer, either the M13 sequencing or a custom primer.  
Results were analysed using 4Peaks version 1.7.1. 
2.5.9 RNA interference 
T. brucei has the required cellular machinery for RNA interference, and this was 
exploited for the inducible depletion of genes of interest.  Primers were designed 
against a unique sequences of the gene using RNAit (Redmond et al., 2003) to 
generate sequences of approximately 500bp, incorporating XhoI and BamHI 
restriction sites onto the ends of the sequences to allow subcloning.  The amplified 
product was subcloned into pGem-T-Easy (Promega) using AT cloning, and the 
construct was then transformed into bacterial cells.  The construct was released from 
the pGem vector through digestion with XhoI and BamHI and ligated into the 
p2T7Tablue vector (http://trypanofan.path.cam.ac.uk/trypanofan/vector/), cut with 
the same enzymes to produce complementary sticky ends.  Once stably transfected 
into S16 cells, the expression of this construct could be inducibly expressed through 
the addition of 1µg/ml tetracycline.  Clones successfully transfected with the 
construct were then maintained in hygromycin to prevent loss of the construct 
through selective pressure. 
2.5.10 Immunofluorescence 
1 million cells were harvested per slide through centrifugation if cells for 5 minutes 
at 700xg, washing once in PBS and resuspended in 100µl PBS.  The cell suspension 
was gently spread over the slide using the side of the tip and allowed to air dry.  The 
slide was then immersed in cold methanol for at least 30 minutes at -20˚C.  The cells 
were rehydrated in PBS for 5 minutes then blocked in 5% BSA/PBS for 10 minutes, 
and stained with mouse anti-EP antibody (Cederlane Laboratories) diluted 1:500, and  
rabbit anti-AnTat 1.1 VSG antibody diluted 1:10,000, in 5% BSA/PBS for 45 
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minutes in a humidity chamber.  Unbound primary antibody was removed through 
washing three times for 5 minutes in PBS, then slides were probed with anti-mouse 
conjugated TRITC (Sigma) diluted 1:50 in 5% BSA/PBS and anti-rabbit conjugated 
FITC (Sigma), also diluted 1:50, for 45 minutes in a humidity chamber.  The slides 
were washed three times for 5 minutes and then stained with 10µg/ml 4’, 6-
diamnidino-2-phenylindole (DAPI) for 2 minutes and washed a final time.  The 
slides were mounted in 40µl MOWIOL with 10% of the anti-fade agent p-
Phenylenediamine (PDA) and a coverslip added.  Slides were allowed to set 
overnight at 4˚C before visualisation on a Zeiss Axioskop 2 plus microscope.  
Images were captured using QCapture and measurements made using ImageJ 64., 
with at least 100 cells measured per slide. 
2.5.11 qRT-PCR 
2.5.11.1 Primer design 
qPCR primers were designed to amplify a 143-217 bp amplicon using Primer3 
(Rozen and Skaletsky, 2000), with constraints in place to avoid picking primers with 
more than two consecutive repeated bases.  Primers also had to end in a CG clamp 
and have a melting temperature of 60˚C.  All primer pairs were screened using 
Amplify version 3.1 (http://engels.genetics.wisc.edu/amplify/) to assess for formation 
of primer dimers and finally the primers were used as templates in BLAST searches 
to ensure they would uniquely amplify regions from the single target gene.  All 
primer pairs were tested in PCR reactions against genomic DNA using an annealing 
temperature of 60˚C to ensure they were capable of amplification at this temperature 
and did not form primer dimers. 
2.5.11.2 qRT-PCR reaction 
cDNA was made from the same RNA as was used for the microarray using Oligo 
(dT)15 primer to specifically amplify mRNA, in a 20µl total volume using the 
Reverse Transcription System (Promega).  Briefly, 1µg sample RNA was incubated 
at 70˚C for 10 minutes then cooled on ice.  The reaction components were then 
added to the RNA, comprising: 5mM MgCl2, 1x reverse transcription buffer, 1mM 
dNTP mixture, 25 units RNasin ribonuclease inhibitor, 15 units AMV reverse 
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transcriptase, 0.5µg oligo(dT)15 primer.  The reaction was incubated at 42˚C for 15 
minutes, 95˚C for 5 minutes and then placed on ice for 5 minutes and finally diluted 
1 in 5 with nuclease-free water.  cDNA was stored at -20˚C until required.  
Alongside each preparation of cDNA from RNA, a No-RT control was also 
generated, where the same reaction was prepared in the absence of reverse 
transcriptase.   
 
For qRT-PCR, 20µl reactions were set up containing 5µl cDNA in 50% SYBR 
Green Master Mix (Roche) with 0.5µM forward and reverse primers on ice.  In order 
to avoid the possibility of contamination, a master mix solution was prepared of the 
SYBR Green and primers and added to the wells, with the cDNA added afterwards 
and mixed through gentle pipetting.  One row of wells was prepared at a time and all  
other wells were covered with Parafilm.  Plates were sealed with sealing foils 
(Roche) and centrifuged at 1500xg for 2 minutes prior to loading into the qRT-PCR 
machine.  Amplification reactions were carried out in white 96 well plates (Roche), 
in duplicate, in a LightCycler 480 machine (Roche) comprising a 10 minute pre-
incubation step at 95˚C followed by 40 cycles of 95˚C for 10s, 55˚C for 20s, 72˚C for 
10s with a single acquisition read taken at 82˚C.  A meltcurve analysis was 
performed from 65˚C to 97˚C with two acquisitions taken per ˚C, to test for primer 
dimer contamination.  No-RT controls were included for each 96 well plate, whereby 
the qRT-PCR reaction was conducted using as a template, cDNA which had been 
generated alongside the sample cDNA, but which had not had reverse transcriptase 
added.  In addition, no-template controls were also run in each experiment for which 
the cDNA was replaced with dH2O.   
 
Prior to using the primers to amplify sample cDNA, the primers were first tested 
against serially diluted cDNA taken from T. b. brucei EATRO 3420 stumpy form 
cells, to assess the PCR efficiency of the primers.  The cDNA was diluted 1:1000, 
1:100, 1:10 or left undiluted and the Cp of the samples plotted on a graph from which 
the steepness of the curve could be calculated.  From the curve slope it was possible 
to calculate the PCR efficiency of the primer set, and those not demonstrating an 
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efficiency between 90-110% were rejected.  qPCR primer sequences and PCR 
efficiencies are listed in Appendix I.  Relative quantification was calculated using the 
Pfaffl equation (Pfaffl, 2001) using as a standard Tb10.389.0540, a gene encoding a 
hypothetical protein, which was identified as being a stably expressed gene across all 
time points by array analysis. 
2.6 Northern Blotting 
2.6.1 Preparation of riboprobe 
A riboprobe was generated from the same unique sequence used for the RNAi, using 
the Roche DIG RNA labelling kit.  The unique sequence was ligated into pGEM and 
orientation discovered through amplification of the insert using a combination of 
M13 and gene-specific forward and reverse primers.  The insert was amplified using 
the M13 primers and, depending on the orientation of the insert, either the S6P or T7 
RNA polymerase used to generate an antisense RNA probe.  The probe was stored at 
-80˚C.    
2.6.2 Separation of mRNA on a denaturing gel 
RNA was prepared from trypanosomes during the slender and stumpy lifecycle 
stages taken from a rodent, and procyclic stage grown in culture, or from cultured 
monomorphic bloodstream form cells using a Qiagen RNA-easy kit according to the 
manufacturer’s instructions, completed with optional centrifugation step.  The RNA 
samples that were to be used for the microarray were also subjected to the optional 
DNase treatment.  All RNA samples were resuspended into 50µl RNase-free H2O 
and the concentration of the RNA was assessed either through loading 1.5µl of the 
sample onto a nanodrop (Thermo Scientific) or through dilution of 1µl sample into 
99µl of H2O and assessment of RNA concentration through absorbance on an 
Eppendorf BioPhotometer.  
 
A 150ml denaturing gel (3% formaldehyde, 1.2% agarose in 1xMOPS) was prepared 
in a fume cupboard.  2µg of RNA was denatured in 9µl formamide, 3µl 37% 
formaldehyde, 2µl 10xMOPS and 2µl RNA loading buffer (Appendix I) at 65oC for 
10 minutes and immediately loaded into the gel.   The RNA was separated in a 
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running buffer of 1x MOPS at 150 volts for approximately 90 minutes at which point 
the RNA would be adequately resolved.  The gel was stained with ethidium bromide 
for 15 minutes, destained twice for 30 minutes in water and photographed on a UV 
transilluminator in order to view the rRNA. 
2.6.3 Capillary blotting of mRNA 
MME paper was soaked in 10x SSC, and used as a wick in a reservoir of 10x SSC. 
The gel was flipped upside down onto the wick so that once the mRNA was 
transferred into the membrane it would be in the same orientation as the gel had been 
loaded.  A positively-charged nylon membrane was soaked in 10x SSC and carefully 
placed onto the gel so as to avoid trapping air bubbles.  Two layers of MME filter 
paper (Whatman) were soaked in 2x SSC and laid on top of the membrane, with 
approximately 10cm of paper towels stacked on top and weighted down using ~500g 
weight.  SaranWrap was used to cover to reservoir to prevent evaporation of the 
liquid.  The RNA was allowed to transfer overnight via capillary action and fixed 
onto the membrane using a UV crosslinker (UVI tech Ltd, UK) using a setting of 
0.12 joules for 120 seconds.   
2.6.4 Hybridisation of riboprobe 
The membrane was probed overnight after pre-hybridising for 1 hour at 68oC in 
hybridisation buffer (5xSSC. 50% formamide, 0.02% SDS, 2% blocking solution).  
The pre-hybridisation solution was discarded and 2µl of riboprobe boiled for 10 
minutes in 100µl hybridisation buffer was added to 7ml of prewarmed hybridisation 
buffer and added directly to the membrane and left to hybridise in rolling tubes in a 
Hybaid oven at 68˚C overnight.  The following day the membrane was washed two 
times for 30 minutes at 68oC in 2xSSC/0.1%SDS, then once more for 30 minutes at 
68oC in 0.5xSSC/0.1%SDS.  Washing and blocking steps conducted at room 
temperature were carried out in plastic lunch boxes which were washed with 
detergent and 70% ethanol between each step.  The membrane was rinsed in Wash 
Buffer (0.3% Tween 20 in Maleic Acid) for 1 minute at room temperature and 
blocked with constant agitation for one hour in Maleic Acid with 1% Blocking 
solution (Roche).  After this, the membrane was incubated in Maleic Acid with 1% 
Blocking solution and Anti-DIG (1:25000) for 30 minutes and then washed three 
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times in Wash Buffer.  The membrane was then soaked in Detection Buffer (100mM 
Tris-HCl, 100mM NaCl, pH9.5) for 2 minutes and placed in Bag ‘W’.  The excess 
Detection Buffer was removed and the membrane was labelled with 1:100 CDP-Star 
(Boehringer) in Detection Buffer through incubation in Bag ‘W’ for 2 minutes.  
Excess Detection Buffer was removed and the Bag ‘W’ was sealed in a heat-sealer 
and incubated at 37oC for 15 minutes to activate the CDP-Star then exposed on X-ray 
film (Kodak).  Routinely, the riboprobes used gave a good signal after 30 minutes of 
exposure. 
2.7 Western Blot 
2.7.1 Protein preparation 
2x107 trypanosomes were pelleted for 10 minutes at 600xg , washed in PBS, and 
pelleted again.  The pellets was resuspended in 100µl Laemmli sample buffer and 
boiled for 5 minutes.  Protein samples were stored at -20˚C until needed. 
2.7.2 Protein resolution on acrylamide gels 
SDS acrylamide gels were made up at 6% in order to resolve the 270kDa Tor protein 
as follows: 6% acrylamide-bisacrylimide stock (Severn Biotech Ltd), 375 mM Tris 
pH8.8, 0.1 % ammonium persulphate (APS) (w/v), 0.1% SDS, 0.05 % 
tetramethylethylenediamine (TEMED).  The gel was poured into Bio-Rad 
PROTEAN II casting apparatus, covered with a layer of 70% ethanol and, once set, 
the ethanol was rinsed off with dH2O and the stacking gel poured on top.  The 
stacking gel comprised 125 mM Tris pH6.8, 5% acrylamide-bisacrylimide stock, 
0.1% SDS, 0.1% ammonium persulphate and 0.1% TEMED.  15µl of protein 
samples were loaded per lane, equivalent of 3x106 cells and run alongside All Blue 
prestained protein marker (BioRad).  The protein were separated through applying a 
voltage of 150V for ~60 minutes, or until the dye front had reached the end of the 
gel. 
2.7.3 Transfer 
The proteins were transferred onto nylon membrane (Whatman) using a wet-transfer 
system (Bio-Rad).  The gel was sandwiched with the membrane between four layers 
of filter paper (Whatman) and finally two sponges, each layer placed carefully to 
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avoid trapping air bubbles, and soaked in transfer buffer.  Transfer buffer was 
optimised for transfer of large proteins (20% methanol, 25mM Tris, 150 glycine) and 
the proteins were blotted at 0.30A with amperage constant for 90 minutes, prevented 
from overheating using an ice insert, and checked for efficiency of transfer through 
visualising the transfer of the prestained ladder.  The membrane was rinsed briefly in 
dH2O and stained with ponceau (0.4% Ponceau S, 3% trichloroacetic acid (TCA)) to 
confirm transfer of the proteins, and the ponceau removed through repeated washes 
with dH2O. 
2.7.4 Detection of proteins 
The membrane was blocked in 5% skimmed powdered milk (Marvel) in PBS/0.1% 
Tween 20 for 1 hour with constant agitation, and then stained with 1:500 anti-TbTor 
polyclonal antibody overnight at 4˚C.  The membrane was then washed three times 
for 10 minutes in PBS/0.1% Tween 20, before incubation with 1:5000 anti-rabbit-
HRP conjugate secondary antibody (Sigma) in 5% milk in PBS/0.01% Tween 20 for 
45 minutes at room temperature with constant agitation.  The membrane was washed 
a further three times for 10 minutes in PBS/0.1% Tween 20.  The membrane was 
placed into Bag ‘W’ and Enhanced chemiluminescence (ECL) substrate (GE 
Healthcare) was added for exactly one minute.  The Bag ‘W’ was sealed and X-ray 
film was exposed to the membrane for up to 5 minutes. 
2.8 Microarray 
The labelling of the cDNA for microarray, quality assessment of RNA samples and 
microarray hybridisation were all carried out by Alan Ross (Division of Pathway 
Medicine, University of Edinburgh). 
2.8.1 Preparation of labeled cDNA 
The RNA from cells at different points of differentiation were assessed for quality 
using a Thermo Scientific Nano-Drop™ 1000 Spectrophotometer to assess the 
quantity and then quality analysed on an Agilent RNA 6000 Nanochip (lab-on-a-
chip), using a 2100 Agilent Bioanalyser.  The RNA was used as a template to 
generate labelled cDNA using the Agilent low input amplification protocol.  Briefly, 
a primer containing poly dT and the T7 polymerase promoter was annealed to 500 ng 
of polyA+ RNA and reverse transcriptase used to synthesize the first and second 
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strands of cDNA. Next, cRNA was synthesized from the double stranded cDNA 
using T7 RNA polymerase as specified by the manufacturer, with cyanine 3 (Cy3) 
labelled CTP included in the nucleotide pool and incorporated into the cDNA. 
2.8.2 Microarray hybridization and quality control 
Microarray hybridisations were carried out by Alan Ross.  5ug of the Cy3 labelled 
cRNAs were hybridised to the JCVI Trypanosoma brucei microarrays (version 3) for 
18 hours at 60°C, washed, and scanned using an excitation wavelength of 532nm and 
Cy3 detection filter in an Agilent microarray scanner (G2505B).  Microarray images 
were quantified using QuantArray software version 3 (Genomic Solutions). 
2.8.3 Statistical analysis 
All statistical analysis was conducted by Al Ivens (Fios Genomics). 
2.8.3.1 Normalisation 
The spiked Arabidopsis thaliana standards were used to assess the background 
hybridisation of each microarray and subtracted from the signal intensities for each 
gene.  An average fluorescent intensity was calculated for each gene from the two 
spots on the slides.  The mean intensity of the entire slide was calculated and the 
slides showing poor fluorescent signals were removed from further analysis.  Initially 
the slides were normalised within arrays to correct for variation in hybridisation over 
the entire surface of the slide, using print tip loess.  The normalised slides were 
compared to each other using Pearson correlation and the slides showing poor signal 
intensities were removed from further analysis.  The slides were then normalised 
between arrays using quantile normalisation. 
2.8.3.2 Detection of significantly differentially expressed genes 
The signal intensity of the individual genes was then compared to that of the genes in 
each different time point and the difference in intensity was log2 transformed.  The 
fold change of each gene was then calculated and subjected to a moderated t-test to 
identify those genes showing statistically significant differential expression.  An 
adjusted p value was calculated for each data point to remove errors arising multiple 
testing using the Benjamini and Hochberg method (Benjamini and Hochberg, 1995).  
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The genes that were found to show different levels of expression at a significance 
level of at least p<0.05 were then sorted into ‘profiles’, through implementing a 
trinary code on the data when compared to the expression level in stumpy form cells.  
Those time points showing an increase in expression level above a log2 of 1 when 
compared to the level in stumpy form cells were given the value +1, whilst those 
with a decreased expression level in contrast to stumpy forms of log2 of 1 were given 
a value of -1, with changes in expression between these two points assigned a value 
of 0.  The profiles were sorted according to the trinary codes of a gene expression 
level throughout the time course, with a possibility for 243 different profiles. 
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3 – Microarray Analysis Through Differentiation 
Whole genome microarray studies examining differences in life cycle expression 
patterns in Trypanosoma brucei have previously only focussed on cultured 
monomorphic bloodstream form and procyclic form cells, ignoring the differences 
that must have arisen in cells that have been laboratory adapted versus wild type field 
isolates and also genes expressed specifically in the stumpy form that bridges the gap 
between slender and procyclic forms (Diehl et al., 2002, El-Sayed et al., 2000, 
Koumandou et al., 2008, Brems et al., 2005).  However, an RNA fingerprinting 
experiment conducted on pleomorphic slender, stumpy and procyclic form cells 
showed that numerous genes do show a different expression profile between slender 
and stumpy forms, with two genes seen to have an increased level of expression in 
stumpy forms (Mathieu-Daude et al., 1998).  Similar life cycle microarrays have 
been carried out on parasites of the Leishmania species, one of which explored the 
transient differences occurring during the differentiation of the promastigote form 
found in the sandfly to the amastigote form that survives in the mammalian 
macrophage (Saxena et al., 2007).  From this study, a number of genes were found to 
show temporary up or down regulation, with a small number of genes fluctuating 
between the promastigote and amastigote form, which had never before been 
detected due to the omission of the transition phase between the life stages in 
previous experiments.  Thus we were interested in dissecting the expression 
differences between pleomorphic slender and stumpy forms, as well as changes 
occurring during the differentiation of the bloodstream form stumpy stage to the 
procyclic form to identify genes involved in the differentiation process. 
 
Very little is so far known about the genetic control of events involved in 
differentiation, so our experiment was designed to look at gene expression at key 
points during differentiation that coincide with known morphological or cytological 
events; 1 hour at which point the proteins comprising the procyclic surface coat are 
expressed, 6 hours which marks the loss of the bloodstream form VSG surface coat 
and should also correspond with the beginning of the re-entry to the cell cycle of the 
 
3- Microarray Analysis Through Differentiation 66 
parasites; 18 hours and 48 hours to distinguish between early and more established 
procyclic forms.  In order to generate data that could be meaningfully subjected to 
statistical analyses, we used multiple biological replicates, rather than technical 
repeats, which are not considered to provide useful additional information (Allison et 
al., 2006).  Thus, five stumpy form populations and their subsequent differentiation 
to 48 hours, and four slender populations were generated for microarray analysis.   
3.1 Experimental design 
Figure 3.1 shows, in schematic form, the experimental regime used in the assays.  
Ten mice were immune suppressed through treatment with cyclophosphamide one 
day prior to injection with T. brucei brucei AnTat1.1 parasites.  After three days, 
blood was harvested from four of the mice by cardiac puncture and the slender 
trypanosomes were purified over DE52 columns using PSG.  It is desirable to have a 
homogeneous population of cells when conducting a microarray experiment (Ness, 
2007), therefore to ensure that the slender populations had no stumpy cell 
contamination, the parasites were isolated when the parasitaemia was below 
2x107cells/ml, well beneath the density at which stumpy forms appear.  Between 4.6-
8.1x107 trypanosomes were harvested in total from each mouse from the slender 
infections.  The remaining mice were left until day six by which time the parasite 
infection consisted predominantly of stumpy form cells, and these were similarly 
purified.  Each mouse used to generate stumpy form cells yielded approximately 
1x108 parasites.  Unfortunately, two of the mouse infections for the stumpy 
populations resulted in a poor recovery of parasites, and therefore these two samples 
were pooled following purification; all other mouse infections were analysed 
separately.   
 
In order to limit any ‘cold shock’ induced gene expression (Engstler and Boshart, 
2004), syringes and PSG were kept at 37˚C and, once purified, the trypanosomes 
were rapidly placed into pre-warmed HMI-9 medium for one hour at 37˚C to allow 
them to recover from the purification procedure.  Both the slender and stumpy form 
cells were resuspended into the HMI-9 medium to a density of 1x107 cells/ml.  The 
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entire population was then used to make slides and extract RNA from the slender 
samples, whilst for the stumpy form populations, only 2ml of each sample was 
removed to make RNA and slides.  The remaining 8ml was diluted 1:4 so that the 
cell density was 2.5x106 cells/ml into SDM-79 media with 10mM glycerol pre-
warmed to 27˚C, and induced to differentiate through addition of 6mM cis-aconitate.  
10ml samples were then taken at each time point to generate RNA. 
 
        
 
 




Figure 3.1.  Schematic diagram showing sample generation strategy used for 
the microarray analysis.  The experimental set up shows how slender form 
parasites were isolated after three days of infection in a mouse followed by a brief 1 
hour recovery in HMI-9 media.  Thereafter, cells were fixed and spread onto slides 
or lysed for RNA extraction.  Stumpy cells were isolated after six days of infection, 
recovered in HMI-9 media then differentiation initiated by temperature reduction to 
27˚C and addition of 6mM cis-aconitate.  Slides and RNA samples were prepared at 
0, 1, 6, 18 and 48 hours after the initiation of differentiation. 
Samples from the cells undergoing differentiation were taken at certain time points 
and cell counts conducted, to ensure that cells had successfully resumed proliferation 
following differentiation.  From Figure 3.2 it is possible that see that bio-replicate #5 
shows the poorest growth, and also had the lowest number of cells initially.  This is 
the pooled sample from the combination of the parasites from two mouse infections 
where neither returned a high yield of trypanosomes.  Nonetheless, all of the 
differentiating samples showed an increase in cell number following differentiation. 
1 hour recovery in 
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Figure 3.2.  Growth of differentiating cells.  Samples from the cells were taken 
through differentiation to conduct cell counts to ensure cells were still viable.  Bio-
replicate#5 is derived from pooled samples from two mice and has the poorest 
growth, yet there is an increase in cell numbers over the course of differentiation. 
As the cells had been demonstrated to be viable and showed proliferation following 
differentiation, the samples taken for RNA were processed for the microarray. 
3.2 Quality control of RNA samples 
The quality of RNA used in a microarray hybridisation experiment is the determining 
factor for whether meaningful results are achieved (Morey et al., 2006).  To obtain 
the highest quality RNA possible, RNA was generated using the Qiagen RNeasy kit, 
and analysed by gel electrophoresis to ensure it was intact.  For our analysis it was 
also essential that the cells were progressing through differentiation in the expected 
manner.  To this end, extensive cytological analysis of the cells during differentiation 
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RNA was prepared from cells in such a manner so as to prevent degradation; cells 
were pelleted and washed in PSG before being lysed and RNA harvested using an 
RNeasy kit (Qiagen), with on-column DNase step being used to remove any 
contaminating gDNA.  5µl aliquots of each of the RNA samples were then loaded 
onto denaturating formaldehyde gels and the RNA profile visualised after 
electrophoresis using ethidium bromide to determine the RNA integrity.  Figure 3.3 
shows that the RNA was intact and gives a measure of relative concentration during 
the time series.  For example, the increased intensity of the RNA at 18 hours after the 
initiation of differentiation correlates with the cell division of the parasites at some 
point between 6 and 18 hours as the same volume of RNA was loaded without 
adjustment made for concentration or derived cell number.  This is in keeping with 






Figure 3.3.  RNA profiles of the samples used for microarray hybridisation 
visualised by ethidium bromide staining after resolution on denaturating gels. 
RNA was generated using a Qiagen RNeasy kit and samples visualised on 
formaldehyde gels to assess the quality of the RNA.  The upper panel shows the 
rRNA from RNA samples generated from the first four biological replicates of stumpy 
cells and during their subsequent differentiation; the lower panel shows the fifth 
stumpy sample and the RNA generated from the slender samples. 
In addition to visualisation of the RNA by formaldehyde gel electrophoresis, all 
samples were also quality controlled using a Thermo Scientific NanoDrop™ 1000 
Spectrophotometer to assess the RNA quantity and calculate their 260/280 ratio.  It 
  Bio-replicate#1    Bio-replicate#2    Bio-replicate#3  Bio-replicate#4  




  Bio-replicate#5       Slender  
0h 1h 6h 18h 48h 1    2    3    4 
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was found that all samples showed a 260/280 ratio of greater than 2.1; a good 
indicator that the RNA did not have protein contamination.  The limitation of this 
measurement is that it is unable to distinguish between RNA and any contaminating 
DNA.  However, the possibility of DNA contamination was excluded in later 
analyses when the same RNA samples were used for cDNA generation for qPCR 
analysis of array fidelity (Section 4.3).  In these experiments, RNA samples without 
reverse transcriptase failed to generate any template nucleic acid for amplification in 
the qPCR reaction, demonstrating an absence of contaminating DNA.  Hence, the 
RNA generated was considered suitable for microarray hybridisation. 
3.3 Confirmation that cells were undergoing differentiation 
Prior to using the RNA generated for microarray experiments, it was first necessary 
to analyse the cells the RNA had been derived from to ensure the cells had 
differentiated as expected.  Few molecular markers of stumpy form cells have been 
established and thus cells are usually designated as stumpy based upon 
morphological traits.  Fortunately, the kinetics of stumpy accumulation of AnTat1.1 
cells in vivo is well established and predictable, hence we estimated that harvesting 
bloodstream form cells from mouse infections at >2x108cells/ml would result in 
populations comprising at least 80% stumpy form cells; a density that was reached 
after six days of infection.  Morphological observation of the harvested cells 
confirmed this hypothesis.  Evidence was then required that the stumpy form cells 
had differentiated and this was generated using  analysis of the surface antigens on 
the cells, cell cycle re-entry and kinetoplast repositioning. 
3.3.1 Surface coat exchange 
Over the course of differentiation, the parasite must switch surface coats from the 
variant surface antigen (VSG) coat expressed during the bloodstream stage to allow 
protection from the host immune system, to the procyclin surface coat present on 
procyclic form parasites, thought to be protective against proteases in the insect 
midgut (Acosta-Serrano et al., 2001).  In T. brucei AnTat1.1 cells, the major VSG 
expressed is VSG AnTat1.1 and antibodies are available against both this antigen and 
EP proteins.  Therefore, slides of cells throughout differentiation were co-labelled 
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with antibodies against VSG AnTat1.1 and EP to track antigen coat switching 
(Figure 3.4).   
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Morphological analysis of the slides alone was sufficient to confirm the cells had 
differentiated, as stumpy form and procyclic form cells are easily distinguishable 
purely by shape and structure (Compare the upper and lower panels of the phase 
images in Figure 3.4).   This was verified through in-depth analysis of the surface 
staining of the slides for each biological replicate at each time point, which 
demonstrated that antigen switching had clearly taken place.  Therefore, to track the 
kinetics of the switching the presence of VSG and EP on the cell surface was scored 
for each biological replicate over the time course.  Coat exchange is an early process 
during differentiation, and in T. brucei AnTat1.1, EP has been detected on the 
surface of cells within the first three hours of differentiation (Sbicego et al., 1999).  
Figure 3.5A shows the gain of EP is rapid, with an average of 87% (range 79-94%) 
of cells expressing this protein on the surface by 6 hours into differentiation, with 
100% of cells expressing exclusively EP at 48 hours.  VSG loss is initiated less 
quickly (Figure 3.5B), resulting in a window in which cells express both EP and 
VSG on their surfaces, with over 90% of cells still expressing the VSG antigen at 6 
hours, although nearly all cells have successfully shed their VSG coat by 18 hours. 
 


















Figure 3.5.  Cell surface protein of differentiating cells.  Methanol fixed cells 
were dual stained with antibodies against the cell surface proteins EP and VSG 
AnTat1.1 and scored as either positive or negative for each.  At least 250 cells were 
counted for each slide, and all five biological replicates were scored for time points 
0, 1 and 6 hours, but only replicates #1, 3 and 4 were examined at 18 and 48 hours 
due to slide quality.  (A) EP is expressed on the cell surface almost completely by 6 
hours whilst (B) VSG loss is completed by 18 hours post differentiation.  
EP procyclin is introduced into differentiating cells through incorporation into the 
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differentiation, cells were seen to express both antigens equally.  The antigen switch 
from VSG to EP over the time course is a good indicator of differentiation.  Whilst 
EP surface expression can be triggered through coldshock in the absence of 
differentiation (Engstler and Boshart, 2004), when coupled with the corresponding 
loss of VSG, this data further confirmed that cells had differentiated.  
3.3.2 Kinetoplast repositioning 
Once harvested, it was also possible to monitor differentiation using the distance 
between the kinetoplast and the nucleus as a marker.  Over the course of 
differentiation, through a combination of migration of the kinetoplast towards the 
nucleus and outgrowth of microtubules at the posterior end of the cell, the kinetoplast 
is seen to move from the extreme posterior of the cell in bloodstream form slender 
and stumpy forms, closer towards the nucleus.  The extent of the kinetoplast 
repositioning has been measured previously and showed that the kinetoplast-
posterior distance increased from approximately 1µm in bloodstream form cells, to 
4µm in procyclic populations, although the reason for this is unclear (Matthews et 
al., 1995).   
 
To monitor this parameter, kinetoplast-posterior distance was measured for the entire 
time course of one biological replicate and then the 0 hour and 6 hour time points of 
all replicates, to establish whether all biological replicates were behaving in a similar 
manner.  Figure 3.6A shows schematically how the measurements were made, with a 
line drawn from the centre of the kinetoplast to very posterior and measured using 
ImageJ 64.  For each time point, a minimum of 100 cells were measured, and in later 
time points, once cells had resumed division and thus had two kinetoplasts, only cells 
with one kinetoplast were examined. 
 


















Figure 3.6.  Analysis of the kinetoplast-posterior distance during 
differentiation.  (A) Schematic diagram illustrating the measurement made.  A line 
was drawn from the centre of the kinetoplast to the extreme posterior of the cell and 
distance calculated using ImageJ 64 software.  (B) DAPI-stained parasites from bio-
replicate #1 at 0 hour (left panel) and 48 hours (right panel).  Line represents 50µm.  
Box and whiskers graphs plotting the mean and upper and lower quartiles of 
kinetoplast-posterior distance over the differentiation time course for (C) bio-
replicate #1, and (D,E) time points 0 and 6 hours plotted for each bio-replicate.  For 
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Figure 3.6C shows that there was a clear increase in distance between the kinetoplast 
and the posterior of the cells throughout the time course, initiating between 1 and 6 
hours into differentiation, whereby the distance in stumpy form cells was around 
1µm, increasing to 1.5µm at 6 hours, up to 4µm at 18 and 48 hours, which proved 
highly reproducible between biological replicates (Figure 3.6D and E).  Larger 
variations in size were seen for the later time points, as can been seen by the extent 
of the whiskers at the 18 and 48 hour time points, but this is in keeping with previous 
work (Matthews et al., 1995).  From Figure 3.6B it is possible to see that stumpy 
form cells position the kinetoplast at the extreme posterior of the cells, whilst at 48 
hours there was a clear movement of the kinetoplast towards the nucleus.  Previous 
work has also examined the distance between the nucleus and the kinetoplast 
(Matthews et al., 1995) which was found to decrease throughout differentiation, as 
can been seen through comparison of the two panels in Figure 3.6B.  The changes in 
morphology and organelle positioning from microscopy confirms that cells 
differentiated in the expected manner. 
3.3.3 Cell cycle analysis of differentiating cells 
Due to the quiescent nature of stumpy cells, which are G0 arrested, cell cycle 
analysis can be used to plot the re-entry into the cell cycle, and as such can be 
wielded as a tool to confirm that cells are progressing through differentiation.  
Therefore, to investigate cell cycle stage, parasites were methanol fixed and the 
cellular DNA was visualised using DAPI staining (see Figure 3.7) and analysis 
carried out of the number of kinetoplasts and nuclei in each cell, with at least 250 
cells scored from each slide.  DNA replication of the nucleus and kinetoplast of 
trypanosomes occurs in a tightly co-ordinated manner such that cells with 1 
kinetoplast and 1 nucleus (1K1N) must be either in G0/G1 or S phase (See Figure 
1.4).  Similarly, cells with a 2K1N configuration can be identified as in G2 or early 
mitosis, whereas 2K2N cells are post-mitotic.  During normal logarithmic growth in 
vivo, the majority of cells display the 1K1N configuration as demonstrated in all 
slender populations, with only approximately 15% (10-19%) cells 2K1N and around 
10% (7-13%) 2K2N (Figure 3.7).  Stumpy form cells, by comparison were almost 
entirely in the 1K1N configuration (>99%), confirming that these populations were 
growth arrested.  Over the course of differentiation it was possible to see the cells in 
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each biological replicate gradually resumed cell cycle progression, at 18 hours into 
differentiation between 3-18% of cells were in the 2K1N configuration and a further 
0.5-4% were 2K2N.  The 48 hour time point showed similar proportions of cells.  
Thus the cells in each biological replicate re-entered the cell cycle, with 
approximately the same kinetics between the samples, despite being derived from 











Figure 3.7.  Karyotype analysis of cells throughout differentiation.  Nuclear and 
kinetoplast DNA was visualised through DAPI staining of cells on each bio-replicate 
over the course of differentiation.  At least 250 cells were counted for each sample.  
Proliferating slender cells had a largely 1K1N karyotype, whilst stumpy cells all 
showed the 1K1N configuration, consistent with G0 arrest.  After 6 hours the cells 
re-entered the cell cycle with 2K1N and 2K2N cells present at 18 and 48 hours. 
Previous tracking of cell configurations through differentiation has shown 
predominantly 1K1N cells with a sudden appearance of 2K1N cells at 10 hours into 
differentiation, proceeded shortly afterwards by a lesser increase in 2K2N cells 
(Matthews and Gull, 1994).  Therefore, it appears that we have missed the point of 
cell cycle re-entry in our choice of time points, and somewhere between the 6-18 
hour timepoint an abrupt increase in 2K1N and 2K2N cells would have been seen.  
1 2 3 4     1 2 3 4 5    1 2 3 4 5     1 2 3 4 5    1 2 3 4 5    1 2 3 4 5 
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Thus the karyotypes at the 18 and 48 hour timepoints are more representative of the 
proportions seen in normal proliferative cells. 
 
All together, these results demonstrated that the RNA was of a good enough quality 
to be used for the microarray hybridisations, and analysis of the cells from which the 
RNA was derived assured us that the cells had progressed through differentiation in 
the expected manner.  The RNA samples could therefore be hybridised to the 
microarrays. 
3.4 Hybridisation of RNA to microarray slides 
Hybridisations were carried out using JCVI Trypanosoma brucei v3 glass arrays, 
which comprise 8594 T. brucei genes, with a single 70mer oligonucleotide target for 
each gene spotted in duplicate within the same grid.  Additionally, the slides contain 
500 control 70mers derived from genes from Arabidopsis thaliana, with known 
amounts of labelled cDNA probes from this organism ‘spiked’ into each test sample 
in order to calculate a reference signal intensity that can be compared against all 
arrays in an experiment.  Further “obsolete” 70mers are also present to calculate 
background hybridisation; these sequences do not have 100% homology to any T. 
brucei genes, thus any fluorescence signal from these loci are the result of non-
specific hybridisation and can thus be used as a measure of background signal 
intensity.  The calculated background signal is then subtracted from the overall 
intensity of each array. 
 
The microarray hybridisations were carried out by Dr Alan Ross in the group of 
Professor Peter Ghazals at the Division of Pathway Medicine, University of 
Edinburgh, with quality control conducted by Fios Genomics.  Single colour arrays 
were used in this analysis rather than the more widely used competitive, two-colour 
arrays.  Such one-colour arrays have been shown to be as sensitive and reproducible 
as two-colour arrays (Patterson et al., 2006) but without the issue of dye bias.  
Therefore technical replicates involving dye swap experiments are not required for 
these arrays, allowing more biological repeats to be conducted instead.  The 
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comparisons between the different samples were then carried out after all slides had 
been hybridised and normalised.  
 
As the microarray examines differences in gene expression level, only mRNA was 
required, which was uniquely amplified through exploitation of the polyA+ tail, 
which is present on mRNA but not rRNA.  Using the T7 promoter for generation of 
antisense RNA results in linear amplification, rather than exponential amplification 
as is the case with PCR, thus the relative proportion of the different mRNAs is 
maintained (Phillips and Eberwine, 1996).  Hence, cyanine 3 (Cy3) labelled cDNA 
was generated from the total RNA samples as is shown in Figure 3.8.  A primer 
containing poly dT and the T7 polymerase promoter was annealed to the poly A+ 
RNA, which was then amplified using reverse transcriptase.  The Cy3 label was 
incorporated into the samples via the presence of labelled CTP in the reaction mix 
when synthesising cRNA from the double stranded cDNA.  The labelled antisense 
cRNA samples were then hybridised to individual slides and scanned.  
 



















Figure 3.8.  Schematic diagram showing Cy3 incorporation into cRNA for 
hybridisation onto microarray slides.  In order to amplify the mRNA, a T7 
polymerase promoter and oligo dT sequence were annealed onto the poly A+RNA 
and reverse transcriptase added to produce double stranded cDNA.  This was then 
amplified using the T7 RNA polymerase to make the cRNA using Cy3-labeled CTP, 
which was incorporated into the cRNA product.  The cRNA was then purified prior to 
hybridisation.  (From the Agilent low RNA input fluorescent linear amplification kit 
protocol). 
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The hybridised arrays were then scanned using an excitation wavelength of 532 nm 
and Cy3 detection filter on an Agilent microarray scanner and images quantified 
using QuantArray software version 3. 
3.5 Quality control of hybridisations 
The method of extracting genuine data from the raw intensity values generated from 
the microarray hybridisations is summarised in Figure 3.9.  The background 
fluorescence generated from non-specific hybridisation was calculated from the 
obsolete and blank spots and subtracted from the intensity values for each transcript.  
The spiked-in Arabodopsis standards were used to adjust the overall intensities from 
each slide such that the standards were equal across all slides.  Each array was then 
subjected to within-slide normalisation, which accounted for the errors introduced 
from the printing procedure and for spatial effects.  Finally the slides were 
normalised between arrays to allow comparisons with the other time points and 
biological replicates.  All data processing steps were carried out by Fios Genomics. 
 
 














Figure 3.9.  Flow diagram illustrating the data processing steps applied to the 
raw microarray data.  The sequence of background adjustment and normalisation 
of the microarray are presented alongside the figures to which they relate. 
Background subtraction 
Intensity values calculated from blank and 
‘obsolete’ spots were subtracted from real 
spots. 
Figure 3.9 
Adjustment against standards 
Overall intensities were normalised against 
Arabodopsis standards. 
Normalisation within arrays 
Print tip loess was applied to each slide. 
Normalisation between arrays 
Inter-quantile normalisation was used to allow 
accurate comparisons across the different time 




Raw Intensity Data 
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Before any data analysis was initiated, the raw data taken from the microarrays was 
first ‘cleaned’ through background subtraction, and transformed into logarithms to 
base 2.  Transforming the data in this manner allows a better spread of the data than 
is achieved using raw values, hence making it more suitable for analysis (Stekel, 
2003).  Thus, each integer on the log scale represents a doubling of the raw data such 
that a log2 value of 8 corresponds to a raw intensity of 256 and a log2 value of 9 
corresponds to a raw intensity value of 512 (Stekel, 2003).   
 
In order to gauge the average fluorescent intensity of each slide, the background 
intensity was subtracted from the overall slide intensity.  Background signal occurs 
through non-specific hybridisation and was calculated using a combination of empty 
spots and probes without 100% homology to any transcripts on the array (obsolete 
spots).   The 4048 empty spots on the arrays have no oligo probes, so any 
fluorescence detected from these spots is entirely due to background.  However, the 
use of empty spots alone for background calculation has been criticised because the 
absence of DNA at a spot is not reflective of the situation for the real spots (Draghici, 
2003), therefore the ‘obsolete’ probes are also included, which are more 
representative of the real spots.  Following background subtraction, control probes 
from the Arabidopsis thaliana standards were used as a quality control method to 
assess the efficiency of the hybridisations.  These probes are designed against 500 
targets known to give a range of fluorescent intensities entirely independently of the 
experimental procedure (PFGR), thus the success of the hybridisation can be inferred 
from the deviation of the signal recorded from these spots from the expected 
fluorescence, and the individual arrays can all be normalised against these standards.  
The mean fluorescent intensity of the entire slide was then calculated for each of the 
arrays and drawn as a box plot along with the median intensity of the fluorescence 
for the entire set of slides (Figure 3.10).  The box plots show the log2 intensities of 
each slide in order to determine whether the fluorescent intensity of any of the slides 
strayed greatly from the median.  These graphs show the median log2 intensity of all 
spots for each slide at the centre of the box, with the edges showing the upper and 
lower quartiles, these encompassing the 50% of spots with a fluorescent intensity 
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surrounding the median intensity.  The whiskers represent the spots with maximum 










Figure 3.10.  Box plots of overall intensities of individual arrays.  The box plots 
were generated from un-normalised data with background subtracted.  The solid 
green line represents the median of the entire data set, and black lines the median 
of the individual sample.  Bio-replicate#2 18h was withdrawn from the later 
comparisons due to its very low intensity. 
In Figure 3.10 it is possible to see that the slide for biological-replicate#2 at 18 hours 
through differentiation (circled) has a much lower median fluorescence intensity 
compared to all other slides and was thus deemed to be of too poor a quality to retain 
in the data analysis.  
3.6 Normalisation within arrays 
Variations seen between different probes on the arrays might arise either due to 
biological or technical variations.  In order to eliminate the variations occurring due 
to technical discrepancies, slides were normalised within, and between arrays.  
Within-array normalisation was accomplished using a version of loess (locally 
weighted polynomial regression), print tip loess.  This is the preferred method to 
adjust for variations arising from the physical printing of the oligos onto the arrays 






























































































































































































































































Median of entire data set 
Upper and lower quartiles 
of entire data set 
Median of individual slide 
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physically spot the probes onto the slides can become worn and so oligos situated in 
areas of the array spotted from tips that are slightly worn or damaged in some 
manner will have bound to the slide with varying efficiency.  Print tip loess will 
correct for inaccuracies arising for these mechanical abnormalities and also works as 
a method to normalise locational effects due to spatial blocks on the slides being 
printed as a block.  Similarities between the background-subtracted data, normalised 
within arrays, for the individual slides were calculated using Pearson correlation.  
The results were then represented as heatmaps in order to better visualise the 














Figure 3.11.  Correlation plot, normalised within arrays.  Pearson correlations 
were calculated of the average intensity for each array with respect to each other 
array and the results are presented as a heatmap, such that blue shows a negative 
correlation and red a positive correlation.  Four of the arrays; bio-replicate#4 0 hour, 
bio-replicate#5 0 hour, bio-replicate#2 18 hour and slender#1, show little correlation 
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Pearson correlations were calculated for all arrays to judge the degree of similarity in 
average intensity between each of the arrays.  A value of  +1 (red) is representative 
of a perfect correlation, thus each slide when compared against itself is red, whilst -1 
(blue) is a negative correlation.  Looking at the heatmap it was clear that, in addition 
to bio-replicate#2 18 hour which had been shown to be of unsatisfactory quality from 
the box plot, three other arrays were also unsuitable.  Bio-replicate#4 0 hour, bio-
replicate#5 0 hour and slender#1 all showed largely negative correlation with the 
other arrays in the analysis.  All four of the unsuitable arrays were removed from 
further analysis, as the poor hybridisation efficiency of these slides could skew 
results gained from normalisation. 
3.7 Normalisation between arrays 
The remaining slides were then normalised between arrays to remove variations 
arising from non-biological differences (Smyth and Speed, 2003).  As the individual 
arrays were all identical it was then possible to use quantile normalisation to smooth 
the distribution of intensities between arrays to allow between-array normalisation.  
Following all the normalisation, large differences occurring for technical reasons 
ought to have been removed and thus all subsequent data should represent true 
biological differences. 
 
Figure 3.12 shows density plots of three of the time points before and after 
normalisation between arrays.  The individual slides were all normalised within array 
prior to global normalisation between arrays.  The 6 hour time point is a good 
example of a set of arrays with large variations in magnitude of intensity, whilst the 
three stumpy form samples that remained after quality control all show quite similar 
profiles even before normalisation between arrays.  Following normalisation, all 
biological replicates within and between time points showed the same profile, 
allowing meaningful comparisons to then be done without bias of data from slides 
with higher average intensities. 
 












Figure 3.12.  Density plots of slides normalised between arrays.  As an 
example, density plots of three of the time points are shown after (top panel) 
background subtracted raw data, and (lower panel) after slides had been normalised 
between arrays.  Only the arrays that had been shown to have reasonable 
intensities were considered, which is why only three biological replicates were 
included in between array normalisation of the slender and stumpy form arrays. 
Once the data were all normalised so that each array showed the same distribution of 
intensity, it was then possible to conduct the comparisons between the different time 
points.   
3.8 Summary 
Based on the quality control performed on the RNA prior to hybridisation onto 
microarray slides and then subsequent analysis resulting in the removal of four arrays 
from further analysis, we felt we could have confidence in interpreting the 
microarray as relevant biological changes.  The extensive analysis conducted to 
ensure that the cells used to generate the RNA for the microarray were differentiating 
as expected was also reassuring that the microarray data was certain to be 
representative of genuinely differentiating cells.  The next step was to carry out a 
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statistical analysis to examine differentially regulated genes, although prior to this 
the average was taken of the duplicate spots on the arrays and then the averages were 
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4 - Microarray Validation 
The previous chapter demonstrated that the cells used to generate RNA for the 
microarray analysis were differentiating efficiently and on the expected timescales 
and showed that the hybridisations had been carried out satisfactorily.  The next step 
required was to validate the results from the microarray.  Therefore, stringent 
statistical analyses were carried out to identify differentially regulated genes and 
these were compared against reference genes of known expression profile and 
through alternative methods of detecting expression level.  This chapter presents the 
results of this analysis. 
4.1 Statistical analysis 
Once the arrays for the individual samples had been normalised (see Sections 3.8-
3.9), all samples were then compared to each other and analysed for significance 
using a moderated t-test.  The moderated t-test is an extension of the original t-test, 
tailored to make it more appropriate for microarray analysis; the standard error for 
each gene is moderated based on the standard error for every other gene analysed, 
resulting in a higher level of reliability due to the smoothing of the standard errors 
(Smyth, 2005).  The data were log2 transformed to make interpretation easier 
through conferring equal weighting to all values; thus a log2 value of 1 represents a 
doubling and a value of -1 means the signal is halved.  The fold change of each gene 
was then calculated for each time point and the moderated t-test was used to assess 
the probability that each gene was significantly differentially expressed.  At p value 
<0.001 (0.1%), 407 non-redundant genes were found to be differentially expressed.  
Over 40% of the genes in the list were annotated as ‘hypothetical conserved’ genes, a 
further 6% were ‘hypothetical’ and 9% were ‘hypothetical unlikely’ transcripts.  In-
depth analysis of these genes found to be most significantly differentially expressed 
was encouraging.  Many of the transcripts present in this group had had their 
expression profiles previously investigated and the microarray data showed a strong 
level of agreement with the published literature (Table 4.1).   
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Gene Expression profile Reference 
PSSA2 Increased expression in procyclic 
form cells 
(Jackson et al., 1993) 
Hexose 
transporter 1 
Increased expression in bloodstream 
form cells 
(Bringaud and Baltz, 
1993) 
ESAG6 Increased expression in bloodstream 
form cells 
(Hobbs and Boothroyd, 
1990) 
META1 Increased expression in metacyclic 
promastigotes form Leishmania 
Confirmed increased expression in 
procyclic form T. brucei 
(Ramos et al., 2004) 
 
(Diehl et al., 2002) 
(Queiroz et al., 2009) 
Table 4.1.  Confirmation of the expression profiles of previously published 
developmentally regulated genes with the microarray data.  The published 
information relating to these genes refers to expression profile detected between 
monomorphic bloodstream form cells with cultured procyclic form cells.   
Table 4.1 lists a few genes with experimentally determined differential expression 
that correlated well with the microarray data.  Other genes with well-characterised 
expression profiles are analysed in more detail below.  
 
Figure 4.1 shows a heatmap of all the genes differentially expressed at a significance 
level of 0.1%, colour coded to illustrate their expression levels at each time point 
when compared against expression in stumpy form cells.  From this heatmap it is 
possible to see that the vast majority of differences were between the slender group 
and all others, with a large group of genes strongly up-regulated in slender forms 
only (dark red lines), whereas a smaller group comprised genes down-regulated only 
in the slender forms (dark blue lines).  These observations were anticipated, because 
the slender cells were derived from independent mouse infections to the time-course 
samples.  Furthermore, the different biological slender replicates also showed a great 
deal of variation between themselves.  In contrast, each of the separate biological 
replicate samples used in the time course series were derived from a single infection, 
and so would be expected to show more similarity to each other.  The processes 
involved in cell differentiation from the slender form into the stumpy form are not 
known; however based upon the growth arrest and altered morphology of stumpy 
forms, a correspondingly large alteration in expression profile is not unexpected.  
Many of the genes at this level of significance were known to be required for specific 
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life cycle stages and further validation has been conducted largely on the genes 









Figure 4.1.  Heatmap of the genes differentially expressed at the 0.1% level. 
The heatmap shows the expression profiles of all the genes that were differentially 
expressed significantly to a p value of 0.001 with a minimum 2-fold change between 
the level in stumpy form cells with the level in at least one other time point.  Each 
vertical line represents one gene, with the expression colour coded such that blue 
represents down-regulation in comparison to stumpy, red is up-regulated and white 
is unchanged.  The key contains a histogram showing the number of genes falling 
into each profile.   
These 407 highly significant genes represent less than 5% of the entire genome, so 
whilst all genes in this list can confidently be considered differentially expressed, 
numerous other potentially regulated genes will have been eliminated using such a 
stringent cut-off.  At a p value <0.05 (5% significance), 3396 non-redundant genes 
are identified as being differentially expressed between all comparisons.  However 
when the comparisons were narrowed down to only genes showing a minimum 2-
fold change between the level in stumpy form cells and at least one other time point, 
2166 genes remained differentially expressed.  In order to better dissect the 
differential expression of these genes in the microarray, a trinary code was assigned 
to each gene such that for each time point relative to stumpy form, the expression 
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to be classed as significantly differentially expressed, the difference in expression in 
at least one of the comparisons within the time course had to be significant at 5% and 
the cut off for a gene to be considered increased or decreased was set to a greater 
than 2-fold change.  Therefore a transcript with the profile -1-1-1-1-1 would be 
down-regulated at least 2-fold at all time points in comparison with stumpy forms 
and is thus enriched in stumpy cells, whilst the 00000 profile would represent genes 
that remain unchanged over the course of differentiation.  For each of the five 
comparisons a total of 243 distinct profiles were possible using the trinary code.  
However, only 74 different profiles were observed with 15 of these profiles only 
being represented by a single gene.  The observation that most genes followed a 
limited set of expression profiles is a good indicator of the quality of the microarray 
data as, had we seen multiple genes with wildly fluctuating profiles, it would be 
unlikely that these represented genuine biological events. 
 
Files can be downloaded comprising spreadsheets listing the 407 transcripts 
differentially expressed at the 0.1% level.  Lists of all genes differentially expressed 
between slender and stumpy forms are also available at both the 5% and 10% 
significance level.  In addition, tables for each pairwise combination are also 
available, including results of the statistical analysis.  All information can be 
accessed from http://www.biomedcentral.com/1471-2164/10/427/additional/.  A 
more user-friendly database is due to be launched at TriTrypDB, where it is possible 
for the researcher to choose the time points to compare, the cut-off level for fold 
change and the option to select only transcripts up or down regulated, or both. 
4.2 Validation of microarray against published data 
4.2.1 Phosphoglycerate kinase genes 
Validation of the microarray was first conducted through comparison of the 
microarray data against genes shown to be differentially expressed in the literature, 
although almost all of the published work concentrates on the differences between 
monomorphic cultured bloodstream form and procyclic forms only, with very few 
including expression analysis of stumpy forms.  In T. brucei, the three 
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phosphoglycerate kinase genes have previously been shown to be differentially 
regulated between bloodstream form and procyclic forms (Gibson et al., 1988).  The 
different genes code for the bloodstream form-specific PGKC that localises to the 
glycosome, the procyclic form-specific protein PCKB, present in the cytosol and 
PGKA, which is expressed at similar levels in both life stages, albeit at low levels, 








Figure 4.2.  Expression profiles of the three phosphoglycerate kinase 
determined by microarray.  The bloodstream form specific transcript PGKC is 
expressed at high levels in slender form cells but not in stumpy form cells or the rest 
of the differentiation time course.  PGKB shows increased expression as cells go 
through differentiation, as would be expected from a procyclic form specific 
transcript.  PGKA has a largely stable expression profile throughout all time points of 
differentiation. 
Figure 4.2 shows the expression profiles of PGKA, PGKB and PGKC, confirming 
previous observations (Gibson et al., 1988).   All genes show the expected profile in 
the microarray analysis, with PGKC being expressed predominantly in bloodstream 
form cells, with a clear drop in expression in stumpy form cells in comparison to the 
slender forms, whilst PGKB shows a more gradual increase across differentiation, to 
peak expression at 48 hours, as is expected of a gene that functions specifically in 
procyclic form cells.  Finally, also as expected, PGKA has a non-fluctuating 
expression profile across the time course. 
 
4- Microarray Validation 95 
4.2.2 Genes involved in proliferation 
As stumpy forms are growth arrested, it was possible to validate the microarray 
through analysis of the expression of genes required for active proliferation, which 
would be expected to be lowest in stumpy form cells.  The expression profiles of the 
histone array were examined as a marker of cellular proliferation. Figure 4.3 shows 
that there is a rapid drop in expression of the histone H2A and H2B array and histone 
4 in stumpy forms, which gradually recover to peak between 6-18 hours, as cells are 
actively dividing once more, and then maintained at a slightly lower level at 48 
hours.  This is consistent with previous work examining differentially expressed 
transcripts during differentiation where levels of H2B were seen to peak between 9-
12 hours into synchronous differentiation (Matthews and Gull, 1998, Garcia-Salcedo 
et al., 1999).  Histone H3 follows a similar profile but at much lower expression 
levels with expression not resuming after the drop in stumpy forms until 6 hours into 
differentiation.  Less histone H3 transcript may be expected in comparison with the 
other histone genes, as histone H3 is represented by only seven copies in the genome, 









Figure 4.3.  Expression profile of histone transcripts. The histones all 
demonstrate a decrease in mRNA abundance in stumpy form cells.  This is followed 
by elevation of mRNA levels at 1 hour into differentiation, which is rapidly increased 
over the time course, peaking between 6-18 hours for histone H2A, H2B and H4, 
with H3 resuming expression after 6 hours at lower levels to the others.  
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The peak of the histone transcripts at between 6-18 hours through differentiation is in 
keeping with the anticipated point at which cells would be in S phase.  Studies of 
DNA synthesis in differentiating cells has shown that cells undergo S phase between 
6-8 hours into differentiation (Matthews and Gull, 1994), and the mRNA levels for 
histones H2A, H2B and H4 have been shown to peak in S phase (Ersfeld et al., 
1996), therefore the profile is in line with the published knowledge on histone 
transcript regulation.  The histones were among the most significantly differentially 
expressed genes and all showed the expected profile, thus providing good validation 
of the microarray data. 
4.2.3 Genes up-regulated in procyclic forms 
Major differences in the environment between the mammalian bloodstream and 
tsetse fly midgut require trypanosomes to alter a variety of systems including their 
surface coat and their metabolism.  The procyclin surface coat is composed of both 
EP and GPEET procyclins, with GPEET found on earlier procyclic forms, this 
waning as the cells become more established (Roditi et al., 1998).  The rapidly 
increasing expression of E2 and EP3-2 in Figure 4.4A was expected, as the 
procyclins are not expressed in bloodstream forms, however the peak at 1 hour is a 
little sooner than might be expected; the same cell line has previously been shown to 
have maximal EP mRNA between 4-6 hours (Pays et al., 1993, Rolin et al., 1993).  
This difference could be contributed to by the reduced temperature experienced 
during cell purification, which is known to elevate procyclin mRNA levels (Engstler 
and Boshart, 2004), although syringes and media were pre-warmed to reduce any 
temperature fluctuations.  Alternatively, as previous work used Northern blots to 
analyse expression levels, these may have been less sensitive than the microarray, 
such that EP expression was detected later than seen here.  Additionally, in previous 
studies the total EP levels were examined, whilst we were able to distinguish 
between the different EP procyclin transcripts so will have been more able to dissect 
subtle changes.  A peak in expression of the procyclin mRNAs through 
differentiation was expected because cells have to rapidly cover the entire cell 
surface with the new surface coat early in differentiation and, once fully 
differentiated, the levels can be reduced (Pays et al., 1993).  Whilst EP2 is actively 
transcribed in procyclic cells it is not translated in parasites in culture; however the 
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expression profile for EP3-2, which is translated, was very similar.  The two EP3-2 
transcripts shown on the graphs are derived from different loci: Tb927.6.520 and 
Tb927.6.480, which are 88% identical.  The microarray slides did not contain a probe 
against EP1, however the results from the other EP and GPEET transcripts are a 
good indication that the microarray data accurately distinguished procyclic form 
specific regulation. 
 
The profile for GPEET is also in keeping with the literature (Figure 4.4A).  The 
relative proportions of GPEET and EP in the surface coat vary between individual 
cultures, however, the order of appearance of the different proteins is similar 
between stocks, with GPEET only ever expressed during the early stages of an 
infection (Vassella et al., 2000).  Both GPEET and EP can be detected on the surface 
of the cell from three hours into differentiation (Vassella et al., 2001), with GPEET 
peaking twelve hours into differentiation, around six hours after the peak in EP 
protein levels (Vassella et al., 2000).  The microarray profile of the mRNA levels of 
GPEET showing a peak in expression shortly after the peak in EP expression is in 
keeping with these earlier observations of the protein levels. 
 
The cytochrome oxidase complex is not required in bloodstream form parasites as 
they are able to survive on the abundant glucose present in the host bloodstream.  
However, once the parasites are taken up into the tsetse fly they must derive energy 
from available proline via mitochondrial respiration, and hence the COX subunits are 
up-regulated in procyclic form cells (Mayho et al., 2006).  In our analysis, the COX 
subunits V, VIII and IX were amongst the 407 most statistically significant 
differentially regulated genes (p< 0.001), whilst subunit VI was significantly 
differentially expressed at p<0.05.  Figure 4.4B shows the increasing expression of 
COX V, VI and IX through differentiation, of which the early expression of COX V 
and IX show pre-adaptation for tsetse uptake through up-regulation of these subunits 
in the stumpy form.  COX VIII also has lower expression in slender forms versus 
procyclic forms, but is lowest in stumpy forms.  These data are in accordance with 
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published work which studied the differences between bloodstream and procyclic 















Figure 4.4. Expression profile of procyclic specific transcripts by microarray. 
Expression profile of (A) the EP and GPEET procyclins.  The expression profiles of 
EP2 and EP3-2 are virtually identical, with both transcripts seen to have already 
increased in stumpy form cells, peaking at 1 hour through differentiation and then 
remaining expressed at a high level throughout differentiation, as expected.  A 
similar profile was seen for GPEET, which peaks slightly later at 6 hours through 
differentiation. (B) COX subunits expression profiles showed that, as expected, all 
subunits demonstrated lower expression in bloodstream forms than at 48 hours 
through differentiation.  COX V, IX and, to a lesser extent, VI showed an increase in 
expression in stumpy forms compared to slender forms, whereas COX VIII showed 
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Hence, the expression levels of genes required specifically in the procyclic life stage 
are rapidly increased during differentiation as expected, further validating the 
microarray. 
4.2.3.1 Unusual expression profiles of procyclin-associated genes 
The 0.1% list is so statistically significant that no miss-calls should feature.  Thus it 
was surprising that two procyclin-associated-genes (PAGs), a member of the PAG1 
family Tb10.70.1310 and of the PAG2 family Tb10.70.1300, showed a decrease in 
expression over the course of differentiation, contrary to the expected profile (Figure 
4.5).  Conventionally, PAGs form part of the procyclin polycistronic unit, are 
transcribed by RNA polymerase I and show similar expression profiles to the 
procyclins, with higher expression in procyclic form cells than bloodstream form 
cells (Berberof et al., 1996).  In contrast, these PAGs significantly differentially 
expressed at the 0.1% level, were found to be chromosome internal copies.  
Nonetheless, although the expression of these genes had not before been tested, we 
expected them to follow similar profiles as the sub-telomeric copies in the procyclin 
gene locus.  However, preliminary results from a deep sequencing project have 
shown the same trend for these two genes (Isabel Roditi, personal communication), 
implying that for this cell line at least, the observed expression trend was genuine.  
This provided more credence to the microarray data and highlighted an interesting 
trend.  Subsequent analysis of the procyclin-locus associated PAG2 
(Tb10.6k15.0060) and PAG4 (Tb10.6k15.0070), which were significantly expressed 
at the 5% level, showed that these too followed similar profiles, with decreasing 
mRNA levels over the differentiation time course.  However, PAG3 (Tb927.6.490), 
also significant at the 5% level, did show the expected profile, with transient up-
regulation in expression over differentiation, similar to the profiles of the procyclin 
transcripts (Figure 4.5A). 
 








Figure 4.5.  Expression profiles of members of the PAG family as determined 
by microarray.  The chromosome internal PAG genes Tb10.70.1300 and 
Tb10.70.1310 that were significant at the 0.1% level show a sharp decrease in 
expression from slender to stumpy form and continued to decrease throughout the 
time course.  Tb10.6k15.0060 (PAG2) and Tb10.6k15.0070 (PAG4) in the EP 
procyclin locus are significantly differentiation expressed at p<0.05 and show a 
similar profile. Tb927.6.490 (PAG3) shows an increase in expression during 
differentiation, peaking at 6 hours. 
The expression profile of the PAG genes found in the 0.1% significance list was 
surprising, yet was confirmed through subsequent deep-sequencing technology.  The 
similar profiles seen for the procyclin locus-associated PAG 2 and 4 genes was also 
surprising.  Investigation of the microarray probes used for the Tb10.6k15.0060/70 
locus and Tb10.70.1300/10 locus showed that the probes used for the microarray 
were specific, eliminating the potential for cross hybridisation.   
 
The unusual expression profile of some of these PAGs warrants follow-up work.  In 
particular; it is interesting that there is no correlation between the location of the 
genes or the type of RNA polymerase used for transcription and the expression 
profiles, with PAG 2 and 4 in the EP1/2 locus and PAG3 in the EP3 locus showing 
entirely different profiles despite both being transcribed by RNA polymerase I.  The 
mRNA levels of PAG3 have been analysed previously in monomorphic bloodstream 





PAG2 (EP1 locus) 
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form (Berberof et al., 1996).  As we do not know if the levels seen at 48 hours 
through differentiation are reflective of the steady-state levels of PAG3 in established 
procyclic form cells, and as monomorphic cultures were used for the previous study, 
it is not possible to use these results as a benchmark for validation of the microarray 
data. 
4.2.4 Genes up-regulated in slender forms 
The JCVI version 3 microarray slides used in these experiments were designed using 
the T. brucei TREU927/4 genome reference strain, and hence lack a probe for the 
AnTat1.1 VSG expressed by the parasites used.   Hence the most obvious marker of 
bloodstream form cells could not be examined.  However, the invariant surface 
glycoproteins (ISGs), which are shielded by the VSG coat, were represented on the 
microarray and these are also known to show developmentally regulated expression 
(Ziegelbauer and Overath, 1992).  Figure 4.6A shows the expression profiles of the 
five ISG genes showing differential expression at the 0.1% significance level.  All 
have increased expression in slender form cells and have immediate down regulation 
of expression in stumpy form cells.  The expression profile of the ISGs therefore is in 
keeping with the protein expression, which is seen to disappear entirely in procyclic 
form cells (Ziegelbauer and Overath, 1992). 
 
The metabolic differences between bloodstream form cells and procyclic forms also 
provide good expression markers of life stage to validate the microarray profiles.  
Figure 4.6B shows the expression profile for fructose-biphosphate aldolase, a protein 
localised to the glycosomes and required in glycolysis, showing, as expected, up-
regulation in slender forms.  Previous analysis of the mRNA levels of fructose-
biphosphate aldolase using Northern blots have demonstrated a 6-fold increase 
between procyclic form and bloodstream form cells (Clayton, 1985).  The result here 
of a 4-fold decrease between slender forms and cells 48 hours through differentiation 
is slightly less, however not unexpected, as microarrays tend to underestimate 
differences (Wurmbach et al., 2003).  Interestingly however, the activity of the 
enzyme shows elevation of up to 30-fold in the bloodstream form with respect to 
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procyclic form (Hart et al., 1984), possibly due to the extremely short half life of the 



















Figure 4.6.  Expression profiles of bloodstream specific transcripts.  (A) All ISG 
transcripts showed increased expression in slender form cells and were down-
regulated in stumpy form cells, staying at low levels for the remainder of the time 
course.  (B) The expression profile for aldolase, differentially regulated at a 
significance of 0.1%, also shows up-regulation in slender form cells as expected. 
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4.2.5 Genes up-regulated in stumpy form cells. 
Few genes are expected to be expressed in stumpy form cells due to the associated 
growth arrest and fewer still are known to be up-regulated in stumpy cells.  However, 
recently a family of carboxylate transporters have been characterised, which are 
required for citrate/cis-aconitate dependent differentiation (Dean et al., 2009).  These 
PAD genes lie in an array of eight gene members, of which five were shown to be 
significantly differentially expressed on the microarray, PAD6 at the 0.1% level, and 
PAD1, 3, 4 and 8 at the 5% level.  Figure 4.7 shows the expression profile of each 
gene, demonstrating that PAD1, 6 and 8 are all up-regulated in stumpy forms, with 
PAD8 in particular being expressed predominantly in stumpy form cells.  PAD 3 and 
4 appear to be more highly expressed during the later events of differentiation, 
demonstrating a similar profile to PAD2, which has been shown to be up-regulated in 
procyclic form cells (Dean et al., 2009).  Whilst the coding regions of the genes 
within the array are all highly similar, they do possess largely different 3’UTRs, so it 
is not surprising that they show different expression profiles, although all are seen to 









Figure 4.7.  Expression profiles of members of the PAD array.  Five of the eight 
members of the PAD array showed significant differential expression, with PAD1, 6 
and 8 being highly stumpy-enriched, and PAD 3 and 4 proving to be down-regulated 
in slender form cells. 
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As the initial validation of the microarray against the literature had proven largely 
accurate, we next used other methodologies to investigate whether the microarray 
results were biologically accurate.   
4.3 Validation of the microarray using qPCR 
4.3.1 qPCR control analysis and method evaluation 
Quantitative PCR (qPCR) is a standard method to verify microarray data (Morey et 
al., 2006), and by using SYBR® Green-based methodologies, it is possible to 
analyse numerous different targets.  In this approach, SYBR® Green is added into 
the qPCR reaction and during the extension phase is incorporated into the newly 
amplified PCR product, in which configuration it is activated and fluoresces.  The 
increasing level of fluorescence is measured in real time and a crossing-point (Cp, 
also called Ct) value is assigned to each sample, representing the point at which the 
level of fluorescence crosses the threshold above background.  Once the Cp values 
were determined for sample genes and a reference gene, relative quantification 
calculations were carried out using the Pfaffl calculation (Pfaffl, 2001):  
 
Ratio =  (Etarget)∆CPtarget(control-sample) 
   (Eref)∆CPref(control-sample) 
 
where E is the PCR efficiency of the primers, target refers to the test genes and the 
reference gene is the normalisation control gene.  In this equation, control refers to 
the stumpy form cDNA so that all other samples are calculated with reference to 
stumpy form levels of transcript. 
4.3.1.1 Primer design 
Quantitative PCR was used as a means to validate the microarray data by assaying 
the same RNA samples that had been used to hybridise to the microarray.  The 
individual RNA sample from each of the biological replicates were not pooled, in 
order to avoid potential contamination of good samples if one sample should prove to 
be anomalous (Allison et al., 2006), so all analyses were carried out on single sample 
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sets.  We were particularly interested in confirming that the genes identified as being 
enriched in stumpy form cells were correct, so primers were designed to amplify a 
143-217 base pair fragment from all transcripts in the -1-1-1-1-1 and -10-1-1-1 tables 
using the primer design program, Primer3 (Rozen and Skaletsky, 2000).  The primers 
were then assessed for their suitability in a qPCR reaction by cross-reactivity 
screening through running BLAST searches on the primer pairs, and by assessing 
their ability to form primer dimers using ‘Amplify 3.1’ 
(http://engels.genetics.wisc.edu/amplify/).  All primers were designed to very 
stringent criteria in order to ensure they were suitable for qPCR, these criteria 
included: a melting temperature of 60˚C, the primers must end in a GC clamp and 
must not contain more than two consecutive repeated residues.  Genes for which it 
was impossible to generate primers to these specifications were not analysed.  Prior 
to using the primers in a qPCR reaction, they were first tested on gDNA in a standard 
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Figure 4.8.  PCR amplification of gDNA using primers designed for qPCR. 
qPCR primers were used in a standard PCR reaction using gDNA as a template at 
an annealing temperature of 60˚C to test specificity of the primers.  The primers 
used in lanes 2, 4 and 15 failed to amplify under these conditions and were 
therefore not used in qPCR experiments.  All other primers amplified only one 
product corresponding in each case to the expected size and, with the exception of 
the failed primers, no primer pairs formed primer dimers, so these all underwent 
further testing for suitability in qPCR reactions.  Gene accession numbers relating to 
row number are listed in the table.  M= marker. 
Quantification of a qPCR reaction is conducted through comparing the level of a 
gene of interest against a reference control gene, however in order for the 
comparisons to be accurate, the primer pairs for the different genes must have similar 
PCR efficiencies to each other.  The delta delta Ct (ddCT) calculation is frequently 
used to quantify the difference between the crossing point of the control gene with 
that of the sample gene, automatically assuming the efficiency of the primers are 
100%.  The Pfaffl method is essentially the same equation, however the differing 
PCR efficiency of the primers is taken into account for the calculation (Pfaffl, 2001).  
In order to establish the PCR efficiency of the primer pairs used here, serial dilutions 
of stumpy cDNA from T. brucei brucei EATRO 2340 cells derived from a rodent 
M   11   M    12     M    13    14   15    
M  16  17  18   19   20  21  
M   1    2     3     4     5    6      M    7    8    9  10  
14   15    
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infection were assayed.  Ten-fold dilutions were prepared from the cDNA and qPCR 
reactions carried out in duplicate, from which standard curves were generated.  PCR 
efficiency was calculated from: 
Efficiency = 10(-1/slope)-1 
Only primer pairs providing a PCR efficiency between 90 and 110% were used for 
the validation experiment.  Figure 4.9B shows the standard curve generated from the 
amplification curves (Figure 4.9A) of Tb10.389.0540, which was one of the two 
genes used for normalisation as it was discovered in the microarray to be expressed 
at a constant level in all life stages.  This confirmed that the qPCR reaction was 
giving an accurate qualification of transcript levels in the cDNA dilutions for these 
primers. 
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Figure 4.9.  PCR efficiency of qPCR primers calculated from standard curves. 
(A) Amplification curves of 10-fold serial dilutions of T. b. brucei EATRO 2340 
stumpy form cDNA.  Primers against the normalisation control, Tb10.389.0540, were 
used in a qPCR reaction to amplify stumpy form cDNA to test the efficiency of the 
primers.  (B) From the amplification curves, a standard curve was generated by 
plotting the crossing points for each dilution.  The curve of the slope from the 
standard curve was -3.359, which corresponds with a PCR efficiency of 98.5%. 
At the end of each qPCR experiment, a melting curve was conducted to ensure that 
the fluorescence signal recorded was not the result of primer dimers or non-specific 
amplification.  Melting curves were generated through sequential increase of 
temperature immediately following the qPCR reaction, from 65˚C to 97˚C, taking a 
fluorescent reading every 0.5˚C.  If only one product is present, the meltcurve should 
show a sudden drop in fluorescence as the entire product melts simultaneously, 
becoming single stranded and thus dissociating from the SYBR® Green, which 
therefore stops fluorescing, as can be seen in Figure 4.10A.  The melt peak calculated 
from the melting curve shows the point at which the product melts.  In the case of the 
Slope = -3.359 
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alternative oxidase (TAO) primers the melting point is at approximately 89˚C (Figure 
4.10B).  A number of primers designed for the qPCR did form primer dimers, which 
impacted on the efficiency of the amplification rendering them unsuitable for 
accurate results.  Figure 10 C and D show the melting curve and associated melt peak 
of Tb927.5.4110, with strong primer dimers appearing in the sample at the lower 
concentrations of template.  This rendered these primers unsuitable for qPCR. 
 
In addition, the acquisition temperature was set to 82˚C in order to reduce the 
possibility of detecting signal from primer dimers, which should have a melting 
temperature below 80˚C.  Figures 4.10A and B clearly show that only one product 
was amplified by the primers designed against TAO, indicating that the set of 
primers does not form primer dimers or generate non-specific products.  Four of the 
primer sets caused poor PCR efficiency through to formation of primer dimers so 
were not tested on experimental samples.  The remaining primer sets that did not 
generate primer dimers were used to validate the microarray data. 
 

















Figure 4.10.  Meltcurve analysis of qPCR products to detect potential 
contaminating primer dimer products or non-specific amplification. 
Melting curves and melt peaks generated from the qPCR reaction on the serially 
diluted cDNA to calculate PCR efficiency for (A) TAO, showing a sharp drop on the 
melting curve representing the single peak at 89˚C seen in the melt peak graph, and 
(B) Tb927.5.4110, showing two peaks representing the melting of two products.  
The product with the melting temperature of 88˚C is the desired product, whereas 
the sequence melting at 79˚C reflects primer dimers.  An increase in primer dimers 
is seen with decreasing starting template as at higher template concentrations, the 
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4.3.1.2 Choice of normalisation control 
For qPCR to be accurate, a housekeeping gene is required, against which all the data 
can be normalised.  However, the differentiation process in T. brucei involves radical 
changes in gene expression and even conventionally used housekeeping genes, such 
as tubulin, are not necessarily equally expressed throughout these changes.  Using 
the normalised microarray data, it was possible to search for a gene with the lowest 
standard deviation across all individual samples tested at each time point, which also 
had a relatively high level of expression.  Such a transcript could act as a suitable 
control for comparison against other, regulated transcripts.  To this end, primers were 
designed against Tb10.389.0540, which codes for a hypothetical protein and had a 
standard deviation over all 25 samples of 0.32, and for comparison a second control 
was designed against Tb09.160.2110, also encoding a hypothetical protein, which 
displayed a standard deviation of 0.37.  The trypanosome alternative oxidase (TAO) 
gene had been identified previously by microarray as up-regulated in bloodstream 
form when compared with procyclic form cells (Diehl et al., 2002).  In our extended 
analysis, which looked at key time points during differentiation, TAO was found to 
be significantly elevated in stumpy form cells, and so was used as a good candidate 
to trial the two controls.  Thus, samples were taken from different biological-
replicates and qPCR carried out on different days, this yielding similar general 
profiles for both normalisation controls.  However, Figure 4.11 demonstrates the 
problems involved in choosing a good normalisation gene for qPCR; whilst both of 
the genes chosen confirm that TAO is up-regulated in stumpy forms, they show 
different expression levels across the rest of the time course.  This might be a result 
of using different biological replicates but it also highlights the limitations of using 
qPCR as a method of validating microarrays, as the normalisation procedure for 
qPCR cannot be nearly as ‘global’ as for the normalisation steps used in the 
microarray analysis, potentially leading to inaccurate or bias normalisation.  















Figure 4.11. Comparison of two candidate genes to act as the normalisation 
control in qPCR.  qPCR results using the cDNA generated from differentiating cells 
used in the microarray from TAO primers using different biological replicates, run on 
different days and normalised using (A) Tb09.160.2110 and (B) Tb10.389.0540.  
Samples were expressed relative to their expression levels in stumpy form. 
4.3.2 Microarray analysis and evaluation by qPCR 
To assess the expression levels of transcripts predicted to be up-regulated in stumpy 
form cells by microarray analysis, cDNA was generated using total RNA from a 
single bio-replicate time course, a slender sample and established procyclic form 449 
cells from culture.  Oligo dT primers were used to amplify only the mRNA and not 
the rRNA, as was used for the microarray, and qPCR carried out.  In each experiment 
a ‘no-RT’ control of the stumpy form sample was included, whereby the qPCR 
reaction was carried out on template cDNA, generated from RNA in parallel to the 
sample cDNA, but which lacked the reverse transcriptase, to ensure amplification 
was from the cDNA and not contaminating gDNA.  Additionally, a ‘no-template’ 
control was included, whereby the cDNA was replaced with water in the qPCR 
reaction, to test for genomic contamination from any other reagent source.  The 
generated results were then presented as relative to their expression in stumpy form. 
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Although many of the genes tested gave the expected profile by qPCR, a number of 
qPCR experiments were found to give very different results to those in the 
microarray.  These were reproducible on different biological replicates in different 
reactions, even with different dilutions of the cDNA to ensure that there was no 
saturation of the signal.  Figure 4.12A shows genes whose expression profile from 
qPCR matched that of the array analysis, whereas Figure 4.12B shows the qPCR 
profiles of the genes found to be in disagreement to the microarray.  For those that 
did not agree with the array profile, no pattern was observed in the profiles ruling out 
a technical error in assigning profiles to these genes. 
 















Figure 4.12.  Validation of microarray results using qPCR.  qPCR validation of 
genes classed as ‘stumpy-enriched’ by the microarray of (A) the six genes that 
followed the correct general profile and (B) the seven genes that showed different 
profiles to the microarray.  Even where the qPCR results agreed with the trend 
determined by the microarray, the level of change often differed considerably. 
In conclusion, the qPCR data gave conflicting results to the microarray in some 
cases, and for some of the genes that did show correct trends, the precise expression 
profile differed from the array data.  Such a discrepancy between qPCR and 
microarray data is often seen (Holzer et al., 2006). 
4.4 Northern blot validation 
In order to generate verification data for those stumpy-enriched genes that could not 
be tested using qPCR, either due to failure to design unique primers, inability of the 
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good enough PCR efficiency, Northern blots were used as an alternative method of 
validation.  The gene for alternative oxidase (TAO), which had produced successful 
qPCR data, was also included to gain further confirmation as this gene has a high 
level of expression, thus making it a good candidate for Northern analysis. The TAO 
probe had previously been generated by Melanie Buelmann, and Northern probes 
against two other candidates, Tb09.211.2300 (a putative RNA helicase) and 
Tb927.1.4450 (a potential calcium channel), were generated through using the 
programme RNAit (Redmond et al., 2003) to identify unique sequences of the gene. 
Primers were designed to amplify the unique sequence, which was then inserted into 
a cloning vector (pGem-T-easy), the orientation of the sequence ascertained and 
either T7 or SP6 RNA polymerase was added to generate an antisense riboprobe 
from transcription initiation sites in the vector.  Northern Blots were generated using 
the same mRNA as used for the microarrays, with the addition of mRNA isolated 
from established procyclic form cells (PCF 449) and then riboprobes were used to 
detect the levels of the transcripts throughout the time course.  Figure 4.13 shows 
that Tb10.6k15.3640  (TAO) and Tb927.1.4450 had the expected profiles with a 
higher level of expression for stumpy forms compared with the other time points.  
However, Tb09.211.2300 showed a greatly divergent result to that seen on the 
microarray, with the highest levels of expression at 18 and 48 hours through 
differentiation, and much lower levels seen in stumpy form cells.   
 
 










Figure 4.13.  Expression of transcripts identified as up-regulated in stumpy 
form cells validated using Northern blots.  Northern blots were conducted on the 
same mRNA as used for the microarray to verify the expression profiles of genes 
detected in the microarrays as stumpy-enriched.  (A) Tb09.211.2300 does not follow 
the trend suggested in the microarray because expression levels were found to be 
lower in slender and stumpy forms and increase over the time course.  (B) 
Tb10.6k15.3640 shows the highest expression levels in stumpy forms, with reduced 
levels in cells 18 hours into differentiation, confirming the microarray and qPCR 
data.  (C) Tb927.1.4450 shows an enrichment in stumpy form cells, in agreement 
with the microarray data, although its overall level of expression is apparently low in 
comparison to the other transcripts assayed. The ethidium bromide stained 
ribosomal RNA is shown below as a loading control. 
Again, the lack of correlation between the microarray and Northern analysis for one 
of the transcripts merely corroborates the limited worth of alternative methods of 
validation of microarray data.  In particular, Northern blotting does not use any 
internal normalisation controls; rather the normalisation is based on the equal loading 
of rRNA based on the visual assessment from the ethidium bromide stained gels.  
This is not effective as a loading control for the stumpy form sample because it has 
been shown that in this life form, despite hugely reduced levels of mRNA, rRNA 
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correlate with an equal amount of total RNA loaded in each sample.  In contrast, the 
microarray normalisation takes into account the expression levels of thousands of 
genes simultaneously.  With these constraints taken into account it is perhaps more 
surprising that any of the Northern data showed similar results to the microarray 
rather than the fact that one gene showed a different profile. 
4.5 Comparisons against other microarray analyses in T. brucei 
Historically, most microarray analyses carried out on T. brucei have looked only at 
culture-adapted parasites, and compared only monomorphic bloodstream form cells 
against procyclic cells.  Hence, a detailed comparison of our microarray data against 
these previously published experiments is not likely to be a worthwhile examination.  
Certainly, the assumption that monomorphic cells are a suitable equivalent for field 
isolated bloodstream form slender cells is likely to be wrong, and the compounding 
distinction between in vitro and in vivo grown parasites is liable to generate further 
differences.  Following the publication of our microarray data (Appendix 2), two 
similar microarray analyses were also published investigating differentiation of T. 
brucei (Jensen et al., 2009, Queiroz et al., 2009).  The Queiroz et al (2009) study was 
conducted on the same microarray slides using the same cell line, however the 
parasites used for the differentiation experiment were derived from in vitro 
differentiated cells, which do not develop into true stumpy form cells.  The Jensen et 
al (2009) study was conducted on a custom tile array, such that up to eight probes 
were designed for each gene.  This study also looked at the differences between 
parasites grown in vitro and those isolated from in vivo infections and concluded that 
the differences in environment had very little effect of the gene expression of the 
parasites (Jensen et al., 2009).    
 
In their paper, Queiroz et al (2009) conducted a brief comparison of their data set 
against our data set and conclude that the majority of genes show similar trends in 
both studies, although the genes defined in the different studies as showing the most 
significant differential expression only overlap to a certain degree.  The timing of 
events during differentiation are distorted in the Queiroz et al (2009) study, as the 
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parasites were not true stumpy forms before differentiation, but had merely been 
grown to a high density, at which point they are described as “resembling stumpy 
forms”, however the fact that many genes show comparable trends of expression is 
encouraging.   
 
The Quieroz et al (2009) experimental design differed from ours in that the arrays 
were competitive two-colour analyses, with samples from each time point hybridised 
alongside procyclic form cDNA.  In order to facilitate a comparative analysis against 
our data, which was presented relative to expression in stumpy form cells, the 
authors converted our data to present each time point with respect to expression at 48 
hours, this sample being considered equivalent to established procyclic form cells.  
The limited set of genes chosen for the comparisons show highly similar profiles 
through differentiation, with Tb11.02.2310, a prostaglandin f synthase, proving 
almost identical (Queiroz et al., 2009).  However, the sets of genes differentially 
expressed at the 5% significance level did not overlap extensively between the 
studies, rendering further comparisons unfeasible.  The authors conducted extensive 
bio-informatic analysis of the data derived from the in vitro data set, grouping 
together genes with similar profiles and subsequently assigning likely functions to 
the members of these ‘clusters’ (Queiroz et al., 2009).  Summary analysis of our data 
set did not reveal similar functions for the genes in the different profiles.  The Gene 
Ontology annotations of the genes falling into the different profiles were investigated 
(Kabani et al., 2009), but in general were not revealing due to the poor quality of the 
annotations.  Thus, whilst it is possible to speculate on the nature of the genes, 
functional analyses of the genes will be required to determine whether transcripts 
with the same profile play similar roles or interact with each other. 
 
The Jensen et al (2009) study used a different cell line, and the cells used to harvest 
the RNA for later time points in differentiation do not come from the same 
population as was used to harvest RNA for the stumpy form cells.  Nevertheless, 
some of the comparisons conducted were the same in both studies, such as slender 
from compared with stumpy form.  In this comparison, out of the 33 transcripts seen 
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by Jensen et al (2009) as showing an increase in expression in stumpy form cells 
when compared to slender form cells, 21 of these demonstrated the same expression 
profile in our array (Table 4.2).  This gives a correlation rate of 64%, where most of 
the transcripts showing conflicting results were the ‘hypothetical conserved’ and 
ESAG9 genes. 
Gene  Accession number Confirmed in this study 
aquaporin 3 Tb927.6.1520  
ESAG4 Tb11.03.0990  
Tb927.1.5220  
Tb927.5.120   
Tb927.5.4620  
Tb927.7.170   
Tb09.160.5400   
Tb09.160.5430  x 
ESAG9 
Tb09.v1.0330  x 
Tb09.142.0370 x ESAG9-like 
Tb09.142.0380 x 
glutamate dehydrogenase Tb09.160.4310 x 
GPEET2 procyclin Tb927.6.510  
Tb927.2.2140  
Tb927.6.4270   
Tb927.7.4270  x 
Tb09.160.0465  x 
Tb09.211.1620   
Tb09.v1.0490  x 
hypothetical conserved 




Tb10.70.2840  x hypothetical protein 
Tb10.70.2850  x 
PAD2 Tb927.7.5940  
mitochondrial processing 





protein phosphatase with EF-
Hand domains 
Tb927.8.1130  
purine nucleoside transporter Tb09.160.5480  
pyruvate dehydrogenase complex 
E3 binding protein 
Tb10.70.5380  




transketolase Tb927.8.6170 x 
VSG-related VR2.1 Tb11.01.4560 x 
Table 4.2.  Comparison of stumpy enriched transcripts identified from two 
microarray studies.  The genes found by Jensen et al (2009) as showing increased 
expression in stumpy form cells when compared with slender cells were analysed in 
our microarray.  64% of the transcripts show the same profile in this comparison 
between the studies, with the majority of conflicting profiles found in the ESAG9 and 
‘hypothetical’ genes.  
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The concurrence rate of 64% might appear low, however considering the differences 
between cell lines, isolation of parasites from blood and differences in microarray 
technologies used between the studies, such a level of agreement is considerable. 
4.6 Characterisation of the stumpy enriched genes 
The extensive biological validation of the samples used to generate the RNA for the 
microarray and the validation of the resulting profiles against the published data, 
gave us confidence to investigate further some of the ‘stumpy-enriched’ transcripts 
identified.  These comprised genes up-regulated only in stumpy cells, and those still 
up-regulated 1 hour into differentiation.  Using the cut-off significance of a p value 
of 0.05, 65 genes met these criteria.  Within this cohort, 40% were genes annotated 
by GeneDB to be open reading frames unlikely to code for functional proteins or 
sequence orphans, and a further 33.8% were genes coding for proteins conserved 
with those in another organism.  There was no obvious pattern to the genes within 
these two profiles, with the remaining genes with functional annotations having 
wide-ranging predicted protein functions.  However, three potential ion channels 
were identified: a chloride channel protein (Tb10.26.0220), a calcium pump protein 
(Tb927.5.3400), which is a homologue of the endoplasmic reticulum calcium 
transporters, and a gene putatively coding for a subunit of a potassium channel 
(Tb927.1.4450).  This gene has previously been subjected to RNAi analysis in 
bloodstream form cells, and no growth, motility or karyotype defects were observed, 
however the cell line was not tested for differentiation capacity (Subramaniam et al., 
2006).   
 
In addition, two ATP-dependent DEAD/H RNA helicase genes were present in the 
‘up-in-stumpy’ group (Tb09.211.2300 and Tb10.70.6180).  That two members of this 
family should be enriched in stumpy form cells was intriguing; these proteins have 
wide-ranging functions but little is known of their role in T. brucei.  Previously, a 
DEAD box protein HEL64, with similarities to the nuclear-localised mammalian p68 
protein, was identified in T. brucei, however this protein was found to be localised to 
the cytoplasm so was therefore not a likely homologue of p68 (Missel et al., 1999).  
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Attempts to create cells null for HEL64 in procyclic form cells were unsuccessful, 
suggesting that this protein was essential in this life cycle stage (Missel et al., 1999).  
With the caveat that similarities to homologues in other organisms does not 
necessarily mean a shared function in T. brucei, a BLASTP search was conducted 
against Tb09.211.2300 which showed high similarities to the S. cerevisiae protein 
Spb4, whilst Tb10.70.6180 showed high sequence conservation to RNA helicase 
II/Gu.  The yeast Spb4 protein was shown to be required for processing the 27SB 
pre-rRNA subunits (de la Cruz et al., 1998), and RNA helicase II/Gu has been shown 
in mammalian cells to interact with the ribosomal protein L4, and so aid in the 
production of 28S rRNA (Yang et al., 2005).  Therefore, it may be possible that these 
transcripts enriched in stumpy form cells, are required for ribosome synthesis.  
However, whilst the rate of rRNA synthesis in stumpy form cells has not be tested, 
for mitochondrially-encoded ribosomes at least, rRNA synthesis has been shown to 
occur at the same rate between bloodstream form and procyclic form cells even 
though the protein levels differ (Michelotti et al., 1992).  It is equally possible that 
these proteins perform roles unrelated to those in higher eukaryotes, as another 
DEAD-box protein in T. brucei has been shown to be involved in RNA editing 
(Missel et al., 1997).  Interestingly, an unrelated DEAD/H RNA helicase in 
Plasmodium has been shown to be essential in post-translational regulation of 
mRNAs required for release from quiescence, through sequestering them into the 
cytoplasm and thus regulating the correct timing of development (Mair et al., 2006).   
 
To begin to address the function of these stumpy enriched genes, an RNAi 
experiment in cultured monomorphic bloodstream form cells was carried out for the 
putative chloride channel gene.  Firstly, a unique segment within the gene was 
identified in Tb10.26.0220, using RNAit (Redmond et al., 2003), and then cloned 
into the p2T7TAblue vector (Alibu et al., 2005), which integrates into the ribosomal 
spacer region.  Figure 4.14A shows a Northern blot of two clones generated after 
transfection of an RNAi construct directed against Tb10.26.0220.  Although some 
knockdown of the mRNA was achieved for this gene, no growth phenotype was 
observed in these cell lines even after six days of induction (Figure 4.14B).  
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Similarly, no morphological phenotype was observed.  A number of explanations 
may account for these observations.  Firstly the RNA knockdown may have been 
insufficient to generate a phenotype.  Secondly, it may be that this gene is not 
required in cultured bloodstream form cells; these experiments were carried out in 
monomorphic culture-adapted cells, which may not correspond to the situation in 
pleomorphic slender cells.  A third possibility for the absence of phenotype upon 
knockdown of this gene may stem from the fact that this chloride channel is a 
member of a conserved family through eukaryotes, and two related putative chloride 
channel Tb11.01.8420 and Tb09.211.0430, showing similar expression profiles 
(Figure 4.15), are present in the T. brucei genome.   This raises the possibility that 
these proteins may have redundant functions. 
 



















Figure 4.14.  RNA analysis and growth kinetics of Tb10.26.0220 depleted cell 
lines.  (A) Northern blots of the parental single marker bloodstream form cells with 
and without tetracycline and two clones showing inducible knockdown of 
Tb10.26.0220 through RNAi.  These cells lines show double stranded RNA 
(arrowhead) even without induction through tetracycline, suggesting that the 
expression of the RNAi construct is occurring at low levels in the absence of 
induction.  However, a much higher level of knockdown is seen upon treatment with 
tetracycline.  The transcript is indicated with an arrow.  (B) Growth kinetic analysis of 
the two clones showed no observable growth phenotype. 
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Using Tb10.26.0220 as a query in a BLASTP search identifies two other similar 
proteins, which also have conserved domains in keeping with chloride channels.  
Figure 4.15 shows the expression profiles for each of these putative chloride channel 
proteins: Tb10.26.0220, Tb11.01.8420 (30% identity to Tb10.26.0220) and 
Tb09.211.0430 (35% identity to Tb10.26.0220).  These related genes show similar 
expression profiles to Tb10.26.0220 but fall below the cut-off for being designated 
‘stumpy enriched’, that is, there is not a 2-fold difference between the expression 
level seen in stumpy form cells with those from the other time points.  Significantly 
however, all three transcripts were strongly elevated in stumpy form cells, although 
only Tb10.26.0220 shows transient expression during differentiation, unlike the other 
two genes which are retained in late differentiated cells (Figure 4.15).  The similarity 
of these proteins at the amino acid level, and their similar expression profiles, could 
imply that the proteins are at least partially redundant.  These chloride channel 
proteins show good similarity to the human chloride channel 7 protein (between 22-
29% identity), which has been implicated in controlling pH levels in lysosomes 
through its action as a Cl-/H+ antiporter to maintain a pH of 4 (Graves et al., 2008).  
In trypanosomes, the pH of lysosomes is kept constant in bloodstream forms at 4.84, 
with lysosomes playing an important role in the degradation of glycolysis products 
(McCann et al., 2008).  Interestingly, lysosomes have been shown to co-localise to 
glycosomes during differentiation and glycosomes are entirely recycled during 
differentiation (Herman et al., 2008).  Moreover, lysosomes are particularly enlarged 
in stumpy forms (Herman et al., 2008), so an up-regulation of proteins required for 


















Figure 4.15.  Expression profiles of three putative chloride channels follow a 
similar pattern.  Tb10.26.0220 shows a highly-stumpy enriched expression profile, 
and two other genes that were found to be homologous via a BLASTP search show 
similar profiles to Tb10.26.0220 and even more similar profiles to each other. 
Further investigation into these chloride channels and the other genes shown to have 
increased expression in stumpy form cells will be interesting, but may need to be 
conducted on pleomorphic cell lines in order to provoke relevant results. 
4.7 Genes in polycistronic units do not have similar expression profiles 
As transcription in T. brucei is polycistronic, we analysed the profiles of adjacent 
genes to determine whether genes with similar expression profiles were physically 
clustered together along the chromosome, invoking an operonic organisation. 
Previous examination of genes arranged in tandem copies, such as the PGK and PAD 
genes, has shown that these genes show different regulation to each other between 
bloodstream form and procyclic form life cycle stages (Gibson et al., 1988, Dean et 
al., 2009).  Figure 4.16 shows, as an example, the expression profiles of all genes 
differentially expressed to a significance of p<0.5 levels along chromosome 11, 
where genes up-regulated in comparison to stumpy form are coloured red, and those 
down-regulated are blue.  Adjacent genes do not show similar profiles to each other, 
thus our analysis confirms, on a global scale, that no clustering of differentially 
regulated genes occurs in T. brucei.  Along chromosome 11, the genes which showed 
statistically significant differential expression in at least one time point at the p<0.5 
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level show 48 different profiles; over 60% of all the profiles seen across the entire 
genome.  60 of the 385 genes significantly differentially regulated at p<0.5, show an 
unchanging profile (00000), hence the changes in expression levels, whilst 
statistically significant, are of a magnitude of less than 2-fold.  The same analysis 
was conducted for all 11 chromosomes and each showed an absence of clustering of 









Figure 4.16.   Expression profile of the 385 genes significantly differentially 
expressed at p<0.5 with respective location on chromosome 11.  Genes have 
been assigned their trinary code, where red represents genes showing a 2-fold 
increase compared to stumpy forms, blue represents genes whose signal is halved 
when compared to stumpy forms.  White represents genes that show a significant 
differential expression in comparison to stumpy form cells, but the change was less 
than 2-fold.  Genes that were not significantly differentially expressed at any time 
point were removed from the diagram, thus this is not a scale model because 
spaces are not left for the genes removed.  
The lack of physical grouping of genes with similar expression profiles only 
confirms on a genome-wide scale that which had been previously shown on a smaller 
scale, despite transcription in T. brucei being conducted polycistronically.  This must 
mean that other mechanisms exist to regulate the genes post-transcriptionally.  
Several mechanisms for post-transcriptional regulation have already been shown to 
function in trypanosomes including: regulation of the stability of the RNA, its 
translation into protein, the sequestration of the protein, turnover of the protein and 
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action of RNA binding proteins (Walrad et al., 2009, Mayho et al., 2006, Hotz et al., 
1995, Colasante et al., 2007).  Genes in T. brucei are transcribed polycistronically, 
however it is rare for regulatory activity of genes to be determined by their 5’UTR, 
although DOT1B has two sequences in the 5’UTR which show conservation to a 
consensus sequence for cell cycle regulation (Janzen et al., 2006).  Instead, in this 
organism, regulatory domains within the 3’UTR of several stage regulated transcripts 
have been shown to have an influence on the expression of a gene (Mayho et al., 
2006, Colasante et al., 2007, Hotz et al., 1995, Berberof et al., 1995). 
4.8 Regulatory motifs in stumpy-enriched genes 
As gene regulation in trypanosomes is almost exclusively post-transcriptional, the 
3’UTRs of genes shown to be up-regulated in stumpy cells with respect to slender 
cells were analysed for conserved nucleotide motifs.  For this, one established 
procedure is to analyse the first 300nt following the stop codon, this representing the 
average length of the 3’UTR (Mayho et al., 2006).  Motifs were identified using the 
oligo-analysis (words) programme in RSAT (regulatory sequence analysis tools) 
(Thomas-Chollier et al., 2008).  Using this approach, conserved hexamer and 
octomer sequences were sought, because this length represents the average extent of 
sequence conservation within RNA binding regions in other organisms.  First a 
background frequency was established through scoring the frequency of each 
possible hexamer and octomer sequence present in the 3’UTRs of all genes from 
chromosomes 1 and 2, these comprising a total of 883 genes.  The 3’UTRs of all 40 
genes in the -1-1-1-1-1, that is, all genes showing a statistically significant increase 
in expression levels in stumpy forms, were investigated to find significantly over-
represented hexamer and octomer sequences using the background frequency.  No 
octomer sequences were found to be conserved in the ‘up-in-stumpy’ group, but two 
hexamer motifs, TCTTAC and TTCTTA were found to be over-represented within 
this cohort.  TCTTAC was found in 17.5% of the sequences, compared to 6.2% in 
the 3’UTRs of all 11008 genes in the genome, and TTCTTA was present in 30% of 
the 3’UTRs of stumpy-enriched genes, but in only 11.5% of genes in the whole 
genome.  These two sequences are related and often both would be present in the 
3’UTR of the same gene, sometimes overlapping, such that 33% of genes up-
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regulated in stumpy form cells had at least one of these motifs in their 3’UTR.  The 
TCTTAC and TTCTTA sequences were thus designated as stumpy motif 1 (SM1) 
and stumpy motif 2 (SM2) respectively. 
 
The same procedure was also carried out on genes that were down-regulated in 
slender forms compared with stumpy forms, regardless of the expression levels at 
any other time point.  There were over 3700 genes which qualified as ‘down in 
slender’ when compared to stumpy form cells at a p value of <0.05, but in order to 
only investigate the most significant genes, an adjusted p value was calculated for 
each gene using the Benjamini and Hochberg method (Benjamini and Hochberg, 
1995).  The application of this calculation is standard in microarray analysis to 
reduce the false discovery rate.  Briefly, the genes are sorted according to the p 
values generated from the moderated t-test and ranked, with the gene with the 
smallest p value assigned a rank of 1 up until n, then the p value of the gene is 
multiplied by n and divided by its own rank, resulting in an adjusted p value.  Only 
genes that were down-regulated in slender form in comparison to stumpy forms at an 
adjusted p value of 0.01-0.07 were analysed, this comprising 107 genes.  Again the 
most significant hexamer found was TCTTAC (SM1), present in the 3’UTR of 
14.01% of genes.  Interestingly, the location of the motif did not appear random.  The 
motif was found in 16 of the genes, with three copies present in Tb10.70.6180, two 
of which overlapped and were not included in the positional analysis.  There 
appeared to be a positional bias of the motif to between 151-200 nucleotides into the 
3’UTR, with seven transcripts preferentially positioning the sequence in this segment 
(Figure 4.17B).  Looking at all genes from the entire genome with this motif, no 
positional bias was detected (Figure 4.17A) with the motif found uniformly 
represented in each segment of the 3’UTR. 
 















Figure 4.17. Positional context of the TCTTAC 3’ UTR hexamer.  (A) The motif is 
found apparently randomly distributed across the entire length of the 3’UTRs of all 
genes within the genome found to harbour this sequence, whilst (B) this hexamer is 
found to show a positional bias at 151-200 nucleotides downstream of the stop 
codon in the genes up-regulated in stumpy cells versus slender cells. 
The preferential positioning of this hexamer within the 3’UTR adds credibility to the 
function of this motif as a binding region and thus suggests that it could have a role 
in the regulation of gene expression of transcripts required for cells once 
differentiated from the slender form. 
4.9 Genes annotated as ‘hypothetical unlikely’ 
The presence of a large number of genes recorded as ‘unlikely’ to encode proteins in 
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stringent statistics and the overwhelming number of them.  These genes have been 
annotated as ‘unlikely’ by the gene-calling software, Glimmer, for a variety of 
reasons, and individually analysing them shows a spectrum of: very short genes, 
often clustering together or amongst VSG genes; open reading frames with very high 
AT content; and genes that lie at strand switch regions (Table 4.3).  Strand switch 
regions have been implicated as potential regions of transcription initiation due to the 
enrichment of histone variants in the regions which open up the DNA structure, 
allowing easier access for the transcription machinery (Siegel et al., 2009).  
 
In accordance with the genomic position data, ‘unlikely’ genes clustered together do 
not share similar expression profiles.  Further, the quantity of ‘unlikely’ genes in the 
stumpy-enriched list is in keeping with the proportion seen in the other profiles as, 
out of the 557 ‘unlikely’ genes represented on the microarray (609 genes are 
annotated as ‘hypothetical unlikely’ in the entire genome), almost 40% of them were 
differentially expressed in one of more timepoints at the p<0.05 level.  Nonetheless, 
the ‘unlikely’ genes present in the stumpy-enriched group were amongst the most 
elevated transcripts.  Interestingly, four out of the eleven ‘unlikely’ genes in the 
stumpy-enriched group contained at least one of the SM hexamers in their 3’UTR 

















Other information SM1 or SM2 
motif? 
Tb09.160.3000 195 On opposite strand  
Tb09.v1.0050 111 At strand switch region, amongst VSGs SM2 
Tb927.1.390 285 At strand switch region  
Tb09.160.4070 261 66% AT  
Tb09.211.4050 315 At strand switch region SM2 
Tb09.142.0190 270 On opposite strand, amongst VSGs  
Tb09.211.1710 300 On opposite strand  
Tb927.1.4510 306 63% AT SM1 and SM2 
Tb927.1.5310 645 On opposite strand SM1 and SM2 
Tb09.160.2080 462 On opposite strand  
Tb09.211.1970 546 On opposite strand   
Table 4.3.  The genes showing increased expression in stumpy form cells in 
comparison to all other time points of differentiation which are annotated as 
‘hypothetical, unlikely’.  Many of these genes are on the opposite strand of the 
DNA to the other expressed genes and many are less than 400bp long.  Two of the 
genes were GC poor, which may explain their annotation status.  Four genes have 
an SM motif, which may play a role in regulation of their expression. 
It is possible that the annotation is incorrect for some of these genes; Gopal et al 
(2003) found that by applying different conditions to rank ORFs by their likelihood 
to produce proteins, they were able to reclassify a number of the genes annotated as 
‘hypothetical, unlikely’ on chromosome 1.  Using these optimised definitions, 14% 
of the genes met the conditions to instead be as considered as protein coding (Gopal 
et al., 2003).  However, proteomic studies of the mitochondrion did not identify any 
proteins annotated as ‘hypothetical, unlikely’, implying that such ORFs are not 
translated into proteins (Panigrahi et al., 2009) nonetheless, it cannot be discounted 
that the transcripts instead have roles as functional RNA. 
 
A recent bio-informatic analysis of the non-coding RNAs in T. brucei suggested that 
non-coding RNAs (ncRNA) do not play a role as microRNAs, and indeed it is 
unlikely that this pathway exists in trypanosomes (Mao et al., 2009).  Other than 
acting in the RNA interference pathway, another major function of ncRNAs in higher 
eukaryotes appears to be in the regulation of transcription through binding to RNA 
binding proteins, or directly to proteins, involved in transcription initiation (Ponting 
et al., 2009).  This is unlikely to be the function in kinetoplastids.  However, it is 
highly possible that they are binding to proteins or RNA binding proteins, which may 
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allow them to complete for binding sites onto these molecules and thus aid regulation 
in a post-transcriptional fashion.  Non-coding RNA has also been implicated in 
maintaining the structure of paraspeckles, putative storage vesicles for RNA held 
within the nucleus, as well as other cytoskeletal structures (Wilusz et al., 2009).  
Studies reporting functions for ncRNAs are increasing, and it is entirely possible that 
these ‘hypothetical, unlikely’ transcripts in T. brucei will fulfil some of these roles. 
4.10 Analysis of lipids 
Inositol phosphorylceramide (IPC) has previously been shown by electrospray mass 
spectrometry (ESI-MS) to be a major component of procyclic form cells (Guther et 
al., 2006), but is absent in bloodstream form cells (Martin and Smith, 2006).  A 
tandemly linked array of four genes (SLS1-4) has been implicated in IPC and 
sphingomyelin synthesis (Sutterwala et al., 2008).  Analysis of this array by 
microarray demonstrated that only SLS1 was up-regulated over 6-fold between 
slender and stumpy form cells (Figure 4.18C); the remainder of the array showed no 
significant differential expression.  In order to determine whether these changes in 
gene expression level resulted in differences in the lipid make-up of stumpy form 
cells, a mass spectrometry analysis of the lipids present in the monomorphic 
bloodstream form and stumpy forms was conducted by Terry Smith (University of St 
Andrews).  Initial analysis used ESI-MS to detect differences in the type of all 
phospholipids between bloodstream form cells and stumpy form cells.  Total lipids 
were extracted from the cells and a voltage applied to create an aerosol which could 
then be ionised, with the resulting ions separated via their mass to charge ratio (m/z).  
When no difference in lipid content was observed between stumpy and bloodstream 
form cells, a tandem ESI-MS/MS was conducted using, as parent ions, each 
phospholipid class.  This allowed only one class of phospholipid to be selected at a 
time, which was then fragmented and analysed.  With this more focussed method it 
was possible to distinguish differences in the phosphatidylinositol (GPIno) 
phospholipids, with significant peaks at 778.7m/z and 833.4m/z in stumpy form 
cells.  This information correlates to the number of carbons and degrees of saturation 
of the compound: that is, the number of rings and multiple bonds present.  The peaks 
seen in Figure 4.18B can be identified as IPC, C34:1 and C38:1, which were found to 
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be specific to stumpy form cells and absent in slender forms (Figure 4.18A).  
 






















Figure 4.18. Phospholipid composition of monomorphic slender and stumpy 
cells.  GPIno make-up of (A) monomorphic slender and (B) stumpy cells using ES-
MS/MS.  In the stumpy cells there are two significant peaks corresponding to IPC 
(34:1) and IPC (38:1).  (C) The microarray expression profile of TbSLS1 shows up-
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The presence of IPC in stumpy forms suggests that IPC is being produced to prepare 
cells for uptake into the tsetse fly, or has a specific function in stumpy forms.  
Subsequent analysis of the genes in the array has shown that, whilst SLS3 and 4 are 
responsible for the synthesis of both sphingomyelin and ethanolamine 
phosphorylceramide, SLS1 is exclusively an IPC synthase (Jay Bangs, personal 
communication).  Hence the up-regulation of this gene in stumpy forms fits well with 
the coinciding production of IPC, and provides biological validation of a prediction 
from the microarray analysis that had been previously unknown.   
4.11 Summary 
The analysis of the microarray profiles against previously known differentially 
expressed genes supports their overall accuracy.  However, the stringency of the 
statistical cut-off has meant that several genes that are known to be highly expressed 
in stumpy forms are missing from the list containing the genes significantly 
differentiation expressed at p<0.05.  The stringency used however, means that any 
genes identified as differentially expressed can be confidently believed and thus a 
number of stumpy-enriched genes are now being pursued. 
 
Similar trends in expression were seen for proliferation-associated and procyclic 
form specific transcripts, both showing rapid increases in expression immediately 
after cells begin differentiation.  This observation is not surprising; stumpy cells are 
growth arrested, such that once they resume cell growth they must rapidly synthesise 
new histones as well as initiating developmental changes.  Once this initial 
synchronous return to proliferation has ended, the population will remain dividing 
and the levels of  histones will drop slightly as these are produced at a steady state 
level.  The same sudden increase in expression can be seen for the procyclic specific 
transcripts as they must quickly adapt to the new environment and so produce 
massive amounts of the required RNAs which peak during differentiation and 
decrease into a stable level.  Indeed, there is a global ‘burst’ in RNA levels 
immediately following release from G0 arrest, of both the ribosomal and messenger 
RNA (Pays et al., 1993). 
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The statistics applied to the microarray analysis were deliberately stringent, to take 
into account the multiple testing issues and to minimise the frequency of false 
discoveries from the results.  Inevitably this will have caused us to exclude some 
genuine data through false negatives.  However, this approach was deemed 
preferable to potentially investigating genes that later proved to be false positives.  
The consequences of this can be seen clearly in the microarray data through 
examining genes of known expression profiles which did not fulfil the stringent 
statistical criteria required to place them at an adjusted 5% significance level.  One 
clear example of this are the PAD genes, where PAD1, which has been published 
previously as showing increased expression in stumpy form cells (Dean et al., 2009),  
did not show a significant level of differentiation expression at p<0.05, but did show 
the expected profile when the level of significance was reduced to p<0.1. 
 
Despite this, we cannot rule out that in our results there will be false positives; it 
would be unlikely if every single gene in our significant lists acted exactly as our 
microarray predicts, but the unexpected profiles of the PAG genes with confirmation 
from an independent lab cautions against distrusting results that differ from those 
anticipated.  A further power of the array analysis was the ability to follow transcript 
trends over the time course of differentiation; this provided considerable reassurance 
of transcript profiles over and above projects derived from a single life cycle stage  
 
The use of qPCR and Northern blots for validation proved unreliable, as about half of 
transcripts correlated well with the microarray data, whilst the remaining genes had 
varying profiles.  The simple explanation for this is that it is impossible to normalise 
Northern blots or qPCRs in a manner equivalent to the microarray.  The 
normalisation for the microarray was against every single gene in the genome both 
within and between arrays, whilst the qPCRs were only ever normalised against one 
gene at a time in one sample and Northerns could only be normalised against total 
ribosomal RNA levels.  In addition, the microarray was averaged over five biological 
replicates whilst, due to scarcity of samples, Northerns and qPCRs were at most 
conducted on only two of the replicates.  Thus the microarray remains the more 
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powerful determinant of differential regulation, but it will be necessary to create a 
more suitable normalisation regime for Northerns and qPCRs or to find other 
methods to validate the microarrays.   
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5 – Role of G0 in Differentiation 
It has been shown that stumpy cells are G0 arrested and proceed into differentiation 
in a synchronous manner (Matthews and Gull, 1994).  However, it is also possible to 
trigger the differentiation of asynchronous bloodstream form monomorphic slender 
cells using cis-aconitate and temperature reduction (Ziegelbauer et al., 1990), and the 
field is still divided as to whether or not G0 is essential for differentiation (see 
Section 1.5).  We wanted to pursue this study in a variety of ways; ie looking for 
homologues of proteins shown in other organisms to be required for G0 arrest, and 
through analysing differentiation of cells isolated from specific cell cycle stages.  
Historically it has not been possible to satisfactorily synchronise trypanosomes, and 
methods for arresting cell cycle progression using toxic chemicals were rejected on 
the grounds that stressed cells are not good models for differentiation (discussed in 
Section 1.6.1).  However, using a supravital DNA dye, it was possible to sort cells 
into populations enriched for certain cell cycle stages. 
5.1 FACS sorting to isolate populations in different cell cycle phases 
5.1.1 Experimental design 
The Vybrant® DyeCycle™ stains only fluoresce when bound to double stranded 
DNA, and this feature can be exploited to stain the cellular DNA of cells.  Three 
stains utilising different lasers are available, and the Violet dye was chosen as it has 
been shown to be less toxic when staining stem cells, both in terms of the chemical 
itself and through the use of the violet laser which is less harmful to cells than the 
shorter laser lines required for the other Vybrant® DyeCycle™ stains (Morrow, 
2007).  Subsequently, both the DyeCycle™ Orange and Green, despite being used 
successfully for procyclic form staining (Siegel et al., 2008a), have been shown to be 
toxic for bloodstream form cells (Michael Boshart, personal communication).   
 
Cells were harvested from logarithmically growing monomorphic cell cultures and 
resuspended at 1x106 in HMI-9 media supplemented with 2% FCS, since higher 
percentages of serum interfere with flow cytometry.  Vybrant® DyeCycle™ Violet 
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was added to a final concentration of 1µg/ml and cells were incubated at 37˚C for 30 
minutes (Figure 5.1).  In order to reduce the duration of the sort, the cells were 
concentrated after staining into approximately 3ml of the original staining media 
such that their density would then be ~1.6x107cells/ml, at which density the sort was 
generally completed within 90 minutes.  Sorts were conducted on a FACSAria (BD 
Biosciences) machine, with the dye excited using the violet laser and detection 
emission using the 450/40 bandpass filter.  The dye was found to be highly 
photosensitive, so all experiments were conducted using minimal ambient light.  
During the course of a sorting experiment it was possible to observe a gradual shift in 
fluorescence intensity of the stained sample (compare Figure 5.4A with Figure 5.4B), 
thus for the duration of the sort the gates were required to be constantly adjusted to 
allow for the shifting position of the cells within a gate.  At the end of each sort a 
sample of the recovered populations were re-examined to assess purity of obtained 
samples. 
 













Figure 5.1. Schematic diagram of a FACS sorting experiment.  Cells were 
placed into HMI-9 medium supplemented with 2% FCS and incubated with 
Vybrant® DyeCycle™ Violet for 30 minutes at 37˚C.  The cells were concentrated 
into the staining medium so the density was >1.6x107 cells/ml and were sorted at 
4˚C in a FACSAria machine using PSG as the sheath fluid.  Two populations of cells 
with either a 2C or 4C DNA content were sorted into undiluted FCS, and once 
completed, the harvested populations were returned to culture in HMI-9 
supplemented with 40% FCS. 
The slightly disparate timings of replication of the kinetoplast DNA from the nuclear 
DNA (Woodward and Gull, 1990) should not influence the histograms generated, as 
kinetoplast DNA only amounts to approximately 5% of total cellular DNA, and so 
will not have a significant effect on the histograms (Siegel et al., 2008a).  In order to 
limit the stress caused to cells through the procedure of staining and sorting, PSG 
was used as the FACS machine sheath fluid.  In addition, sorted cells were collected 
into 1ml undiluted FCS in polypropylene tubes, the purpose of the FCS being 2-fold; 
firstly to help the cells recover from the dilution in PSG, and secondly, cells are 
prone to stick to the sides of the tube once sorted, so the FCS was used to coat the 
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wall of the tube and prevent adherence.  The isolated populations were rapidly 
returned to culture following sorting, into pre-warmed HMI-9 medium supplemented 
with 40% FCS, to further reduce the trauma experienced by the cells.  As the cells 
collected from the sorts were returned to culture, it was important to work under 
conditions as sterile as possible.  Hence, the FACS machine was flushed with ethanol 
prior to use, the PSG sheath fluid was autoclaved and FCS in collection tubes was 
filter sterilised.  In addition, once cells were returned to culture, the HMI-9 media 
supplemented with 40% FCS was prepared with fresh penicillin/streptomycin to 
reduce contamination.  In spite of all these measures, cells returned to culture 
invariably showed bacterial contamination after approximately 24 hours.  
Presumably the addition of an antibiotic drug such as tetracycline to the media could 
prevent this problem, although this was not tested. 
5.1.2 Gating of samples 
It was essential that the samples prepared for a sort experiment were in a single-cell 
suspension to avoid mistaking clumped G1 stage cells for G2 cells.  As 
trypanosomes are non-adherent and cells were not fixed, the cultures showed little 
clumping of cells, thus filtering of the cells prior to sorting was not required.  Any 
cells that had stuck together were gated out of the analysis and were not sorted.  
Figure 5.2 shows the gating used for the sorts; primarily cells were plotted via 
FSC/SSC so that cells were distributed according to volume and density, intact cells 
were identified and a gate placed around them to exclude the damaged cells (Figure 
5.2A).  This population was then further gated by area/width to eliminate aggregated 
cells and cell debris such that only single cells (singlets) remained (Figure 5.2B).  
These gates removed around 20% of the total starting material, with the number of 
cells in G2/M and G0/G1 in roughly a 3:1 ratio (Figure 5.2C). 
 











Figure 5.2.  Gating to acquire a singlet population.  (A) Scatter plot of all cells 
distributed via their volume to density (FSC/SSC) with a gate set up around the 
intact cells.  (B) Distribution of the cells when plotted via their area/width with a gate 
set up to only sort non-aggregated cells.  (C) Table with the proportion of cells 
remaining once dead and doublet cells had been removed, showing also that 
following sorting, G0/G1 and G2/M are recovered in an approximately 3:1 ratio. 
Figure 5.2C shows that, of the 80% of cells remaining after gating, only 35% of cells 
were then collected in the G0/G1 fraction with just less than 10% in the G2/M 
fraction.  The recovery rate in this experiment of 45% of the initial population was 
representative of all sorting experiments, which ranged from 39.5-52.8% from a total 
of seven experiments.  Of the cells that were in the viable singlet population, over 
40% did not fall between the gates for the G0/G1 or G2/m population, and so were 
removed. 
5.1.3 Cell cycle specific toxicity of supravital dyes 
In other cell types it has been shown that cells in S phase demonstrate higher 
sensitivity to DNA intercalating dyes such as Hoechst 33342 than cells in other cell 
cycle stages (Siemann and Keng, 1986).  Therefore, cell cycle specific toxicity was 
examined in trypanosome cells through sorting the cells into G0/G1, S phase and 
G2/M populations and assessing viability as determined by cell growth for 24 hours 
Population     #Events % Parent % Total 
All Events   5,361      100  
    Intact 4,691   87.5     87.5 
      Singlets      4,249   90.6     79.3 
        G0/G1      1,881   44.3     35.1 
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post sorting (Figure 5.3A).  For this 3-way sorting, 5ml collection tubes were used, 














Figure 5.3.  Viability of sorted cells in different cell cycle stage.  (A) Each of the 
different populations show similar viability post-sorting, although all fail to show an 
increase in cell number compared to non-stained, unsorted cells.  It is not clear 
whether the absence of increase in cell number is due to cell cycle arrest or an 
increase in cell death.  However, if the reason is increase in cell death, then this is 
not associated with a particular cell cycle stage.  (B) The post-sort profiles show that 
there was poor distinction between the S phase and G2/M populations. 
Figure 5.3A shows that the cells from all the sorts grew poorly following the sort, 
with little cell growth seen 3.5 hours following the sort, and the G0/G1 and G2/M 
populations showing a small decrease in cell number at 25 hours post-sort.  In 
parallel, the unsorted control cells were incubated in conditions mimicking the sort; 
ie they were incubated at 4˚C in HMI-9 medium supplemented with 2% FCS whilst 
the samples were sorted, before being returned to HMI-9 medium supplemented with 
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40% FCS at 37˚C.  In contrast to the sorted cells, however, these cells show a clear 
increase in cell number after 25 hours, suggesting that the reason for the poor growth 
of the sorted cells was due to the stain, rather than the temperature changes and 
depletion of serum associated with the sorting process.  The post-sorted populations 
taken from the S phase and G2/M fractions were almost indistinguishable on the 
DNA histograms (Figure 5.3B), thus the S phase population is unlikely to contain a 
very pure population of cells at this cell cycle stage.  Nonetheless, as little difference 
in cell growth was seen between the G0/G1 populations and either the S phase or 
G2/M, it is likely that the dye does not display particular toxicity towards cells at a 
certain point within the cell cycle. 
5.1.4 Isolating cell cycle specific populations 
Due to the poor recovery of pure S phase populations, only the G0/G1 and G2/M 
populations were isolated for all future experiments.  One benefit to using 2-way 
sorting was that it allowed the use of larger, 15ml collection tubes, reducing the 
number of tubes required to harvest each population.  Figure 5.4A shows histograms 
generated from stained logarithmically growing cells and the gating used to isolate 
the two sorted populations. 
 




















Figure 5.4.  Histograms of cells stained with Vybrant® DyeCycle™ Violet with 
gates set for stringent cell cycle stage specific recovery.  (A) Pre-sort profile of 
cells with gating showing from where the different cell-cycle populations were 
collected.  (B) G0/G1 sorted cells, showing 97.3% cells with G1 content, (C) G2/M 
sorted cells with 79.9% of the population showing DNA content expected in G2/M 
cells, (D) overlay of B and C.  The post-sort populations show a reduction in 
fluorescence intensity as the dye was gradually eliminated from the cells during the 
sort. 
Population   % parent  
G0/G1 sort     97.3 
G2/M sort        2.5 
Population    % parent  
G0/G1 sort     16.7  
G2/M sort       79.9 
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Nuclear G1 in T. brucei accounts for approximately 40% of the procyclic cell cycle, 
thus in a logarithmically growing culture, more cells will be in the G0/G1 cell cycle 
stage than in S phase and G2/M.  As G0/G1 cells were in the majority in the starting 
population, it was possible to set extremely stringent gates around the very centre of 
the 2C peak (Figure 5.4A) without compromising high yields (Figure 5.4B).  The 4C 
gate was set from the inner quartile peak to the outer peak, with a 79% pure G2/M 
population recovered, although overall fewer cells than were recovered for the 
G0/G1 population (Figure 5.4C).  Overlaying the histograms of both sorted 
populations revealed clear distinction of the populations (Figure 5.4D), which was 
subsequently confirmed using microscopy.  Of note is that the fluorescent intensity 
of the dye observed in the post-sorted population was much reduced from the initial 
population, with the average intensity for the G0/G1 population dropping from 
approximately 90,000 from the pre-sort population, down to 50,000 post-sort.  This 
was likely due to the transient/dynamic nature of the dye binding, such that after 90 
minutes, the dye had largely diffused out of the cells.  The dye was also seen to be 
highly photosensitive, thus some of the reduction may have been due to dye 
bleaching from exposure to ambient light, although this was limited as far as 
possible.   
5.1.5 Assessment of synchronisation 
Since a method for reproducibly synchronising trypanosomes has yet to be 
established, especially for bloodstream form cells, the sorted populations were 
tracked for up to 17 hours post-sort to determine whether the cells grew 
synchronously.  We were also interested to observe whether there was a lag period 
before the cells resumed replication, as has been seen for mammalian cells (Bradford 
et al., 2006).  Hence, cells were sorted and slides prepared hourly to allow cell cycle 
scoring and so determine re-entry into the cell cycle.  As a control to ensure that the 
culturing conditions and temperature changes were not having an effect on the cell 
cycle progression, cells that were unstained and unsorted, but were subjected to the 
same changes of media and incubations at 4˚C, were also analysed. 
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Figure 5.5.  Cell cycle progression of sorted cells.  Following a sort, every hour 
for up to 17 hours, samples were taken for microscopic analysis and the DNA 
visualised with DAPI so that the proportion of cells with 1K1N, 2K1N and 2K2N 
could be determined in (A) the G1/G0, and (B) the G2/M sorted populations.  (C) 
Unsorted cells were also analysed as a control.  The G2/M population was tracked 
for only 7 hours after recovery due to the lower number of cells harvested.  For each 
time point, at least 250 cells were counted.  
Figure 5.5A and B show that the sorted cells were not synchronised post-sort, with 
the cells from the G0/G1 population returning to the pre-sort ratios of cell cycle stage 
within seven hours, and the G2/M population returning to pre-sort ratios within five 
hours.  Figure 5.5C, in contrast, is a good representation of the normal proportion of 
unsynchronised cells with the expected different nuclear/kinetoplast configurations 
in an actively dividing population.  Hence, most cells within the culture were in the 
1K1N configuration, which is seen in cells in G0, G1, S phase and early G2, thus 
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For the G0/G1 sorted population,  5 hour lag phase following sorting before the 
appearance of with a 2K1N configuration was observed.  Cells at the end of G1 
could show a second kinetoplast within ~3 hours, whilst those at the very start of G1 
would take up to 6 hours before a second kinetoplast appeared (Figure 5.6).  There 
are two possible explanations for this delay.  The inability of the sorting to 
distinguish between cells at different positions within the G1 peak, means that cells 
immediately entering G1 and those about to commence DNA synthesis are 
indistinguishable on the FACS profile, so the first possibility for the delay in the 
appearance of cells with a 2K1N configuration could be because the sorted cells were 
predominantly in the early stages of G1.  The second explanation could be that there 
was a delay in cells returning to a proliferative cell cycle.  Such a delay would be 
possible, as similar studies on human cells also resulted in a lag time (Bradford et al., 
2006) and could explain why cells with a 2K1N karyotype are not seen earlier. The 
former is the more likely reason, as the G2/M sorted cells change configuration 










Figure 5.6.  Cells sorted from different points of G1 will progress through the 
cell cycle at different times.  Schematic diagram demonstrating that a cell at the 
start of G1 could take up to six hours before a second kinetoplast will be observed.  
Yet a cell towards the end of G1, which will also be sorted into the G0/G1 fraction, 
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The G2/M sorted population comprised 36% cells with 2K1N and 9% with 2K2N, 
with the highest numbers of 2K2N cells seen after two hours, when the proportion of 
2K2N cells rose to over 20%.  This implies that the 1K1N cells present in the G2/M 
sorted population were in late S phase, thus two hours post-sort these cells would 
have progressed rapidly into a 2K1N configuration.  Indeed, a reduction in cells with 
a 1K1N configuration was seen during the first three hours post-sort.  Repeating the 
sort showed reproducible trends, with the maximum enrichment of 2K2N cells 
always being found two hours post-sort. 
 
The proportion of cells in the different karyotypes in the sorted populations was 
highly reproducible between different experiments and different cell lines (Figure 
5.7).  In each instance the G0/G1 population showed a nearly 100% population of 
cells in the 1K1N configuration immediately following a sort (between 98-100%), 

























Figure 5.7.  Analysis of the recovered cells post sorting.  (A) Cell cycle 
configuration of cells immediately after sorting as determined from fluorescence 
microscopy of DAPI stained cells.  At least 250 cells were counted for each slide 
with the data representing the mean of seven independent experiments with error 
bars showing the standard error.  The G0/G1 sort generated a very pure population 
of cells with 1K1N reproducibly, whilst the G2/M sort yielded a mixed population 
showing enrichment in 2K1N and 2K2N cells.  (B) Microscope images of cells 
immediately post-sort for G1/G0 (upper panel) and G2/M (lower panel) sorted 
populations.  Phase contrast images show the morphology and integrity of the cells 
whilst the DAPI images showed that the G0/G1 population only had cells with 1 
kinetoplast and 1 nucleus, whilst the G2/M population had many cells with 2 
kinetoplasts.  All cells appeared intact post sorting. 
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5.1.6 Viability of sorted cells 
The viability of the cells post-sorting was essential in order to conduct experiments 
on the isolated populations.  The redox indicator alamarBlue® was used as a means 
to track cell viability following a mock-sorting experiment.  Thus, cell viability after 
treatment with Vybrant® DyeCycle™ Violet was tested through recreating the 
temperature and media changes that occur in the FACS experiment, although the 
cells were not sorted, only diluted into PSG and finally returned to HMI-9 
supplemented with 40% FCS.  The importance of temperature on viability was also 
tested.  To prevent cells progressing through the cell cycle during the sort, the FACS 
machine was cooled to 4˚C prior to sorting the cells, thus it was estimated that the 
temperature of the samples would fall from 37˚C to below 20˚C.  However, the fall 
in temperature might have had deleterious effects of the viability of the cells, 
therefore the viability of cells was assessed at both 37˚C and 4˚C.  
 
Following the mock-sort, cells were incubated with alamarBlue® to test for 
metabolic activity with or without the Vybrant® DyeCycle™ Violet, at the 
experimental temperature of 4˚C and also as a control, at the preferred temperature 
for viability, 37˚C.  Hence, 100µl volumes of the samples were loaded in triplicate 
into 96-well plates and the colour change occurring from the reduction of the 
alamarBlue® inspected after 24 hours.  Control wells of unperturbed cells growing in 
HMI-9 supplemented with 20% FCS were also included to assess the extent of any 
loss of viability, and wells containing media without cells and without alamarBlue® 

















Figure 5.8.  Cell viability of Vybrant® DyeCycle™ Violet-stained cells 
measured using alamarBlue®.  alamarBlue® in its non-reduced state is blue as 
can be seen for the 0 hour wells, but once reduced through the action of cell 
metabolites the dye turns pink.  On the 24 hour plate, it is possible to see that only 
the control wells have shown an obvious colour change.  For the calculations to plot 
the reduction of the alamarBlue®, the control wells using media only, media + 
alamarBlue® only and media + cells only were included in order to subtract 
background changes in absorbance.  The unsorted control cells were grown in HMI-
9 supplemented with 20% FCS whilst the experimental cells were grown in 40% 
FCS supplemented medium, thus controls for each for included. 
Figure 5.8 shows that the metabolic activity of cells treated with Vybrant® 
DyeCycle™ Violet, both and 4˚C and 37˚C is much less than in unstained cells.  The 
rate of metabolism was then quantified by taking an absorbance reading of the 
reduction of alamarBlue® over a time course.  Plates were loaded into a BioTek® 
Elx808 plate reader at a constant temperature of 37˚C, sealed to prevent evaporation 
of the sample, and readings taken every hour for 24 hours.  In addition, cells were 
counted on a Beckman Coulter counter at 0 and 24 hours after resuspension in 40% 
FCS-supplemented media.  Figure 5.9A shows that the differences between the 
metabolic activities of the cells at the different temperatures was very slight, but that 
treatment with Vybrant® DyeCycle™ Violet dye was inhibiting metabolism.  
Interestingly however, the cell counts revealed that cell growth did not correlate well 
with cell metabolism (Figure 5.8B).  Nonetheless, from this data it was concluded 
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that treatment with Vybrant® DyeCycle™ Violet at a sorting temperature of 37˚C 














Figure 5.9.  Assessment of cell viability post sorting.  (A) Metabolic activity of 
cells as determined through reduction of alamarBlue®, comparing stained and 
unstained samples incubated at 4˚C (squares) and at 37˚C (circles).  In both cases 
the stained sample showed lower metabolic activity, with the samples stained and 
incubated at 4˚C showing the lowest levels of metabolism.  (B) Cell counts 
conducted on the same samples as in (A) taken at 0 and 24 hours. 
Figure 5.9A shows the effects of Vybrant® DyeCycle™ Violet staining on the 
metabolic activity of cells incubated at either 4˚C, the preferred temperature to 
prevent cell cycle progression during the sort, and at 37˚C, being the preferred 
temperature of the cells for viability.  Comparisons of both unstained samples 
incubated at 37˚C (empty circles) and at 4˚C (empty squares) reveals that whilst the 
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over the time course is exactly in parallel with the cells incubated at 37˚C.  Thus, 
although the cells initially have a lower metabolic activity, they are proliferating at 
the same rate.  However, comparison of the unstained samples with the stained cells 
at either temperature shows that the cells treated with the dye have impaired growth.  
The stained cells incubated at 37˚C diverge from the unstained cells after around 13 
hours, whilst the stained cells incubated at 4˚C diverge much earlier at around 6-7 
hours.  These results would seem to suggest that the cells stained and sorted at 4˚C 
would be less healthy and grow more slowly than those incubated at 37˚C, however 
the cell counts carried out on the same samples contradict this hypothesis (Figure 
5.9B).  Using cell counts as the indicator of cell viability suggests that staining cells 
at 37˚C is detrimental, whereas staining cells at 4˚C, although still severely inhibiting 
growth, does not irreversibly prevent cells from replicating.  Interestingly, the 
unstained samples showed similar growth at both 4˚C and 37˚C, thus demonstrating 
that the limited time that the cells spend at 4˚C during sorting should not have any 
impact on their subsequent proliferation. 
 
Whilst relative absorbance of alamarBlue® has been shown to be a good indicator of 
cell number in primary cell cultures (O'Brien et al., 2000), we have found that this is 
not the case for trypanosomes.  It is likely that the toxic properties of the Vybrant® 
DyeCycle™ Violet on the cells had indirect effects of the metabolism of cells, 
particularly the cells exposed to the dye and kept at 37˚C.  Thus in these cells there is 
no clear correlation between cell number and alamarBlue® reduction.  Other 
research groups have also questioned the value of using alamarBlue® on 
bloodstream form trypanosomes for studying the growth kinetics of drug-treated 
cells (Gould et al., 2008).  Instead, alamarBlue® was considered better for end-point 
analyses, where the alamarBlue® was added only at the end of the treatment and 
used to compare the treated cells against controls (Gould et al., 2008).  In addition, 
prolonged treatment of bloodstream form trypanosomes with alamarBlue® has been 
shown to reduce the cell doubling time, meaning results could be complicated by the 
effects of the alamarBlue® itself (Sykes and Avery, 2009).  Thus for this experiment, 
using the cell counts as the more reliable indicator of cellular proliferation, it 
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appeared that prolonged incubation at 37˚C of cells treated with Vybrant® 
DyeCycle™ Violet was toxic to the cells, and resulted in disruption of their 
metabolism. 
 
To further dissect the importance of temperature on the viability of sorted cells, 
instead of a mock sort, a more extreme version of the normal sorting experiment was 
conducted.  For this experiment, in addition to the usual practice of regulating the 
temperature of the collection tubes, the temperature of the sheath fluid was also set 
prior to sorting, either cooled on ice to 4ºC or warmed to 37˚C.  Using a sorting 
temperature of 4˚C, ten million cells were stained, resuspended in a 1ml volume of 
the staining media and sorted within 1 hour, with cell counts conducted for 24 hours 
afterwards.  Attempting the same experiment but prewarming the sheath fluid and 
carrying out the sort at 37˚C with 10 million cells resulted in the recovery of only 
87,000 cells, suggesting that the toxicity of the dye is high and even prolonging the 
time the cells spend in the dye from 30 to 90 minutes at 37˚C, results in significant 
cell death in the population. 
 
These results confirmed that Vybrant® DyeCycle™ Violet was toxic to cells at 37˚C 
and thus the optimal method for use was to limit the time the cells were exposed to 
the dye and to keep the temperature of the cultures low during the sort procedure. 
 
5.1.7 Differentiation capacity of sorted populations 
The sorting experiments demonstrated that it was possible to recover enriched 
populations of cells in G2/M and very pure populations of cells in G0/G1.  
Therefore, we sought to discover the differentiation capacity of the two populations.  
Cells were sorted into G0/G1 and G2/M populations and re-cultured at a density of 
5x105 cells/ml and induced to differentiate through addition of 6mM cis aconitate 
with temperature reduction to 27˚C.  Cell samples were taken from the cultures every 
four hours and fixed onto slides, and immunofluorescence analysis conducted to 
examine the expression of EP procyclin as a differentiation marker. 
 















Figure 5.10.  Differentiation kinetics of cells sorted into different cell cycle 
stages.  (A) and (B) show the percentage of cells differentiated in two separate 
experiments of cells sorted into G0/G1 and G2/M populations and then differentiated 
through addition of cis aconitate and temperature reduction.  Control cells are those 
which have neither been stained with Vybrant® DyeCycle™ Violet nor sorted.  (C) 
The averages of the two experiments with error bars representing the standard 
error. 
Figure 5.10 shows the percentage of cells that have differentiated during 24 hours 
after sorting of the cells into different cell cycle positions.  Both the G0/G1 and 
G2/M populations differentiated with similar kinetics, although the control cells, 
which had not been stained with Vybrant® DyeCycle™ Violet or sorted, started to 
differentiate four hours earlier and did so in a more efficient manner.  However, 
Figure 5.10A demonstrates the difficulties of interpreting data taken from slides, as 
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procyclin between 20-24 hours.  This is almost certainly the result of a technical 
error such as poor staining of the entire slide or a section of the slide at the 24 hour 
time point, rather than a true biological event.  This possibility is given more 
credence because the control cells in Figure 5.10B show a similar trend between 16-
20 hours, yet those cells were unperturbed and should show normal differentiation 
kinetics.  One of the limitations of detecting cell differentiation from slides is that it 
is possible to get uneven staining of slides, and the scoring of cells is subjective.  A 
potentially superior method of detecting differentiation is using FACS.  However, 
until (i) G0 populations can be separated from G1 populations, and (ii) increased cell 
viability post-sort can be obtained, it will still not possible to conclusively determine 
using this methodology, whether cell cycle position is a factor in differentiation. 
5.1.8 Summary 
The method described here for sorting cells according to their natural cell cycle 
position allows recovery of pure G0/G1 populations and of G2/M populations highly 
enriched for cells with 2K1N and 2K2N.  This method is not capable of creating 
synchronised populations, but does however, allow significant enrichment of cells in 
a given cell cycle stage, with a yield appropriate for harvesting RNA or protein from 
the samples.  This opens several opportunities for studying cell cycle regulated 
events.  However, the problem associated with cell viability post sort render this 
approach in its current form of limited value for studying the cell-cycle dependence 
of differentiation.  In order to determine with more precision the cell cycle position 
of the cells, other groups have used quantitative DAPI-imaging of the nucleus (Siegel 
et al., 2008a), or assessment of nuclear shape (Forsythe et al., 2008), both of which 
are time-consuming and thus not appropriate for experiments analysing large 
numbers of cells.  Other methods include using antibodies against proteins expressed 
in a cell cycle specific manner, such as the antibody against the non-acetylated form 
of histone H4, which is only present during S phase (Siegel et al., 2008b).  
Unfortunately, there are no known markers for G0 in T. brucei, which would be the 
most useful for our experiments into the role of G0 in differentiation. 
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5.2 Target of Rapamycin 
The target of rapamycin proteins in other organisms are known to be involved in G1 
arrest.  Therefore a T. brucei homologue was sought in order to determine whether 
this protein was required for the cell cycle arrest accompanying the formation of 
stumpy form cells.  Also, it was hoped that perturbation of these molecules might 
assist analysis of the proposed link between cell cycle position and differentiation 
capacity. 
5.2.1 Identification of Tor homologues 
The full-length human mTor protein sequence was used as a template to query the T. 
brucei protein database using BLASTP at GeneDB 
(http://www.genedb.org/genedb/tryp/).  The closest match was encoded by 
Tb10.6k15.2060, showing a sequence identity of 22% and the second most related 
protein was encoded by Tb927.4.420.  Using only the rapamycin binding domain 
(FRB) domain of mTor as a template, the product of Tb927.4.420 showed the highest 
level of homology; thus this protein has the more conserved FRB domain, although 
its over-all homology to mTor was lower.  Both these proteins were identified in the 
Barquilla et al (2008) study, as were two additional Tor-like proteins, so named 
because these proteins either lacked, or had additional, domains to those in the other 
Tor proteins characterised (Barquilla et al., 2008).  However, the proposed TbTor-
like 2 protein (Barquilla et al., 2008) lacks an FRB domain, and thus would be more 
accurately described as a PIKK, rather than a Tor, given that the only feature setting 
Tor proteins apart from PIKKs is the presence of a rapamycin binding domain.  In 
accordance with Barquilla et al (2008), Tb10.6k15.2060 is hereafter referred to as 
TbTor1 and Tb927.4.420 as TbTor2. 
  
Using TbTor1 as the template, the protein was used to query the entire protein 
database at NCBI.  TbTor1 demonstrates most homology to the L. major orthologue, 
LmjF36.6320 (with 50% similarity), but after this the greatest homology was with S. 
cerevisiae Tor2 (with 27% similarity).  The level of similarity was not constant 
across the length of the protein, however, with an increase in similarity being 
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detected towards the C terminus (Figure 5.11).  The C terminus is the most 
evolutionarily conserved region due to the presence of the catalytic and regulatory 
elements.  In comparison, the N terminus harbours the HEAT repeats, which might 
be considered more prone to evolutionary drift, particularly if the proteins they bind 




Figure 5.11.  Homology of TbTor1 with S. cerevisiae Tor2.  The overall identity of 
these two proteins is 27%, but the individual domains of the protein show increasing 
sequence identify towards to C terminus.  The numbers above the domains relate to 
their position within the TbTor1 protein. 
The gradual increase in conservation towards the C terminus of the protein is in 
keeping with results found in the levels of conservation between yeast Tor2 and 
human mTor (Brown et al., 1994, Sabatini et al., 1994), confirming the importance of 
the catalytic domains of the protein. 
5.2.2 Lifecycle expression of TbTor1 and TbTor2 
Due to the role of Tor in cell cycle arrest, the levels of TbTor1 and TbTor2 mRNA 
were investigated in different lifecycle stages to evaluate whether the genes were 
more highly expressed in the growth arrested stumpy form of the parasite.  Hence, 
riboprobes were designed against unique sequences of the genes and used to probe 
Northern membranes containing RNA from T. b. brucei EATRO 2340 slender and 
stumpy form cells and cultured Lister 427 procyclic forms. 
 Domain                          FAT                FRB        PI3 PI4 kinase    FATC   
 Homology with S. cerevisiae Tor2          24%             31%          54%      58% 
1449-1774     1891-1989         2057-2306      2400-2432 
 










Figure 5.12.  Developmentally regulated expression of Tor homologues in T. 
brucei.  Northern blots of bloodstream form slender and stumpy EATRO 2340 cells 
derived from a rodent infection, and established procyclic form cells probed with (A) 
TbTor1, (B) TbTor2 and (C) alpha tubulin, used as a transfer control. (D) Ethidium 
bromide staining of the ribosomal RNA was used as a loading control.  TbTor1 is up-
regulated in stumpy form cells and maintained in procyclic form cells with additional 
smaller bands, possibly representing degradation products.  TbTor2 follows the 
same trend, with very low levels of expression seen in bloodstream forms. 
Figure 5.12 shows the life cycle specific expression of the T. brucei homologues of 
Tor1 and Tor2, with TbTor1 showing less expression in slender form cells, this being 
substantially increased in stumpy form cells and with similar levels seen in procyclic 
form cells (Figure 5.12A).  The TbTor2 expression follows a very similar profile, 
although the hybridisation intensity was much lower than for TbTor1 (Figure 5.12B), 
perhaps suggesting lower expression.  Tubulin expression was used here as a control 
and showed the expected profile, with down regulation in stumpy forms to coincide 
with growth arrest (Figure 5.12C).  The TbTor1 Northern also shows numerous 
smaller bands in the procyclic form sample only, which might be the result of 
degradation of the mRNA.  A BLAST search conducted against the region covered 
by the riboprobe did not show any homology with other genes, so this probe ought to 
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the result of cross hybridisation of the probe.  Interestingly, the RNA expression 
profile seen here conflicted with the protein levels reported by Barquilla et al (2008), 
where the amount of TbTor1 and TbTor2 protein were found to be equal in both 
bloodstream form and procyclic forms (stumpy form cells were not included).  Thus 
it is possible that the mRNA is differentially translated in the different cell cycle 
stages, although differences between the laboratory lines could also be responsible.   
 
mTor mRNA has been shown to be expressed in all mammalian organs examined, 
however the level of expression varies dramatically (Kim et al., 2002, Murakami et 
al., 2004).  In addition, the levels of both mTor mRNA and protein show no change 
throughout the cell cycle (Liu et al., 2007).  Conversely, Tor transcript levels show 
transient up-regulation during development in zebra fish embryos (Makky et al., 
2007).  Therefore the developmental regulation of the TbTors is quite unusual.   
5.2.3 RNA interference of TbTor1 
The effect of TbTor1 depletion was assessed through knockdown of the gene 
expression using RNAi to determine whether absence of the protein would result in 
G1 arrest as is seen when TORC1 is disrupted in yeast cells (Barbet et al., 1996, 
Koltin et al., 1991, Kunz et al., 1993).  Primers were designed using ‘RNAit’ 
(http://trypanofan.path.cam.ac.uk/software/RNAit.html) (Redmond et al., 2003) to 
amplify a unique section of the gene as described in Section 4.6, with the sequence 
ligated into the RNAi vector p2T7TaBlue 
(http://trypanofan.path.cam.ac.uk/trypanofan/vector/).  Importantly, this region was 
carefully examined to ensure it would generate no cross-reaction with TbTor2.  One 
clone was generated that showed inducible knock down of the transcript, and this 
showed severe growth and morphological defects (Figure 5.13).   
 

















Figure 5.13.  Growth kinetics and morphological phenotype of bloodstream 
form cells depleted of TbTor1.  (A) The cells induced to perform RNAi against 
TbTor1 show an inhibition of growth even within 24 hours.  The S16 parental cell 
lines were included as a control.  (B) Images of cells 72 hours after induction of 
TbTor1 RNAi, showing phase contrast images and cells stained with DAPI to 
visualise the DNA.  After this length of induction of TbTor1 RNAi, the majority of 
cells were dead, and those that remained intact demonstrated a morphological 
phenotype consisting of multiple kinetoplasts, nuclei, flagella and enlarged vacuoles.  
Scale bar represents 15µM.  (C) Cell cycle configuration of TbTor1 depleted cells 
showed no G1 specific arrest.  Cells with abnormal configurations were not scored, 
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Depletion of TbTor1 in bloodstream form cells resulted in a severe growth 
phenotype, with cells showing a huge reduction in cell number when compared with 
parental or uninduced cell lines (Figure 5.13A).  In cells depleted for TbTor1, a 
number of cells with multiple flagella and aberrant numbers of nuclei and 
kinetoplasts were observed (Figure 5.13B).  The cells also showed enlarged vacuoles 
with the cells ‘rounding up’.  However, since my observation of these morphological 
phenotypes, a publication from another group showed that depletion of TbTor2 
resulted in cells that were enlarged, whilst knockdown of TbTor1 resulted in cell 
cycle arrest in G1, generating cells that were slightly smaller than wildtype 
(Barquilla et al., 2008).  However Figure 5.13C shows that no accumulation of cells 
with a 1K1N configuration is observed upon depletion of TbTor1 up to 72 hours 
after induction of RNAi.  For the purposes of kinetoplast and nucleus scoring, only 
cells with a normal configuration were counted to avoid skewing the results through 
the inclusion of aggregated dying cells.  However, after 48 hours, approximately 
10% of the population would generally be considered to be in an abnormal 
kinetoplast-nucleus configuration.  
 
In order to investigate the differences between my data and those of Barquilla et al 
(2008), the same sequence used by Barquilla et al (2008) to induce RNAi was used 
to generate another RNAi cell line.  Thus, the product amplified with the primers 
from that paper was inserted into p2T7TaBlue and transformed into single marker 
bloodstream form cells.  One clone with inducible knock down of the transcript was 
generated using this sequence.  Growth kinetic analysis of this TbTor1 RNAi cell 
lines showed a similar effect to that seen in the original TbTor1 depleted cell line 
(Figure 5.14).  Furthermore, the cellular morphology generated upon RNAi induction 
was the same using either RNAi construct. 
 
 








Figure 5.14.  Growth kinetics of bloodstream form cells depleted of TbTor1 using the 
RNAi construct designed by Barquilla et al (2008).  The growth kinetics of the clone 
generated to perform inducible RNAi using this construct do not have such an 
immediate growth defect, with RNAi-induced cells showing similar growth kinetics to 
the uninduced cell line after 24 hours.  However, by 48 hours the depleted cells 
demonstrated a much reduced growth rate.  In this experiment the parental S16 
cells appear to grow much more slowly than the transfected cell lines, but this is 
because these are an independent stock from the S16 line used earlier (Figure 
5.13). 
Hence, depletion of TbTor1 in bloodstream form cells, using either of the RNAi 
constructs, caused both growth and morphological phenotypes.  These phenotypic 
observations match closely those seen for TbTor2 knock down cell lines reported by 
Barquilla et al (2008), and were reproducible between the different constructs using 
different sections of the gene.  This is in clear contrast to the TbTor1 knock-down 
cell lines described by Barquilla et al (2008) using the same construct, which showed 
only a minor morphological phenotype of a slightly reduced cell volume and an 
accumulation in G1 (Barquilla et al., 2008). 
5.2.3.1 Confirmation of TbTor1 depletion in RNAi cell lines 
In order to confirm that the phenotypes observed in both RNAi cell lines were due to 
the depletion of TbTor1, a TbTor1 antibody (kindly supplied by Miguel Navarro) 




































Figure 5.15.  Western blot of TbTor1 depleted bloodstream form cell lines 48 
hours after induction of RNAi.  Both TbTor1 RNAi lines show depletion of TbTor1 
protein after 48 hours of RNAi.  Protein harvested from 3x106 cells was loaded into 
each lane and the amido black-stained membrane was used to confirm equal 
loading of samples.  
The Western blot in Figure 5.15 shows that both the induced TbTor1 cell lines were 
efficiently performing RNAi, as the protein had disappeared after 48 hours.  This 
confirmed that the phenotypes seen in both RNAi cell lines were the result of 
depletion of TbTor1.  It is concerning that Barquilla et al (2008) have conflicting 
phenotypes, particularly as the Western blots shown in their paper also confirm the 
depletion of TbTor1 and the same sequence was used to direct RNAi.  The extent of 
depletion between the cell lines generated by Barquilla has not been compared 
against those generated here, and thus the depletion efficiency could possibly 
account for the difference in phenotype. 
5.2.4 Rapamycin 
5.2.4.1 Treatment of T. brucei with rapamycin 
As human Tor1 is present in both the TORC1 and TORC2, it was possible that the 
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two pathways; one of which would be involved in cell cycle control and the other in 
cytoskeletal regulation.  Rapamycin is a selective inhibitor of the TORC1; 
presumably the conformational arrangement of Tor1 in TORC1 allows access to the 
rapamycin binding domain, whilst this is inaccessible when it is present in TORC2 
(Loewith et al., 2002).  Therefore, it was anticipated that rapamycin treatment would 
result in specific inhibition of just one pathway, most likely the TORC1 pathway 
involved in cell growth.  However, mapping alignments of the FRB domains of 
TbTor1 with those from other organisms showed the absence of one of the highly 
conserved serine residues (Figure 5.16), thus it was not certain whether 
trypanosomes would be sensitive to rapamycin.  This conserved serine residue is 
even present in the FRB domain of the Tor homologue in C. elegans which is 
insensitive to rapamycin, therefore the absence of this residue in T. brucei was 
predicted to indicate rapamycin insensitivity.  Interestingly, the Tor2 protein in T. 
brucei and its homologue in L. major have an alanine residue in place of the serine, 
which has been shown in mutational studies to still allow rapamycin binding (Chen 
et al., 1995, Zheng et al., 1995). 
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Preliminary analysis of the effect of rapamycin on trypanosomes had shown no effect 
using a maximum dose of 400nM, although the rapamycin in this case had been 
dissolved in DMSO.  However, the Barquilla et al (2008) study showed a dramatic 
growth and morphological phenotype using low concentrations of rapamycin (IC50 = 
152nM), thus the experiment was revisited.  For this experiment, a rapamycin 
titration was carried out on bloodstream form T. brucei using the same conditions as 
the Barquilla et al (2008) study: ie the drug was dissolved in ethanol and a range of 
concentrations from 10nM to 10µM was used.  Finally, the assay was allowed to 











Figure 5.17.  Growth kinetics of bloodstream form cells treated with 
rapamycin.  A slight growth inhibition of the cells was seen after 24 hours for the 
highest concentration of rapamycin.  By 48 hours the growth inhibition from 10µM 
rapamycin was more pronounced and the cells treated with 5µM rapamycin were 
also showing inhibited growth.  By 72 hours the growth inhibition at the 5µM dose 
was very much more apparent and there were slight differences from the lower 
doses in comparison with the drug solvent alone.  At the 72 hour time point the cells 
treated with 50nM rapamycin appeared to have a higher cell count than the control. 
Figure 5.17 shows that only the highest doses of rapamycin (≥5µM) showed any 
significant growth inhibitory effect of bloodstream form cells.  From these 
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experiments very little difference in cell number was seen below a rapamycin 
concentration of 5µM, in contrast to the data from Barquilla et al (2008), where 
significant inhibition was seen at concentrations of >100nM.  It cannot even be 
certain that such a high concentration of drug is physiologically relevant, as at such 
high doses non-specific effects are possible.  Interestingly, an increase in cell growth 
was seen in the cultures treated with 50nM rapamycin, which was a reproducible 
effect seen in every assay, this not becoming evident until 72 hours of treatment.  
The use of low doses of rapamycin has been seen to cause lifespan extension in 
yeasts and mammals (Powers et al., 2006, Harrison et al., 2009).  In yeast, rapamycin 
concentrations between 300pg/ml to 1ng/ml have been shown to increase lifespan via 
a transcription factor responsible for the specific regulation of stress-induced genes, 
Msn2 (Powers et al., 2006).  Msn2 is under the control of Tor and, in normal 
logarithmic growth, this protein is located in the cytoplasm, but upon depletion of 
Tor, Msn2 shuttles into the nucleus and induces transcription of a cohort of genes 
involved in stress response (Powers et al., 2006).  Using concentrations of rapamycin 
below 300pg/ml had no effect on the lifespan of yeast cells (Powers et al., 2006), 
which is similar to these results seen in T. brucei, where the 10nM dose did not 
appear to cause an increase the cell numbers.  Hence, this positive effect of low doses 
of rapamycin in T. brucei appears to be effective over a narrow concentration, similar 
to the effects on lifespan in yeast. 
 
To calculate the dose at which the rapamycin caused a growth reduction of 50% in 
bloodstream form cells in comparison to the drug vehicle alone, the cumulative cell 
numbers from the growth kinetic experiments (Figure 5.17) were calculated after 72 
hours of drug treatment and a non-linear regression curve fitted.     
 










Figure 5.18.  Dose-response curve of rapamycin on bloodstream form cells.   
The cumulative number of cells after 72 hours of growth was plotted as a 
percentage of the ethanol control.  The dose of rapamycin causing a 50% reduction 
in growth was determined as ~6.5µM. 
The dose required to cause a 50% inhibition of growth in comparison to control cells 
was estimated from the dose-response curve (Figure 5.18) and was approximately 
6.5µM, over 40 fold higher than that calculated by Barquilla et al (2008). 
5.2.4.2 Assessment of rapamycin activity 
The data presented here suggested that the sensitivity of T. brucei to rapamycin was 
much lower than that discovered by Barquilla et al (2008).  However, in order to 
ensure that the lack of rapamycin sensitivity shown by the cells in my assay was not 
due to low rapamycin activity, the drug sensitivity titration assay was repeated using 
different batches of the drug.  This always showed reproducible sensitivity at levels 
higher than reported by Barquilla et al (2008).  Furthermore, to validate the 
rapamycin sensitivity, its activity was tested against yeast cells.  Although 
convincing studies titrating the sensitivity of S. cerevisiae cells in response to 
rapamycin are not available, one study has shown that cells treated with 200nM 
rapamycin undergo condensation of the nuclear DNA within six hours, 
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demonstrating that this concentration of the drug was sufficient to show a 
physiological effect on the cells (Tsang et al., 2007).   
 
Therefore, overnight cultures of S. cerevisiae BY4741 were diluted to an optical 
density of 0.005 (measured using an Eppendorf BioPhotometer at wavelength 600nm 
(OD600)), into pre-warmed YPD medium and incubated at 30˚C until the OD600 
reached 0.01, such that the cells were considered to be in logarithmic growth.  Then 
3ml of the culture was placed into glass vials and rapamycin added to the cells to the 
following concentrations: untreated, ethanol only (drug vehicle), 10nM, 50nM, 
100nM, 500nM, 1µM and 10µM.  Importantly, these drug dilutions were aliquots of 
the same rapamycin batch used against trypanosomes in the assays described earlier.  
These cultures were incubated at 30˚C with shaking for eight hours, and OD600 
recorded every two hours.  In addition, to allow a longer time course experiment and 
to assess the kinetics of the drug action, 100µl samples of the drugged cultures were 
also loaded in triplicate into 96 well plates and their OD595 was recorded on a 
BioTek® Elx808 plate reader every hour for 12 hours. 
 

















Figure 5.19.  Growth kinetics of rapamycin treated S. cerevisiae.  The growth 
kinetics of S. cerevisiae liquid cultures treated with rapamycin were assessed 
through (A) analysis of 3ml cells grown in a shaking incubator with OD600 readings 
taken every two hours for eight hours.  Overnight cultures of cells were diluted to an 
OD600 of 0.005 and then monitored regularly until the OD600 reached 0.01 at which 
point the cultures were split into different vials and the drug added (arrow).  (B) 
Automated readings from a plate reader at OD595 taken hourly for 12 hours of the 
same cells grown in 96 well plates.  These cultures were taken at the time 0 point of 
Figure 5.19A, at the point at which the rapamycin was added.  Both methods show a 
minor growth perturbation when ethanol alone is added to the cultures, but a severe 
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Figure 5.19A shows that rapamycin was active against liquid cultures of S. cerevisiae 
even at the lowest dose of 10nM.  Figure 5.19B shows a longer time course 
experiment, although in this case the density of the cultures cannot be considered 
fully quantitative as the cells were grown in sealed wells with 100µl culture per well, 
such that the cells would not have had enough oxygen to grow optimally.  
Nonetheless, this figure is included as a qualitative indicator to allow comparisons 
between the treated and untreated cultures.  Figure 5.19A gives a more accurate 
measure of growth of the yeast cells in rapamycin containing media and shows that 
even 10nM of the drug causes cells to arrest in growth after four hours of treatment. 
 
The growth of yeast was also analysed on solid medium containing rapamycin.  
Thus, logarithmically growing liquid cultures of yeast were spotted onto YPD agar 
plates containing rapamycin.  Overnight cultures diluted to OD600 0.005 and 
allowed to reach OD600 0.01 were then serially diluted into sterile water and 10µl of 
each dilution was spotted onto plates, which were incubated at 30˚C for 48 hours. 
 










Figure 5.20.  S. cerevisiae shows high sensitivity to rapamycin.  Logarithmically 
growing cultures were subjected to 10-fold serial dilutions and spotted onto the YPD 
plates with either the drug vehicle (ethanol) or the indicated concentrations of 
rapamycin.  The cells were viable and form robust colonies on the ethanol plates but 
only extremely small cells can be seen in the undiluted spots for all other doses of 
rapamycin suggesting that the sensitivity of S. cerevisiae cells is well below 100nM.  
This result confirms that the rapamycin is active. 
The growth assay on the solid agar medium confirms the results seen in Figure 5.20, 
with 100nM rapamycin sufficient to severely inhibit cell growth.  Thus, both figures 
demonstrate that the rapamycin is active against yeast at very low concentrations, 
hence discounting the possibility that the lack of an effect of rapamycin on T. brucei 
was due to inactivity of the drug. 
5.2.5 Summary 
At least two homologues of Tor are present in the T. brucei genome.  Depletion of 
TbTor1 does not result in G1 arrest as is seen in some other organisms and in the 
Barquilla et al (2008) study, neither do the depleted cells have a smaller volume that 
wildtype cells.  Instead, the phenotype seen in the TbTor1 depleted cell line was very 
similar to that seen for the TbTor2 RNAi cell line created by Barquilla et al (2008), 
regardless of which region of the gene the RNAi effect was directed against.  Also in 
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show sensitivity to rapamycin within physiologically relevant concentrations.  The 
IC50 calculated by Barquilla et al (2008) was 152nM, whilst the results presented 
here show that rapamycin only starts to inhibit growth over 1µM, with the dose 
required for a 50% inhibition of cell growth approximately 6.5µM; over a 40 fold 
increase. The dose calculated here is much more similar to the EC50 of rapamycin in 
Leishmania major of 4.9µM (Madeira da Silva et al., 2009), which seems logical as 
the Leishmania ssp Tor homologues show high sequence identity to the TbTors.  Due 
to the rapid lethality of TbTor1 depletion in bloodstream form cells and their failure 
to accumulate in G1, it was not possible to determine if this protein is required 
during differentiation. 
 
The dramatic phenotype seen in bloodstream form cells depleted of TbTor1 was 
surprising considering that the mRNA expression levels were relatively low in this 
lifecycle stage.  Depletion of TbTor1 in procyclic form cells might be expected to 
show a more severe phenotype; however, another report shows a reduction in cell 
growth only initiating 72 hours after induction of RNA interference, associated with 
the appearance of cells with aberrant numbers of nuclei and kinetoplasts (Monnerat 
et al., 2009).  Thus, the phenotype seen in procyclic form cells depleted of TbTor 
shows no similarity to that seen by Barquilla et al (2008) when RNAi was conducted 
in bloodstream form cells, but was much more similar to the phenotype observed in 
the results shown here.  However, it was surprising that the growth phenotype was 
not seen until 72 hours after induction of RNAi considering that this gene was so 
highly expressed in this life cycle stage as detected by Northern blot (Figure 5.12).  
One explanation may be that the protein is more stable in procyclic form cells and 
thus the delay in growth phenotype extends from the increased time for turnover of 
the residual protein.  Alternatively, the efficiency of transcript depletion may have 
been less in the procyclic form study. 
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5.3 Cdh1 
5.3.1 Identification of TbCdh1 
In yeast, the APC/C interacting protein Cdh1 is responsible for G0 regulation, in 
addition to functions in the maintenance of G1 and the correct progression of S phase 
(Sigl et al., 2009, Brandeis and Hunt, 1996, Kitamura et al., 1998).  Thus, the T. 
brucei genome was searched for homologues, using the human Cdh1 protein as a 
template for a BLASTP query.  Tb927.8.6500 was identified as showing the highest 
levels of similarity, however this protein has previously been annotated as the T. 
brucei Cdc20 homologue (Kumar and Wang, 2005).  In order to determine whether 
Tb927.8.6500 was more similar to Cdh1 or Cdc20, the Homo sapiens Cdh1 or Cdc20 
were both aligned against Tb927.8.6500, which was found to show 33% identity to 
Cdc20 and 34% identity to Cdh1.  As the alignments did not identify definitively 
which protein Tb927.8.6500 was more similar to, a phylogenetic tree was generated 
using the Cdc20 and Cdh1 orthologues from a number of eukaryotes alongside 
Tb927.8.6500 to see in which branch it was situated.  All the Cdh1 and Cdc20 
protein sequences from Homo sapiens, Sus scrofa, Mus musculus, Gallus gallus, 
Xenopus, Drosophila melanogaster, Xenopus, Schizosaccharomyces pombe and 
Saccharomyces cerevisiae were downloaded from GeneDB or NCBI and aligned on 
Clustalx version 2.0.12 (Figure 5.22).  Pairwise alignments were created using 
parameters allowing a gap opening penalty of 10 and a gap extension penalty of 0.1 
to prevent the presence of too many gaps and thus reduce the possibility of false 
matches (Hall, 2001).  The multiple alignment parameters were set using the gap 
opening penalty of 15 and gap extension penalty of 0.3 and the delay divergent 
sequence was set to 25%.  These are the parameters recommended by in the ClustalX 
tutorial guide (Hall, 2001).  The alignments were uploaded into PAUP* and a 
phylogram was generated using the Neighbour Joining distance method. 
 














Figure 5.21.  Tree of Cdh1 and Cdc20 homologues.  Unrooted phylogram 
prepared in PAUP* of the Cdh1 and Cdc20 homologues from chicken, human, frog, 
pig, Drosophila, budding yeast and fission yeast and the putative Cdh1 homologue 
from T. brucei.  The Cdc20 orthologues from yeast do not fit well with any of the 
other sequences, although all sequences from all other organisms lie distinctly in 
either the Cdc20 clade or Cdh1 clade, with Tb927.8.6500 falling into the Cdh1 clade.  
However, this sequence is also the most similar of all organisms to the Cdc20 
orthologues in yeast, so it is difficult to make a firm declaration of which clade the T. 
brucei protein should be a member.  The scale bar represents 50 substitutions in the 
amino acid sequence. 
The phylogram in Figure 5.21 shows two distinct groups comprising the Cdh1 and 
Cdc20 proteins, with the Cdc20 homologues in S. cerevisiae and S. pombe forming a 
separate group within the Cdh1 clade, nearest to the Cdh1 homologues of yeast.  
Tb927.8.6500 falls into the Cdh1 clade, however it is still highly related to the two 
yeast Cdc20 homologues.  This is similar to a tree compiled by Sigrist and Lehner 
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(1997) containing the sequences of Cdh1 and Cdc20 from budding yeast, frog, pig, 
human and Drosophila, where both the Cdh1 and Cdc20 homologues from S. 
cerevisiae were present on the same branch.  Similarly, a tree showing the 
relationships between the Cdc20 and Cdh1 proteins in these organisms, in addition to 
an extensive number of plant species, also showed that S. pombe Cdc20 was highly 
divergent when compared to all other sequences (Tarayre et al., 2004).   
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Figure 5.22.  Clustalx alignment of Tb927.8.6500 with Cdh1 and Cdc20 
orthologues from other organisms.  The full length sequences of Cdh1 and 
Cdc20 proteins from yeast, Drosophila, Xenopus, chicken, mouse, human and pig 
aligned against Tb927.8.6500.  Motifs present in the Tb927.8.6500 protein 
sequence are labelled. 
The sequence of Tb927.8.6500 was analysed in detail to determine the conserved 
domains (Figure 5.22).  The Cdc20 and Cdh1 proteins have a number of shared and 
specific domains.  The shared domains include the seven WD40 domains, which are 
present in Tb927.8.6500 and a C box at the N terminal domain which is required by 
both proteins for binding the APC/C (Schwab et al., 2001).  Tb927.8.6500 has a 
fairly well conserved C box with the sequence DRFISDR, which correlates well with 
the consensus sequence of DR(F/Y)IPxR generated from the C boxes found in higher 
eukaryotes.  The position of the C box in Tb927.8.6500 is closer to the N terminus 
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than is seen in other proteins and is much more apparent than a C box in S. pombe.  
Cdh1 also has two destruction (D) boxes, with consensus sequence RxxLxxxxN 
upstream of the C box (Listovsky et al., 2004).  Nothing similar to the consensus 
sequence was found at this position in Tb927.8.6500 due to the close proximity of 
the C box to the N terminus, also no D boxes were found elsewhere in the sequence.  
In contrast, whilst the Cdc20 protein in S. cerevisiae also has two D boxes (Prinz et 
al., 1998), these are absent in mammalian Cdc20, which instead has a KEN box that 
is also recognised by Cdh1 for degradation (Pfleger and Kirschner, 2000).  A KEN 
motif was found in Tb927.8.6500 at position 55-57.  Thus even though the KEN 
motif in T. brucei is much closer to the N terminus than in mammalian Cdc20, in 
both organisms the KEN boxes are both positioned a similar distance away from the 
C box: 14 and 13 residues respectively, although in T. brucei the KEN box is 
downstream of the C box, whereas in mammals it is upstream.  Mammalian Cdc20 
also contains a CRY box, which also allows degradation through recognition by 
Cdh1 (Reis et al., 2006), however this motif is not present in Cdc20 homologues in 
yeast, and a CRY box was not identified in Tb927.8.6500.  Tb927.8.6500 differs 
from both human Cdh1 and Cdc20 in that the final two residues do not conform to 
the IR motif that is so conserved in other organisms, and is necessary in this 
organism for binding to the APC/C.  Rather, an LR motif, which is also seen in the S. 
pombe Cdc20, was present.  Another motif was discovered in plants, ~50 residues 
downstream of the C box that was present only in the Cdh1 homologues and not 
Cdc20 proteins.  The consensus sequence for this motif was generated from Cdh1 
proteins in eukaryotes as YxxLL(K/R)x(E/A)L(F/L)G, which was designated the 
CSM (Cdh1 specific motif) (Tarayre et al., 2004).  The CSM motif also appears to be 















WD40 7 7 7 7 
D box 2 0 0 0 
KEN box 0 0 1 1 
C box Yes Yes Yes Yes 
IR motif Yes Yes Yes No – LR motif 
CSM Yes Yes No No 
Table 5.1.  Conserved domains in Cdh1 or Cdc20.  Many of the domains 
associated with Cdh1 in other organisms were not conserved in Tb927.8.6500, 
however one motif specific to the Cdc20 proteins was found in Tb927.8.6500. 
Despite the presence of the KEN box and lack of a CSM motif, we shall cautiously 
consider Tb927.8.6500 to be TbCdh1.  This is based on the positioning of this 
protein with Cdh1 in the phylogenetic tree, the fact that the protein shows slightly 
more similarity to human Cdh1 than Cdc20 and the absence of a CRY motif. 
5.3.2 Expression profile of TbCdh1 
The mRNA levels of Cdh1 and Cdc20 in higher eukaryotes fluctuate throughout the 
cell cycle with both Cdh1 and Cdc20 transcripts highest in G2 cells (Fang et al., 
1998).  Likewise, the protein levels of Cdc20 parallel the mRNA profiles, however 
the profile of Cdh1 protein expression is controversial.  Some studies suggest that 
Cdh1 protein is constant throughout the cells cycle (Fang et al., 1998), and others 
report that the protein level also fluctuates with the mRNA level (Kramer et al., 
2000).  The reasons behind the variation between different groups is suggested to be 
due to the quality of antibody and the method of cell synchronisation used, which 
may be having direct or indirect effects on Cdh1 protein expression (Kramer et al., 
2000).  It would not be implausible that the Cdh1 protein would be much more stable 
throughout the cell cycle than Cdc20, as Cdh1 is largely regulated at the post- 
translational level through phosphorylation, whereas the Cdc20 protein is degraded 
by the APC/CCdh1 (Kramer et al., 1998).  In order to determine the mRNA levels in T. 
brucei, the expression profile of TbCdh1 as determined by the microarray was 
investigated (see Chapter 4), and validated using Northern blots using the same 
mRNA samples as used for the microarray (Figure 5.22B).  In addition, the 
expression profile was determined in another pleomorphic T. brucei brucei strain, T. 
brucei brucei EATRO 2340, contrasting the levels in slender, stumpy and procyclic 
form cells (Figure 5.22C). 
 
















Figure 5.23.  Expression profile of TbCdh1.  (A) Microarray profile of TbCdh1, 
showing transient elevation during differentiation with a marked increase from 
slender to stumpy, peaking at 18 hours before dropping at 48 hours.  (B) Northern 
analysis using RNA generated for the microarray (from a T. b. brucei AnTat1.1 cell 
line), shows elevation during differentiation, with the peak at 48 hours before 
decreasing in established procyclic forms.  (C) Northern analysis of slender and 
stumpy form T. b.brucei EATRO 2340 cells with established procyclic form cells 
shows the greatest expression is in stumpy forms with lower levels in slender form 
cells.  
The TbCdh1 transcript showed enrichment during differentiation on the microarray 
(Figure 5.23A), although this result was not quite so apparent looking at results from 
Northern membranes probed with a riboprobe against TbCdh1 (Figure 5.23B). 
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However, in that case, as can be seen from the rRNA levels in the ethidium bromide 
stained gel, the gel was unevenly loaded.  The expression profile of a second 
pleomorphic cell line, T. b .brucei EATRO 2340, showed a slight increase in 
transcript level in stumpy form cells when compared against slender and procyclic 
form cells (Figure 5.23C).  It is possible the increase in TbCdh1 in differentiating 
cells is because they are in G0 stage, as Cdh1 from other species is known to 
maintain the G0 state (Inbal et al., 1999).  Cdh1 also plays an important role in G1, 
and it would be expected that this transcript remained high in cells entering the first 
cell division following release from G0 arrest, but would be lower in asynchronously 
growing populations, which would fit well with the profile revealed by the 
microarray (Figure 5.23A).  However both Cdh1 and Cdc20 show peak expression 
levels at the end of G2 phase (Fang et al., 1998), which would fit with the maximal 
expression in the differentiation time course at 18 hours, as previous studies 
examining the cell cycle following differentiation shows that the G2/M phase would 
occur between 13-14 hours into the time course (Matthews and Gull, 1994).  These 
kinetics are in keeping with the cell cycle scoring analysis carried out, showing that 
2K1N cells appeared after 6 hours through differentiation (Figure 3.7).  Therefore, 
the 18 hour time point would be expected to have a higher proportion of cells 
towards to end of G2, than any other time point sampled.   
5.3.3 Depletion of TbCdh1 
TbCdh1 was depleted in bloodstream form monomorphic cells using the 
p2T7TAblue vector to express double stranded RNA of a unique sequence of the 
gene and thus induce the RNAi system.  Two clones were generated, both showing a 
growth phenotype with the induction of RNAi, although the non-induced cells also 
showed poorer growth than parental cells lines suggesting that dsRNA was being 
expressed at a low level (Figure 5.24A).  After 72 hours following induction of 
RNAi, the cells returned to normal growth kinetics – likely reflecting a selection for 
a minority of cells deficient in RNAi and hence able to outgrow the Cdh1 depleted 
population.  TbCdh1 depleted cells also showed gross morphological phenotypes 
with cells with multiple flagella, consistent with defects in cytokinesis (Figure 
5.24B).   
 















Figure 5.24.  Growth kinetics and morphological phenotype of TbCdh1 
depleted bloodstream form cell lines.  (A) Two clones with inducible knock down 
of TbCdh1 were generated and both showed impaired growth within the first 24 
hours after induction of RNAi.  After 72 hours these knock down cell lines appeared 
to recover, as RNAi deficient cells out competed the TbCdh1 depleted cells.  The 
growth rate of the uninduced cell lines was slower than the parental single marker 
cells probably due to leaky expression from the RNAi vector.  (B) Bloodstream form 
cell lines after 48 hours of TbCdh1 depletion.  Many cells showed aberrant numbers 
of kinetoplasts and nuclei. 
Depletion of TbCdh1 resulted in severe growth effects with cells failing to grow 
within the first 24 hours after the induction of TbCdh1 RNAi (Figure 5.24A).  The 
reason for the poor growth was high levels of cell death, with cells showing aberrant 
cell division to form cells with multiple nuclei, kinetoplasts and flagella (Figure 
5.23B) leading to death.  In other organisms Cdh1 is non-essential, and depletion of 
S16 uninduced  
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the protein leads to only minor cell cycle abnormalities, mostly altering the length of 
cell cycle phases ((Brandeis and Hunt, 1996, Floyd et al., 2008, Visintin et al., 1997, 
Yamaguchi et al., 2000).  Therefore, this result showing a clear essential role of 
TbCdh1 in T. brucei may mean this protein is more similar to Cdc20, which is an 
essential protein in other organisms, or it may be because T. brucei has only one 
APC/C co-activator and thus the role of this protein is much more wide-ranging that 
Cdh1 in other organisms.  Certainly, however, depletion of the protein did not cause 
a specific cell cycle arrest, thereby limiting its usefulness in analysis of G0/G1 
control in trypanosomes. 
5.3.4 Antibody 
In order to see whether the protein levels were also altered during differentiation and 
to find out the localisation of the protein in the cells, an antibody was raised against 
TbCdh1.  The N terminus was targeted, as the C terminus forms complex tertiary 
structures and thus might be harder to access.  A peptide sequence corresponding to 
amino acids 9-24 was synthesised and injected into two rabbits on four occasions, 
with a final bleed taken after 28 days by Eurogentec.  Although time constraints 
limited the analysis that could be carried out with this reagent, this will allow in 
depth analysis of TbCdh1 in the future. 
5.3.5 Summary 
It is difficult to definitively describe Tb927.8.6500 as either the homologue of Cdh1 
or Cdc20, although considering that it appears to be the sole activator homologue of 
APC/C, it is perhaps inadvisable to name it either, as the role it plays will almost 
certainly differ from that of either protein in other species.  Certainly this protein is 
essential in the bloodstream form parasite as depletion results in rapid lethality, 
rendering it difficult to assist in studies examining a potential role in G0 and 
differentiation. 
 
It might be that TbCdh1 has different degrons to those in other homologues, 
especially considering the sequences involved in targeting the mammalian APC/C 
coactivators for destruction differ significantly from those in yeast.  The seven 
APC/C subunit homologues found in T. brucei show sequence identity ranging from 
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14-25% with those in S. cerevisiae, with TbCdc27, the subunit that binds to the co-
activators, showing only 20% identity to the yeast homologue (Kumar and Wang, 
2005).  Thus, it is highly likely that the mechanism of binding might differ.  The 
expression profile of TbCdh1 can also not aid in distinguishing between Cdc20 and 
Cdh1, as high Cdc20 expression is observed in yeast arrested in G1with alpha mating 
factor, even though normal G1 the levels are quite low (Prinz et al., 1998), which 
may explain the high levels of mRNA seen in stumpy form cells. 
5.4 Chapter summary 
This chapter describes the approaches taken to examine G0 in T. brucei.  
Unfortunately, neither of the proteins identified as homologues to G0 regulator 
proteins in other species demonstrated a specific role in G0 control in trypanosomes.  
However, the divergent functions of these proteins from those seen in other 
organisms will prove interesting for further study from an evolutionary perspective.  
The method described for isolation of cell cycle specific populations was unable to 
create synchronised populations, and was not suitable for examination of G0 as it 
was not possible to distinguish between G0 and G1 populations.  Nevertheless, this 
technique will allow future investigation of cell cycle regulated proteins, and is 
particularly useful for examination of G1 enriched populations as no other method 
for isolation of this cell cycle stage currently exists. 
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6 – Discussion 
The aims of this PhD were to study the underlying genetic events occurring 
throughout differentiation from the stumpy form into the procyclic form and to 
analyse the role of G0 in the initiation of this process.  This was addressed in several 
ways using a whole-genome microarray, individual characterisation of two pathways 
involved in G0 in higher eukaryotes and through development of a method for 
isolating cells in specific cell cycle stages. 
6.1 Microarray validation 
The aim of the microarray was to analyse the expression profiles of genes through 
the differentiation process.  The main objective was to generate data that was 
amenable to statistical interrogation, and to that end five biological replicates were 
examined for each time point.  A consensus does not exist regarding which statistical 
methods are most appropriate for microarray validation, however it has been shown 
that applying different statistical analyses to microarray data can be performed and 
still give the same results (Minning et al., 2009).  Thus our choice of statistics for this 
analysis were not as important as the level of significance applied, and the statistical 
analysis of the data was deliberately stringent to reduce the possibility of false 
positive results.  Furthermore, extensive validation was also carried out to confirm 
the microarray data using a combination of methods including qPCR, Northern Blots 
and mass spectrometry, in addition to verification against the published literature 
(Chapter 4).  The combination of the stringency of the statistic threshold applied and 
the extent of the validation of the microarray data should overcome many of the 
shortcomings of the microarray slides.  Comparison of the data retrieved from the 
microarray against that published was generally very consistent; significantly the 
published literature historically has focussed on the most highly expressed 
transcripts, which might show better sensitivity on the microarray.   
 
Puzzlingly, a poor rate of correlation was found between the qPCR and the 
microarray, even though the same RNA samples were used for both assays (Figure 
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4.12).  In microarray studies, results gained from qPCR and microarrays often show 
disparate results, leading some researchers to reject qPCR as a method for microarray 
validation (Allison et al., 2006); however, superior methods of validation have not 
been suggested in its stead as no other method can recreate the extent of 
normalisation used in a microarray.  Other limitations in our ability to find 
correlation between the data generated from the microarray and qPCR and those 
generated from Northern Blots could be in part due to using oligo-dT primers to 
make the cDNA for the qPCRs and microarray, such that only mRNA, and not 
rRNA, was transcribed into cDNA.  The presence of rRNA in the Northern blots 
makes the results generated from this method of validation unrepresentational of the 
profiles based on poly A+ mRNA used for both the qPCR and microarrays.  One 
option to make Northern Blots more representative of microarrays would be to use 
the same probe as was used for the microarray, so that any cross-reactivity on the 
microarray would be duplicated on the Northern Blot (Kane et al., 2000).  It would 
also be possible to normalise the Northern data using a second probe against a 
transcript showing unchanging expression across the time points.  However the 
current, qualitative, system of processing Northern blots in our laboratory using film 
does not allow accurate quantification of signal, therefore a quantitative method for 
Northern blotting is required before such a control strategy is revealing.  
Alternatively, a spiked transcript could be used as a control, thus overcoming the 
problem of finding a suitable internal control showing a non-fluctuating profile, 
which had proved to be an obstacle for the qPCR experiments (Kane et al., 2000). 
 
Due to the different criteria for designing probes for microarrays, Northern Blots and 
qPCR, in our analyses, the probe used for the validation very rarely matched the 
probe that was used in the microarray.  This may have influenced the validation in 
multiple ways as, should these mRNAs be degraded over the course of 
differentiation, using a probe that bound closer to either the 3’ or 5’ end of the 
sequence would alter the probability of detecting it.  Such a factor might be an 
important issue for genes showing transient differentially regulated expression 
profiles, which was the case for a number of the transcripts used for validation of the 
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microarray, thus these transiently changing transcripts might be more prone to errors 
and were therefore not the best candidates for verification.  One factor that accounts 
for low correlation between qPCR and microarray results is a low p value of the 
differential regulation of a transcript, thus the best candidates for validation are those 
transcripts showing differentiation expression with a p value of p<0.0001 (Morey et 
al., 2006).  A better method for qPCR validation of these data, therefore, would have 
been to look at genes differentially expressed at a p value of p<0.0001 and only 
examined the comparisons with this high probability of significant differential 
expression.  Our method was instead to find genes where at least one comparison had 
a p value of p<0.05 and examine all time points for this transcript, even those where 
the difference in expression level did not reach this level of significance. 
6.1.1 Evaluation of performance of arrays 
The microarray slides used for the lifecycle analysis were the publicly available 
JCVI Trypanosoma brucei v3 arrays.  Most of the 70mer probes on the array are 
unique and will only bind to a single target, however some probes will cross-
hybridise with genes that are extremely homologous to the extent that a 100% unique 
target would be impossible to design.  
 
Tile arrays are sometimes viewed as more accurate since several different probes are 
designed for each gene and can be distributed across the slide, circumventing 
problems associated with varying locational hybridisation.  Shortly after the 
publication of the microarray data reported here, another paper was published 
describing the gene expression profiles of slender and stumpy form cells using a 
custom-made NimbleGen chip (Jensen et al., 2009).  This microarray comprised 
eight different 60mer targets per gene, present in triplicate, however the genes 
annotated as ‘hypothetical, unlikely’ on the database were not included on this array.  
There was a good amount of correlation between the two sets of data, and the 
transcripts showing divergent results between the arrays could have arisen due to 
strain specific differences or may have been the result of the different procedures for 
isolation of the parasites.  As the NimbleGen arrays are designed to such stringent 
criteria, no validation of the results was carried out for these experiments.  The two 
 
6- Discussion 191 
data sets will be useful for researchers to get information about a gene of interest in 
two different strains and at slightly different time points; our microarray examines 
the continuous process of differentiation from stumpy form cells whilst the Jensen 
study examines separate points in differentiation.  The different studies also included 
slightly different cohorts of transcripts; the ‘hypothetical unlikely’ genes were 
excluded from the NimbleGen array, yet are represented in our microarray, therefore 
our microarray provides information on an additional subset of the genome which 
might prove to be of great interest and biological relevance.  Similarly, the Jensen et 
al (2009) arrays included a number of genes encoded by the mitochondrial genome, 
thus the separate datasets are able to complement each other with the different data 
they provide.  
 
One point highlighted from the two studies is the extent to which differences in the 
experimental design between our microarray and that of Jensen et al (2009) could 
potentially skew the expression profiles seen, through the manner of parasite 
isolation.  The parasites used on the NimbleGen array were used for RNA extraction 
immediately after purification from blood, in contrast to the cells used in our arrays, 
which were allowed one hour to recover from the purification process, during which 
time a number of cellular processes could have become activated. 
 
A third microarray study published at the same time as both these studies also looked 
at the process of differentiation using the JCVI Trypanosoma brucei v3 arrays, but 
took the slightly different approach of studying the differentiation of cells in vitro 
(Queiroz et al., 2009).  Even if of pleomorphic origin, slender form cells in culture do 
not take on a clear stumpy morphology and thus the authors cultured the slender cells 
to a high density before inducing differentiation with cis aconitate (Queiroz et al., 
2009).  This study will be of use to other researchers who do not have access to true 
stumpy form cells, and then the results can be cross referenced against the two in 
vivo differentiated cells to compare the results in a more biologically relevant 
context.  Moreover this in vitro study seemed to suggest that slender cells progress 
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through a stumpy transition before differentiation to procyclic forms (Queiroz et al., 
2009).  This supports the notion that stumpy form cells are essential for transmission. 
6.1.2 Future genome-wide analyses 
Some of the most interesting and important features of differentiation may have been 
lost from our analysis because we concentrated on the differentiation associated with 
the stumpy to procyclic transition.  Indeed, there are likely to be many genes 
involved in the differentiation from slender cells, through intermediate stage and then 
into stumpy forms.  For example, genes that we have detected to ‘spike’ in stumpy 
and immediately decline in abundance, may have been already up-regulated in 
intermediate or early stumpy form.  Further, we may have entirely missed genes that 
were only transiently required for these early events.  It would benefit the 
examination of differentiation to be able to study the events leading up to cells 
becoming stumpy, but as yet the process of slender cells transforming into stumpy 
forms is ill defined.  Additionally, for microarray studies a homogenous population is 
beneficial (Ness, 2007), whereas slender cells are unlikely to proceed into stumpy 
form cells in a synchronous manner.  The problems associated with these 
heterogeneous populations were highlighted in the slender samples used for our 
microarrays, which showed far more variability than the uniform stumpy 
populations.  It would also be interesting to investigate whether the genes we have 
identified as showing up-regulation during differentiation, are also required for the 
differentiation events that occur during the metacyclic to slender transition, as these 
cells are also released from a G0 arrest (Shapiro et al., 1984), or whether these genes 
are unique for preparing the parasite for tsetse fly survival.  
 
Improvements in technology are occurring rapidly and even tile arrays are being 
surpassed by the newest deep sequencing methods.  One such methodology emerging 
as a successor of microarray technology is RNA-Seq, in which cDNA is fragmented 
and sequenced from one or both ends, resulting in a high coverage quantitative 
measurement of transcript abundance (Nagalakshmi et al., 2008).  This technology 
does not suffer the problem of cross hybridisation as microarrays do, thus very little 
background is present.  It is also a much more sensitive technology, so that it can be 
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used to identify transcripts present in low abundance such as those which are rapidly 
degraded (Nagalakshmi et al., 2008).  Experiments on yeast looking at expression 
profiles throughout meiosis have shown that RNA-Seq has advantages over 
microarrays in terms of identifying novel sequences including mitochondrial 
transcripts (Wilhelm et al., 2008), something that would be useful for T. brucei 
research as the microarrays publicly available do not contain mitochondrial gene 
probes. Microarray results can be biased based on where the probes target; if they lie 
towards the 3’ end, then transcripts that are degraded might be appear to be present at 
higher levels than in reality.  This problem is resolved using RNA-Seq studies, where 
it is possible to distinguish between full-length transcripts showing high expression 
and those in the process of being actively degraded, thereby defining the 
‘degradome’ (Lister et al., 2009). 
 
The use of long 70mer oligos in the microarrays is beneficial, as unique probes can 
be generated for transcripts that are similar; however it has been reported that only 
15 consecutive bases are required for cross hybridisation of transcripts showing over 
50% similarity when using 50mer oligo probes (Kane et al., 2000).  RNA-Seq is 
capable of distinguishing between much more similar transcripts than microarrays, 
which would be helpful for T. brucei as many genes in tandem repeats have coding 
regions too similar to allow discrimination on the microarray, such as the PAD array, 
where the probes on our array against PAD4 also had cross-reactivity with PAD6 and 
PAD8.  In general however, the extent of discrimination between highly similar 
transcripts on these 70mer arrays was good.  The three PGK genes show up to 94% 
sequence identity, and the probe for PGKB had 29 consecutive residues of identity 
with PGKC, however these three transcripts all showed distinct profiles on the 
microarray, therefore the stringency of the hybridisation conditions used were 
suitable for differential binding.  In the case of the PAD genes however, whilst the 
PAD4 probe showed 84% identity with PAD1 and 27 residues were consecutive, this 
transcript did not hybridise to the probe, yet the probe also showed 97% identity with 
PAD6 and 94% with PAD8 and cross reacted with both these transcripts.  
 
 
6- Discussion 194 
In an opinion paper, Duncan (2004) suggests that a better use of microarrays in the 
study of gene expression in kinetoplastids would be in the comparisons of the mRNA 
associated with the polyribosome, which will distinguish the transcripts being 
actively translated and will be a more accurate representation of the genes required 
under certain conditions (Duncan, 2004).  Such an approach has been attempted 
previously in T. brucei, but was unsuccessful due to poor recovery of pure 
polyribosome-associated mRNA (Brems et al., 2005).  The concept has been 
demonstrated in T. cruzi, where increased association of one stage regulated mRNA 
with the polyribosome has explained why the protein and mRNA levels of this gene 
were incongruent in two life cycle stages, demonstrating that association of mRNAs 
with ribosomes is an important mechanism of regulation in kinetoplastids (Nardelli et 
al., 2007).  Future experiments optimised to recover polyribosome associated mRNA 
in T. brucei will help to narrow down the genes important in different life cycle 
stages.   
 
Studies of the importance of the probe design in signal output have shown that the 
annealing temperature of probes is far more important for signal intensity than the 
length of the probe, particularly as it appears that only the final 40 nucleotides of the 
probe are able to perform hybridisation; the sequence closest to the slide surface are 
shielded from the cDNA (Wei et al., 2008).  This would suggest that a better method 
for probe design would be to design probes that have similar annealing temperatures, 
rather than similar lengths as was the criteria in the TIGR microarray.  However, 
other more complex attributes also alter binding efficiency, such as C/G content, 
therefore all probes would need similar percentage of C/G to avoid bias being 
generated by the strength of hybridisation (Wei et al., 2008).  Applying all these 
conditions when designing probes would be extremely time consuming and, in many 
cases, impossible.  Hence, the approach used in the JVCI microarrays, and the 
NimbleGen tiling arrays, are likely to represent the most appropriate for the platform 
used, although other technologies do not suffer from these constraints. 
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Other studies that would strengthen the knowledge of the developmental effects in T. 
brucei would be the investigation of the proteome of differentiating parasites.  Rather 
than a stand-alone data set, proteomic data would complement the transcriptome 
data, and would add another dimension of information about gene regulation.  A 
proteomic study of Leishmania infantum cells at different stages of their life-cycle 
identified a number of proteins with differential expression, and analysis of the 
transcript levels of these proteins using a microarray showed that the transcript 
regulation approximately mirrored that of the proteins.  However, the protein 
information not only showed the levels of expression but also provided data on the 
modifications of the proteins in the different life cycle stages and inherent bias from 
the over representation of highly expressed proteins was avoided through the use of 
prefractionated samples (McNicoll et al., 2006).  Nonetheless, proteomic studies are 
usually of lower sensitivity than transcriptome analysis, rendering most useful for 
only relatively abundant proteins. 
6.1.3 Oligo motif scoring 
The identification of a conserved hexamer with a positional bias in the 3’UTR of a 
significant cohort of stumpy-enriched genes will provide a very interesting avenue 
for further research.  The sequence of the motifs, TCTTAC and TTCTTA are not 
unusual as 3’UTR regulatory motifs, as RNA binding motifs are often AU rich 
(Haile and Papadopoulou, 2007), including those found in the COX subunits, PGKB 
and EP procyclin.  RNA binding proteins in T. brucei have been shown to be 
involved in regulation of gene expression, with the recently characterised DRBD3 
shown to bind to a conserved motif in transcripts that are up-regulated in procyclic 
form cells (Estevez, 2008).  A genome-wide search for potentially conserved cis 
acting RNA elements between T. brucei and L. braziliensis was recently conducted, 
which identified 21 potential regulatory elements in the 3’UTR of functionally 
related genes (Mao et al., 2009).  The hexamer from the stumpy-enriched genes was 
not identified in this study, but because the stumpy enriched genes do not share 
functional attributes this group would have been overlooked in the analysis.  The 
Mao (2009) study highlights the variety of conserved sequences in non-coding 
regions of the genome, and indeed in PGKC, six of the conserved sequences were 
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discovered in the 3’UTR suggesting that more than one sequence might be regulating 
the same gene, as we have also found for genes with copies of both SM1 and SM2. 
 
In order to understand the function of the identified conserved motifs, the 3’UTR, or 
regions of it, would conventionally be fused onto a reporter construct such as CAT or 
luciferase so that the role played by the 3’UTR in stability or translation could be 
examined.  Another essential experiment would be to identify the proteins that 
recognise these motifs.  Methods are available to isolate RNA binding proteins, such 
as the StretpoTag system, in which the motif of interest is fused onto a streptomycin-
binding sequence, which is used to attach the construct onto a streptomycin-coated 
column (Bachler et al., 1999).  RNA binding proteins are then isolated through 
separating cell extracts over the column and eluting those that bind to the motif 
through release of the streptomycin-binding sequence by washing with streptomycin 
(Bachler et al., 1999).  The method has been optimised to allow binding of proteins 
with low affinities for their targets, and the motif of interest can range up to 600nt, 
allowing an entire 3’UTR to be studied if necessary (Dangerfield et al., 2006).  
Estevez successfully used a similar method to identify the TbDRBD3 RNA binding 
protein, whereby all proteins interacting with the various regions of the 3’UTR of 
PGKB, were identified (Estevez, 2008).  However, in that case the selected protein 
was found to not regulate the target transcript, highlighting that target specificity 
remains a significant challenge. 
 
One caveat of using a such a ligand selection approach to identifying RNA binding 
proteins is that it is only suitable for proteins recognising primary motifs, 
additionally this methodology is conducted in vitro so might not show true biological 
associations.  Should the above method fail to identify the RNA binding protein 
recognising SM1 and SM2, an in vivo method could be considered.  A method for 
identifying the RNA binding proteins binding to UTRs has been developed for use in 
live cells, through generating a peptide nucleic acid (PNA) oligonucleotide designed 
to bind to regions of the 3’UTR of interest and associate with the RNA binding 
proteins also present nearby (Zielinski et al., 2006, Zeng et al., 2006).  The PNA 
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oligo contains a cell membrane-penetrating peptide to allow entry into the cells, and 
a photoactivatable amino acid adduct, which, when excited with UV, will induce 
cross linking of the surrounding proteins, thus linking the RNA and RNA binding 
protein with itself (Zeng et al., 2006).  The PNA oligo and its binding partners are 
then isolated using a strepavidin magnetic bead fused with the sense sequence of the 
oligo target and purified, before the proteins are separated on an SDS-PAGE gel and 
identified using mass spectrometry (Zielinski et al., 2006).  The problems of such an 
analysis include the expense of the reagents, particularly as oligos would preferably 
be designed for the analysis of both the SM motifs.    
6.1.4 Applications of the microarray to the field 
The microarray data generated here will provide researchers with a greater depth of 
knowledge of the expression profile of their gene of interest.  It will also highlight 
genes for further study that show regulated expression at stages distinct from the 
conventional cultured bloodstream and procyclic forms.  These genes which have 
been shown to be transiently up-regulated in stumpy forms hold potential as new 
stumpy markers in addition to PAD1 (Dean et al., 2009), and may provide 
information of transmission biology.  Targeting such genes for drug therapy is also 
an attractive option, as many of the genes up-regulated in stumpy forms are unique to 
kinetoplasts and thus would not incur any cross-reactivity with the host.  If such 
genes could be targeted to force slender form cells to differentiate into stumpy form 
cells, the parasite infection would arrest with a single VSG coat and could thus be 
cleared entirely by the immune response.  Should an inhibitory RNA binding protein 
be found that was responsible for the stage specific degradation of transcripts 
required only in the stumpy form, this would be an excellent possible target.  The 
next experiments to conduct based on the microarray data will be further analysis of 
the stumpy enriched genes and their biological functions, and investigation of the 
regulation potential of the SM1 and SM2 motifs. 
 
One of the transcripts found to be strongly up-regulated in stumpy form cells, a 
predicted chloride channel, was knocked down using RNAi in monomorphic cells, 
but no growth phenotype or differentiation effect was observed (Figure 4.14).  This 
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may be due to redundancy of the proteins, as this chloride channel has several related 
genes in the genome.  However it may be that the transcript depletion methods used 
thus far are not suitable for dissecting the true function of this gene in pleomorphic 
cells.  For example, depletion of  ZFK or TbMAP5 in pleomorphic cells resulted in 
rapid formation of stumpy form cells, but no effect was detected in monomorphic 
cells (Domenicali Pfister et al., 2006, Vassella et al., 2001).  Thus, follow up 
experiments should include conducting the RNAi experiment in pleomorphic cells, 
which has proved successful for a number of genes (Dean et al., 2009) (Szoor et al, 
submitted).  However, RNAi experiments cannot be conducted directly on stumpy 
form cells, as they are quiescent, therefore the RNAi would need to be induced in 
slender forms, which would then be left to transform into stumpy forms.  Another 
option will be the degron system that has been used successfully in Leishmania 
(Madeira da Silva et al., 2009), in which an unstable domain from FKBP12 is fused 
onto the protein of interest, and maintained in the presence of a rapamycin-based 
drug.  Release from the drug then allows destruction of the unstable domain, thus 
effectively depleting the protein  (Edwards and Wandless, 2007).  Further 
characterisation of the genes showing significantly increased expression in stumpy 
form cells must also be conducted through over expression of the wildtype proteins, 
or mutant protein, allowing investigations of their function by a dominant negative 
approach.      
 
At present there are no characterised markers of G0 in T. brucei, and only one 
recently discovered marker exists now for stumpy form cells (Dean et al., 2009). 
Previously the only markers to distinguish a stumpy form cell were morphology, 
mitochondrial activation and growth arrest.  The scarcity of knowledge relating to 
gene expression in quiescent cells and stumpy form cells means that whether the 
transcripts identified as being significantly up-regulated in stumpy form cells are 
later found to be transcripts specific for G0 maintenance rather than lifecycle stage 
specific, they will still be invaluable markers.  Markers for stumpy form cells will be 
potentially useful to dissect out differences between true stumpy form cells and 
stumpy-like cells that can be generated through treatment with drugs such as 
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troglitazone, the cysteine protease inhibitor Z-Phe-Ala-CHN2 and hydrolysis 
products of cAMP analogues (Denninger et al., 2007, Scory et al., 2007, Laxman et 
al., 2006).  With better markers, or markers that distinguish slender, intermediate, 
and stumpy cells, it would be possible to generate refined mathematical models to 
determine the kinetics of stumpy cell formation during a T. brucei infection (Fenn 
and Matthews, 2007, MacGregor and Matthews, 2008). 
6.2 Synchronisation of T. brucei 
The cell cycle enrichment method described in Chapter 5 will be a good alternative 
to current synchronisation techniques used in T. brucei which arrest the cell cycle 
progression through treatment of cultures with hydroxyurea, followed by release into 
fresh media, thereby allowing cells to continue replicating DNA.  Such ‘batch-
release’ approaches for whole culture synchronisation should be used with caution, 
as such severe disruption of the cell cycle is likely to have complicated follow-on 
effects on the released cells.  Studies on human cell lines synchronised through 
release from cell cycle block caused by drug treatment, have shown that the DNA 
content of the cells did not correlate with other features of cell cycle progression 
such as cell size and levels of cell cycle regulation proteins.  This suggested that the 
cell cycle arrest merely represented a superficial arrest of DNA synthesis (Urbani et 
al., 1995).  In consequence, an interpretation of the events occurring in such cells 
following release into fresh medium would be impossible, as the cells were in an 
abnormal cell cycle arrest. 
6.2.1 ‘Selective’ methods of synchronisation 
Instead of using chemicals to trigger cell-cycle checkpoints or arrest proliferation, 
‘selective’ methods to fractionate cells from the entire cell population on the basis of 
their cell cycle positions.  Several alternative methods of selective synchronisation 
exist.  In other organisms for example, cell sorting has been used to isolate 
populations in different cell cycle stages through fusing a fluorescent tag onto a 
known cell cycle regulated protein (Coquelle et al., 2006).  Theoretically several 
proteins could be tagged with markers fluorescing at different wavelengths allowing 
proteins specific to different cell cycle stages to be selected simultaneously in order 
to isolate pure populations.  At present very few cell cycle regulated proteins are 
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known in T. brucei, and those that are known generally show maximal expression in 
S phase cells (Archer et al., 2009).  Such experiments would require that extensive 
genetic manipulation would be needed to generate the tagged cell lines, potentially 
complicating the results and adding additional transfections into an experiment.  
Moreover, one concern when using cell cycle regulated genes as markers is that these 
genes may themselves be aberrantly regulated when cells are perturbed by batch-
release protocols (Cooper, 2004).  In addition, the same cell cycle markers may not 
be useful in bloodstream form and procyclic form cells, as these different life cycle 
stages can show different regulation of cell cycle proteins (Hammarton et al., 2003, 
Hammarton et al., 2004, Kumar and Wang, 2005, Janzen et al., 2006, Li and Wang, 
2006, Gourguechon and Wang, 2009).  Instead of a fluorescent marker fused to the 
protein, if antibodies exist against a cell cycle regulated protein, then this could be 
used to sort cells.  A candidate would be the histone variant H4K4, which is only 
present in its non-modified form in S phase immediately after it is produced, and 
antibodies have been developed that are able to distinguish this form from the 
acetylated form found throughout the remainder of the cell cycle (Siegel et al., 
2008b).  However, this approach can only be successful if the cells can be stained 
without requiring fixation so that viable populations can be recovered.  This is 
unlikely to be feasible for cell cycle regulated proteins, which are usually 
intracellular. 
 
The various selective methods of synchronisation described thus far have a range of 
benefits for analysis of cell cycle proteins.  However a superior method still would be 
the ‘baby machine’ endorsed by Cooper used for the production of cells 
synchronised on the basis of both cell cycle and age (Helmstetter et al., 2003).  This 
process allows the collection of the daughter cells from each cell division and is a 
more gentle process than FACS, which can stress cells due to shearing force and 
dilution in buffer solutions.  It is yet to be determined whether this would be possible 
for T. brucei, which require motion for division (Ralston et al., 2006, Monnerat et al., 
2009) and thus might be impeded if adhered to a filter.   
 
 
6- Discussion 201 
Another selective method for isolating populations in a certain cell cycle stage is 
elutriation, where cells are forced through filters via centrifugation, with the size of 
cell recovered dependent on the speed of the rotor, such that increasing the speed 
recovers larger cells.  Earlier methods for elutriation had the disadvantage that the 
process pushed cells into G0 arrest (Zickert et al., 1993), presumably through serum 
starvation, and thus the cells generated were not representative of cells going through 
a normal cell cycle progression.  Additionally, cells recovered following elutriation 
have shown abnormal levels of cyclin mRNAs (Mikulits et al., 1997).  Modification 
of the protocol has been shown to minimise the stresses on the cells, and these 
include returning cells into conditioned media following elutriation or for adherent 
cells, choosing the correct density of cells to allow rapid re-adherence to the culture 
vessel.  Nonetheless, even using these optimised conditions all recovered populations 
showed a 30 minute lag period before resuming proliferation (Mikulits et al., 1997).  
In addition, conditions must be optimised for each cell type, and the length of the 
centrifugation is never less than two hours (Mikulits et al., 1997).  Moreover, with 
these selective methods for isolating cell cycle specific populations, the sterility of all 
equipment is of paramount importance and contamination of the cultures is more of a 
possibility than with batch-release methods.  Probably, the best method of selection 
varies for each cell type, although it should be noted that elutriation is optimised for 
mammalian and yeast cells, all of which have a circular morphology, whereas 
trypanosomes, with a more elongated structure, might prove more difficult to 
separate according to cell size.  In addition, the process of elutriation subjects the 
cells to extreme stresses caused by the sustained centrifugation, whilst those 
experienced by the FACS sorted cells will be much lower, and the exposure to the 
laser has been shown to have no negative effect on cells (Siemann and Keng, 1986). 
 
One of the concerns about the Vybrant® DyeCycle™ Violet was that it might show 
cell cycle specific toxicity as has been seen with Hoescht staining, which shows 
exclusive toxicity to cells in S phase (Siemann and Keng, 1986).  This was not found 
to be the case with Vybrant® DyeCycle™ Violet staining of T. brucei bloodstream 
form cells (Chapter 5); however the dye did show a low level of toxicity to cells 
 
6- Discussion 202 
irrespective of cell cycle position, which could be reduced through limiting the time 
the cells were exposed to the dye and keeping the cultures cooled to below 20˚C.  
Using these conditions it was possible to recover around half of the cells initially 
stained and the recovered populations showed good motility post sorting and would 
therefore be amenable to further experimentation.  This synchronisation method was 
particularly suitable for isolating pure G1 populations, with a much poorer recovery 
of S phase cells; this sorting experiment was therefore limited to harvesting G0/G1 
and G2/M populations only, in order to recover as pure a population as possible.  
When more accurate knowledge of the levels of cell cycle associated proteins in T. 
brucei are known, it would be a worthwhile exercise to examine their levels in 
Vybrant® DyeCycle™ Violet synchronised cells to assess the extent, if any, of cell-
cycle perturbation during sorting. 
6.2.2 Applications of synchronising T. brucei cells 
Although little is known of cell cycle regulation in T. brucei, especially in 
bloodstream form cells, many of the mechanisms discovered differ significantly from 
those in higher eukaryotes.  A method for selecting cells in specific cell cycle stages 
will allow the study of the levels of expression of genes in different cell stages and 
allow comparisons between those seen in bloodstream form and procyclic form. 
Synchronised populations could be used in microarray, or other whole-genome 
studies in the future, to determine the cell cycle regulated transcripts.  It remains to 
be determined whether the Vybrant® DyeCycle™ Violet method of cell cycle 
specific enrichment will be suitable for use in sorting pleomorphic bloodstream form 
cells, which may prove more sensitive to the physical strains of the sorting process 
than the culture-adapted monomorphic cells used for these analyses. 
6.3 Target of rapamycin 
The repertoire of protein kinases has been detailed for T. brucei, T. cruzi and L. 
major (the TriTryps) and has been shown to differ from that of higher eukaryotes 
(Parsons et al., 2005).  Thus the unusually high number of Tor homologues in the T. 
brucei genome is not so unexpected; Barquilla et al identified four Tor homologues 
in the T. brucei genome (Barquilla et al., 2008).  However, from the absence of a 
rapamycin binding domain from Tor-like 2, this final member of the Tor family is 
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more likely to represent a PIKK member rather than a Tor.  There are no homologues 
in the genomes of the TriTryps or Plasmodium species of the normal eukaryotic 
tyrosine kinases, although certain atypical tyrosine kinases are present, and it is 
likely that kinases with activity against more than one residue are responsible for the 
tyrosine phosphorylation occurring in these kinetoplastids (Parsons et al., 2005) 
(Fenn and Matthews, 2007).  Tor proteins show phosphorylational activity against 
both serine and threonine residues and the functions of the Tor-like proteins will be 
interesting to study as these appear to be unique to trypanosomes.  
6.3.1 TbTor1 
Tor has been shown to act in regulation of G1 arrest when in the TORC1 complex in 
a wide range of organisms.  Depletion of TbTor1 using RNA interference caused a 
severe growth phenotype in bloodstream form cells, as cells depleted of TbTor1 
showed significantly reduced cell growth compared with wildtype cells (Figure 
5.13).  These cells also showed dramatic morphological phenotypes with the 
appearance of cells with multiple nuclei, kinetoplasts and flagella suggesting that the 
cell cycle has been impaired in these cells.  These results conflict with the results of 
Barquilla et al (2008), who detected these phenotypes in TbTor2 depleted cells, but 
found that TbTor1 depletion resulted in a slight decrease in cell volume and cell 
cycle arrest.  In my analysis, the same growth and morphological phenotype also was 
observed in TbTor1 depleted cells in cell lines transfected using the same sequence 
to induce RNAi as was used in the Barquilla et al (2008) paper. 
6.3.2 Rapamycin sensitivity in T. brucei 
Bio-informatic analysis of the rapamycin binding domains of the TbTor proteins 
highlighted the lack of conserved residues in TbTor1, regarded as essential for 
rapamycin interaction in other organisms (Chen et al., 1995).  The FRB domain of 
TbTor2 has an alanine at the site of the conserved serine residue, which has been 
shown to still allow rapamycin binding (Chen et al., 1995, Zheng et al., 1995).  
Nonetheless, initial treatments of bloodstream form cultures with rapamycin up to 
400nM showed no effect on growth rate in contrast to what might be expected, since 
the drug triggers G1 arrest in all sensitive organisms.  Following the publication of 
the rapamycin sensitivity of the same T. brucei cell line (Barquilla et al., 2008), the 
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experimental conditions used in the paper were used to reassess sensitivity in our 
laboratory.  Whilst a growth inhibitory effect was observed, this was not until 
micromolar levels of the drug were used (Figure 5.18), in contrast to Barquilla et al 
(2008) where the dose required to cause a 50% inhibition of cell growth was 
calculated as 152nM (Barquilla et al., 2008).  The possibility that the lack of 
sensitivity to rapamycin in our laboratory was due to low activity of the drug was 
ruled out, as a titration of the same aliquots of rapamycin were used against S. 
cerevisiae both in liquid culture and on agar plates containing the drug (Figures 5.19 
and 5.20).  Both experiments showed that yeast cells were highly sensitive to doses 
of rapamycin as low as 10nM, confirming that inactivity of the rapamycin in our 
experiments was not the reason for the discrepancies between the levels of sensitivity 
seen.  The EC50 calculated from the experiments presented here was similar to that 
seen in Leishmania major (Madeira da Silva et al., 2009), which is consistent with 
the FRB domain of a Tor homologue in L. major showing strong similarity to 
TbTor2.  It is not certain, however, whether the growth phenotypes observed with the 
high doses of rapamycin were due to a specific effect from inactivating a TORC 
complex or whether they were a non-specific effect resulting from using such high 
concentrations of the drug.   
 
The low sensitivity of T. brucei to rapamycin does not make rapamycin a good 
candidate for drug therapy to cure human African trypanosomiasis as was suggested 
by Barquilla et al 2008.  This drug is prescribed for the treatment of certain tumours 
as it prevents proliferation of the cancerous cells and also for transplant patients, 
since it prevents the proliferation of cells of the immune system and thus prevents 
immune rejection (Ballou and Lin, 2008).  For transplant patients, the rapamycin 
concentration in the blood must be maintained between 12-20µg/ml (equivalent to a 
maximum of 21.9nM) (Committee, 2009), and our experiments show that the 
growth of half the parasites is inhibited at 6.5µM.  Hence, the concentration of 
rapamycin necessary to clear a trypanosome infection would be sufficient to also 
inhibit the immune system.  This would be an unfavourable side effect in 
trypanosomiasis patients, who largely live in poor areas in sub-Saharan Africa and 
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are exposed to numerous pathogens.  However, TbTor1 could still provide a good 
drug target as depletion of the protein causes cell death, and the difference between 
TbTor1 and mammalian Tor would suggest that drugs targeting TbTor1 would not 
cross-react with the host’s Tor pathway. 
 
A reproducible observation during the rapamycin titration assays was the increase in 
cell number of the cultures treated with 50nM rapamycin after 72 hours (Figure 
5.17).  This discovery suggested that rapamycin was directly targeting TbTor1, 
therefore the growth defects seen at high concentrations of the drug probably do 
result from specific inhibition of a Tor protein.  The growth benefit only becomes 
visible in the saw-tooth graph rather than the dose-response curve, because the 
increase only occurs after 72 hours and thus is not observed when the data are 
presented according the cumulative cell number.  In the Barquilla et al (2008) study, 
the growth of rapamycin treated cells was displayed only as cumulative data, so it is 
unknown whether a similar phenomenon was detected in their experiments.  
However, the authors did report an increase in cell numbers in the early stages of 
TbTor1 depletion, prior to their growth arrest, suggesting that depletion of TbTor1 
renders cells more resistant to stress (Barquilla and Navarro, 2009a).  Similar results 
have been seen in other organisms, including vertebrates, where treatment of mice 
with low doses of rapamycin leads to increased lifespan (Harrison et al., 2009).  
Additionally in C. elegans, which is resistant to rapamycin, and in Drosophila, 
depletion of Tor leads to an increase in lifespan (Vellai et al., 2003, Kapahi et al., 
2004).  Experiments examining the effect of Tor depletion in budding yeast, through 
a combination of methods, showed that treatment with doses of rapamycin between 
300pg/ml and 1ng/ml increased the lifespan of non-proliferating cells and that the 
addition of the drug caused the transcription factor Msn2 to relocate into the nucleus 
(Powers et al., 2006).  This transcription factor is specific for genes involved in the 
stress response, and the rapamycin-treated cells also showed increased resistance to 
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However, autophagy is also implicated in the increased survival of rapamycin-treated 
cells (Diaz-Troya et al., 2008).  TORC1 is known to regulate the phosphorylation of 
the autophagy related gene ATG13 in yeast, and when this protein is in its 
phosphorylated state, it is unable to associate with the other autophagy related 
protein ATG1, thus preventing the formation of an active complex that leads to 
autophagy (Chang and Neufeld, 2009).  Treatment with rapamycin, or depriving cells 
of essential amino acids, inactivates TORC1 allowing ATG13 to associate with 
ATG1 and thus activate autophagy (Chang and Neufeld, 2009).  Tor inactivation 
(through either nitrogen depletion or treatment with rapamycin) also results in the 
translocation of Gln3 to the nucleus where it specifically transcribes genes required 
for autophagy (Chan et al., 2001).  TbTor1 has already been implicated to play a role 
in autophagy as double-membraned structures corresponding to those seen in 
autophagy in other organisms are seen upon depletion of TbTor1.  The authors 
claimed it was impossible to infer the role of autophagy in these phenotypes due to a 
lack autophagy markers for T. brucei, although double-membraned detected in 
TbTor1 depleted cells certainly implied that autophagy was occurring (Barquilla et 
al., 2008, Barquilla and Navarro, 2009a).  Whilst bloodstream form T. brucei cells 
depleted of TbTor1 appear to show enhanced resistance to the stresses caused by 
growing the cells in media leached of nutrients, depletion of TbTor1 rapidly leads to 
growth arrest and thus it is not possible to ascribe this stress resistance to TbTor1 
(Barquilla et al., 2008).   
 
Another morphological marker of autophagy in T. brucei is the co-localisation of 
glycosomes into the lysosomes, a phenomenon that occurs during differentiation, 
demonstrating that pexophagy (autophagy of glycosomes) is occurring, thus this 
phenotype could also be examined in the TbTor1 depleted cells.  Certainly, no 
molecular assays are available to quantify autophagy in T. brucei; ATG8 is used as a 
marker in a number of other species, where immunofluorescence using an antibody 
directed against this protein reveals punctate staining of autophagic vesicles at the 
initiation of autophagy (Chang and Neufeld, 2009).  However, even though an ATG8 
homologue exists in T. brucei, such a punctate pattern is not seen under conditions 
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inducing autophagy (Barquilla and Navarro, 2009a).  Nonetheless, in a bio-
informatic search, out of 40 yeast proteins involved in autophagy queried, 20 
homologues were found in the T. brucei genome (Herman et al., 2006), therefore it 
should be possible to discover a genetic marker for autophagy.  
 
In Drosophila, Tor directly regulates the ATG1/ATG13 complex through 
phosphorylation (Chang and Neufeld, 2009), yet there is no clear homologue of 
ATG1 or ATG13 in the T. brucei genome (Herman et al., 2006).  Similarly, an 
alternative mechanism of Tor-dependent autophagy regulation in higher eukaryotes, 
through the induction of a transcription factor to specifically transcribe autophagy 
related genes, is unlikely to show conservation in T. brucei due to the polycistronic 
nature of transcription.  Therefore, if autophagy is under TbTor1 regulation, it is 
conducted through a novel process.  
6.3.3 Future directions 
It was not possible to determine the reason for the differences seen between the 
effects of rapamycin presented here and those observed by Barquilla et al (2008), 
moreover as the same supplier of the rapamycin was used and the same solvent used 
to dissolve the drug in both studies.  Also inexplicable are the differences in 
phenotype seen between the two studies in relationship to TbTor1 depletion, again 
peculiar as one of the clones generated used the same sequence for RNAi as was 
used in the Barquilla et al (2008) study.  The results showing the poor response of T. 
brucei to rapamycin was consistently observed between batches of the drug, using 
both ethanol and DMSO as the solvent, and the high sensitivity of the S. cerevisiae 
positive control confirms that the rapamycin used for the T. brucei titration was 
active.   
 
From the perspective of this PhD, based on the results I have generated, it seems that 
depletion of TbTor1 does not cause a specific G1 arrest, limiting the possibility that 
this protein would direct the cell cycle arrest required for stumpy cell formation.  
Further study of the TbTor pathway would be of great interest to fields beyond 
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parasitology due to the unique feature of at least three Tor homologues in T. brucei 
and possibly also in Leishmania.  The early branching of trypanosomes from the 
other organisms that have characterised Tor pathways will allow interrogations into 
the evolution of these pathways, however the exact roles of the TbTors must first be 
confirmed. 
 
Very little is known about autophagy in T. brucei, or indeed to what extent this 
process occurs, as the parasite appears to contain only a subset of the autophagy 
genes present in other species (Herman et al., 2006).  Tor plays a major regulatory 
role in autophagy in a diverse array of organisms and so knowledge of the Tor 
pathway in T. brucei may allow greater investigation of the autophagy pathway in 
this organism.   
6.4 Cdh1 
It has proved difficult to designate Tb927.8.6500 as either the homologue of Cdc20 
or Cdh1, however the most interesting result from the analysis of APC/C coactivators 
was that there were no other suitable candidates for either protein in the rest of the 
genome, so either there is only the one activator of APC/C in T. brucei, or the other 
activators are evolutionarily very different.  This is in contrast to the situation seen in 
a number of other organisms, which, in addition to having two APC/C coactivators 
for regulation of the mitotic cell cycle, also have more than one isoform of Cdh1.  
Examples include mammalian Cdh1, which is active in two alternatively spliced 
isoforms, showing differential expression between tissues and different localisation 
within cells (Zhou et al., 2003b).  Furthermore, four Cdh1 homologues are present in 
the chicken genome with non-overlapping functions (Wan and Kirschner, 2001) and 
two Cdh1 isoforms are present in plants, although only one is capable of binding to 
the APC/C (Tarayre et al., 2004).  The sequence of TbCdh1 is intriguing in having 
some Cdc20 specific domains, but not others.  It is possible that the KEN box in 
TbCdh1 is sufficient for degradation and thus no other motifs, such as a CRY box, 
are required.  Alternatively, TbCdh1 may have other sequences that recruit proteins 
to degrade it; deletion studies will be able to address these questions. 
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Depletion of TbCdh1 is lethal in bloodstream form cells as cells lose coordination of 
the cell cycle, resulting in cells with aberrant numbers of nuclei, kinetoplasts and 
flagella (Section 5.7).  This phenotype suggests that TbCdh1 plays an important role 
in cell cycle regulation and shows more similarity to the results of Cdc20 depletion, 
rather than Cdh1 depletion, in higher eukaryotes.  In yeast and mammals Cdh1 is not 
required for survival, however cells depleted of Cdh1 are unable to perform G1 arrest 
in response to the normal triggers of G1 arrest such as nutrient starvation or 
treatment with mating pheromone for yeast cells (Kitamura et al., 1998).  It is 
possible that the severity of depletion of TbCdh1 occurs because it is the only 
activator of APC/C, and thus it has more diverse functions than the homologue in 
other organisms and could be required for other points in the cell cycle.   
 
Knowledge of the role of TbCdh1 in regulation of the cell cycle is essential to 
understand more about the APC/C in T. brucei, and now that an antibody has been 
designed against this protein, the proteins that interact with it can be identified.  
Using an antibody against TbCdh1 for pull-down assays will rapidly allow the 
discovery of the proteins that are required for entry and exit of certain cell cycle 
stages.  Further study of TbAPC/C might give more insight into cell cycle regulation 
if the proteins that interact with it during the different cell cycle stages can be 
identified.  The role of TbCdh1 in differentiation also needs to be investigated and 
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Appendix A – Primer sequences 











Tb927.7.7160 AGGCATCCATCGAGTACAGC TATCCTTCCGCAACACCTTC 98.2% 
Tb10.6k15.3640 ACGGCCTCGTTGATACACTC CAACATTCCACCGACCATC 100.4% 
Tb927.3.2710 GCAAGTCCATCACACAGGAG GAAGAGGCTACGGACACACC 95.3% 
Tb927.1.4450 AGCAGCAGGTTATGGTGGAG ATACAACGATTCCGGTGAGC 91.3% 
















































Tb09.160.2110 ATGCTAACAACGGCGAAGG CTCTCGGCTAATCACATCAGG 92.5% 
 
 
Appendix  234 
Cloning primers 
 
Experiment Primer name Sequence 
Tor_F  ccggatccgCTACTCAACCTGTCGGAGC   RNAi TbTor1 
Tor_R ccctcgagACTGCCTCCACATTTCCAAC 
Tor_Barquilla F ggatccCGGATTGTTGCGGTGAAAAC RNAi TbTor1 
(Barquilla 2008) 
Tor_Barquilla R ctcgagATGCTTTATGCTTGCCTTCC 
Tor_B_F ccggatccgGTCGGACTTCGTTCAAGAGC RNAi TbTor2 
Tor_B_R ccctcgagAAACCAACCGTGTCCTTCAG 
Tor2_Barquilla F ggatccTACGATGCGCGGAAAGTGGAGG RNAi TbTor2 
(Barquilla 2008) 
Tor2_Barquilla R ctcgagAGTCTACCGTTTTCTTCCTGTT 
Tb10.26.0220 F ACAGTGATCCCCGTTACTGC RNAi 
Tb10.26.0220 
Tb10.26.0220 R TTGTGCCACCCACAAAACTA 
Chd1 F ACTCGCTGGGTGTGGTATTC RNAi Cdh1 
Cdh1 R CAAACCACACACACTTTGCC 
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Appendix B - Solutions 
YPD 
Bacto-yeast extract    1% w/v 
Bacto-peptone     2% w/v 
Dextrose     2% w/v 
Autoclave.   
For plates, 2% agar was added to the medium prior to autoclaving, and plates were stored at 4˚C. 
Northern blot solutions 
[10x] MOPS 
MOPS 46.26 g/l 
Sodium-Acetate (pH 7.0) 50 mM 
EDTA 10 mM 
Autoclave.  Solution stored in the dark at 4 °C.   
RNA Gel Loading Buffer 
Formamide 30 % 
Formaldehyde 6.1 % 
Bromophenol blue 0.01 % 
MOPS 1 × 
glycerol 10 % 
Maleic Acid Buffer 
Maleic acid 100mM 
NaCl 150mM 
pH7.5 with NaOH, autoclaved  
10% Block Solution  
Blocking reagent 10 % (w/v) 
Maleic Acid Buffer 1 × 
Wash Buffer 
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Maleic Acid Buffer 1 × 
Tween 20 0.3 % 
Detection Buffer  
Tris-HCl 100 mM 
NaCl 100 mM 
pH 9.5  
Western blot solutions 
[10x] Running Buffer 
Tris-HCl, pH8.3 0.25 M 
Glycine 1.92 M 
SDS 1% 
Laemmli Sample Buffer 
Tris-HCl, pH6.8 62.5 mM 
SDS 2 % 
Glycerol 10 % 
Bromophenol blue 20 µg 
[10x] Blot Transfer Buffer Stock 
 Tris (do not pH) 0.025 M 
Glycine  0.15 M  
1×  Completed Transfer Buffer 
SDS 0.2 % 
[10x] Transfer Buffer Stock 10 %  
Methanol 20 % 
Ponceau Stain  
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DAPI working stock 
4',6-diamidino-2-phenylindole (DAPI) 10 µg ml-1 
MOWIOL Mounting Medium 
Glycerol 25 % w/v 
MOWIOL 10 % w/v 
Tris pH8.5 0.1 M 
MOWIOL dissolved through incubation at 50˚C with regular stirring.  Clarified by centrifuging 
at 5000xg for 15 minutes.  Aliquots were stored at -20°C. 
Phosphate Buffer Solution (PBS) 
NaCl 137 mM 
KCl 3 mM 
Na2HPO4 16 mM 
KH2PO4 3 mM 
pH7.6  
Small scale plasmid preparation solutions 
Solution I  
glucose 50 mM 
EDTA 10 mM 
Tris-HC1 (pH 8.0) 25 mM 
Solution II  
NaOH 0.2 M 
Sodium dodecyl sulfate (SDS). 1% 
Solution III  
Potassium acetate 3 M 
Glacial acetic acid 8.7% 
pH 5.2  
 
TAE 1×   
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Tris-Acetate 40 mM 




NaCl      132mM 
KCl      8mM 
Na2HPO4     8mM 
KH2PO4      1.5mM 
MgOAC.4H20     0.5mM 
CaOAc/Cl2     90µM 
Glucose      0.5% 
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Appendix D - Publications 
Two publications have so far been generated from the work presented in this thesis.    
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KABANI, S., FENN, K., ROSS, A., IVENS, A., SMITH, T. K., GHAZAL, P. &  
MATTHEWS, K. (2009) Genome-wide expression profiling of in vivo-derived  
 bloodstream parasite stages and dynamic analysis of mRNA alterations during  
 synchronous differentiation in Trypanosoma brucei. BMC Genomics 10(1):  
 427.  
  
KABANI, S., WATERFALL, M. & MATTHEWS, K. R. (2009) Cell-cycle   
synchronisation of bloodstream forms of Trypanosoma brucei using   
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